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ABSTRACT
Chapter 1 begins with a review of the current literature on cross-coupling methods to
generate a-arylcarbonyl compounds, with a special emphasis on asymmetric arylations.
The second section of chapter 1 describes the development of an asymmetric Negishi
arylation of a-bromoketones using a nickel/pybox catalyst. The third section details the
development of a Suzuki arylation of a-bromo- and a-chloroamides using aryl-(9-BBN)
reagents. Both of these cross-coupling procedures are stereoconvergent, as they
convert the racemic starting electrophile to an enantioenriched product.
Chapter 2 describes new studies into the chemistry of boratabenzene-containing
transition-metal complexes. In particular, a new method for preparing complexes
bearing a diphenylphosphidoboratabenzene ligand is disclosed, starting from a
transition metal-diphenylphosphide and a boracycle, which is an intermediate in the
synthetic route previously used in the preparation of these complexes. In addition, the
preparation and characterization of a new, tri-ortho-substituted variant of potassium
diphenylphosphidoboratabenzene is described. This new species is used as a ligand in
an iron complex, which is characterized. In addition, preliminary studies towards the
synthesis of palladium complex bearing this new ligand are disclosed.
Thesis Supervisor: Gregory C. Fu
Title: Firmenich Professor of Chemistry
Preface
Portions of this thesis have appeared in the previous publications:
"Catalytic Asymmetric Cross-Couplings of Racemic a-Bromoketones with Arylzinc
Reagents"
Lundin, P. M.; Esquivias, J.; Fu, G. C. Angew. Chem., Int. Ed. 2009, 48, 154-156.
"Asymmetric Suzuki Cross-Couplings of Activated Secondary Alkyl Electrophiles:
Arylations of Racemic o-Chloroamides"
Lundin, P. M.; Fu, G. C. J. Am. Chem. Soc. 2010, 132, 11027-11029.
Acknowledgments
There are many people whom I wish to thank for their encouragement and support in my
pursuit of my PhD degree.
First, many thanks to Greg. I am very fortunate to have had the opportunity to work in your
lab on interesting projects and to be surrounded by other people doing great chemistry. I don't think
I could have picked a lab better suited for my goals for graduate school, and for that I am grateful.
Your scientific integrity and dedication to the research in our lab is great model to aspire to as a
researcher. Furthermore, I appreciate your willingness to make time for me whenever I've need to
chat about my projects or my career goals and everything in between. I've usually walked out of
your office feeling better than when I walked in, and I feel fortunate to have had a research advisor
who has taken the word "advisor" to heart.
Second, I would like to thank Prof. Maurice Brookhart, my undergraduate research advisor.
His belief in me and what I could achieve was something that I held onto during my graduate career,
especially when I was having doubts. Undoubtedly, his invitation to talk about his research group
was a pivotal moment in my undergraduate career. Little did I know what a great group I was being
invited to join. Another pivotal moment was when he told me that I needed to go to the best
graduate school possible. If we had not had that conversation, I would never have considered
applying to MIT. On my visits home to NC, his door is always open and he's always had plenty of
encouraging words. Without a doubt, I lucked out in starting my research career under his guidance.
I've benefited from the tutelage of many great mentors over the years. In Brook's lab,
Alison Cartwright Sykes had so much patience with me, and was always willing to take time to fix a
glovebox that was wigging out, go over NMR spectra with me, help me find potential subjects for
class projects-- really anything that would crop up. Amy Roy MacArthur was also always willing to
answer my questions with an infinite amount of patience.
At MIT, I was fortunate to be paired up with the great Francisco Gonzilez-Bobes who
unselfishly allowed me to take over his project, and who patiently helped me with my conversion
from inorganic to organic chemist. Even after he had moved on, he was always ready to offer
advice and insight. Plus he was just a lot of fun to be around.
Thanks to Jorge Esquivias, from whom I took over the Negishi project. His organization
really made that transition to the project much easier than it could have been, and I appreciate his
continued enthusiasm and support after he had left.
Luis Arizpe and John Anderson deserve a shout-out for being such great collaborators on
DPB chemistry; their advice has been instrumental in my "return" to inorganic chemistry. I've
really enjoyed running ideas by them, and I'm constantly awed by their sharp insights. A second
thanks to John for solving my crystal structures, and then answering all my questions, especially in
preparation for this thesis.
The number of colleagues from whom I have learned much about chemistry, both in the
abstract and in practice, is too large for me to name everyone, but a few people do deserve special
mention. Jackie Murphy's knowledge of inorganic techniques has been priceless, and she has
always been willing to help out without a hint of hesitation or irritation, even when I have asked the
question three times already. Xing Dai's advice on organic technique was equally valuable, as well
as his advice on life. My benefit from being his benchmate during my second and third years is
immeasurable. Neil Strotman, Bunnai Saito and Sha Lou were also incredibly helpful resources for
me, and I thank them. Thanks as well to Sunghee Son for being a great role model of a positive
graduate student, and to her, Jacob Berlin, and Catharine Larsen for being there to help me take a
time out when I needed it. Zhe Lu has been my special ally in making sure the lab has been run
(more or less) properly. Koyel Bhattacharrya was a source of some much needed girl talk, and Sue
Zultanski has always been up for a good adventure. Thanks to Alex Bissember, J.T. Mohr, Ash
Wilsily, Luis Arizpe, and Jackie Murphy for proofreading this thesis.
Diane Johansen has been a great friend for the last several years, and has always made me
feel special. Such people can be awfully rare in graduate school. Other fantastic people our
department is fortunate to have include Susan Brighton, Melinda Cerny, Mary Turner, and Liz
McGrath. Thanks to Steve Buchwald and Tim Swager for their suggestions and taking time to meet
with me regarding my post-graduate plans.
Swetha Sama has been my friend for going on 15(?!) years now, and it was my lucky day
when she decided to move to Boston. Having her in the area for four years, and my roommate for
two, has been a blessing and kept me grounded. When Swetha had to move out, Nicole Davis
moved in and has been a fantastic roommate as well, always willing to chat, hang out, and even do
some proofreading. Between the two of them, I don't think I could have asked for a better "home
life".
The MIT chemistry incoming class of 2005 featured some pretty amazing people, many of
whom are now my dear friends: Alisha Weight, Angelyn Larkin, Brenda Goguen, Kristin
Schleicher, Lindsey McQuade, Kevin Jones, Meredith Hartley, Montana Petersen, Nancy Yerkes,
Omar Ahmad, Peter Bernhardt, Scott Geyer, Wendy Iskenderian-Epps and Zhe Lu.
Scott Geyer deserves special mention for taking the last three years and putting them into
Technicolor. Even though his advice sometimes led me into places such as the Charles River, with
him I've also hiked to the top of Mt. Washington, swum across Walden Pond, walked along the
beaches of Tobago, toured the vineyards of California, and ventured into the castles of Nashua, NH.
I look forward to our future journeys together.
Lastly, I could not possibly be where I am today without my family. I couldn't have asked
for more supportive parents who always remind me of how loved I am, often going above and
beyond the call of duty. Thank you for the phone calls, the care packages, the flowers, and the
unwavering confidence in my abilities. My grandparents have been great role models in what it
means to be good people, and the pride they have taken in my accomplishments has been
inspirational. My brother David and my sister Karen have made sure all this love and pride hasn't
gone to my head, and they have also stepped in with many a comic strip, wall post, and obscure
movie (and Stan Freberg) quote to keep me laughing. I am also the fortunate beneficiary of a large
network of aunts, uncles, cousins, great-aunts, great-uncles, etc. who have always been there for me
with visits, heart-to-heart talks, encouraging emails, and love. Even though we've been far apart,
you've meant the world to me.
To close, as someone who has found inspiration from the acknowledgments pages of
former group members who had successfully made it, I'd like to offer these words to anyone finding
themselves in a similar situation. The path through graduate school is not easy and not graceful, and
it's easy to get bogged done with the frustration inherent in life in the lab. Don't forget to take a
breather once in a while-go for a walk, get some exercise, clear your head. You aren't alone;
between the lines of the theses on these shelves are the stories of people who have been there, too.
If I can do it, so can you.
Table of Contents
Chapter 1: Cross-Coupling Strategies for the Asymmetric Arylation of a-
Halocarbonyl Compounds
Section 1.1: Precedents for a-Arylation of Carbonyl Compounds
A: Introduction 10
B: Transition-Metal Catalyzed Asymmetric Arylations of Metal 12
Enolates with Aryl Halides
C: Transition-Metal Catalyzed Cross-Couplings between a- 18
Halocarbonyl Compounds and Aryl Metal Reagents
D: Conclusions 27
Section 1.2: Asymmetric Negishi Arylation of a-Bromoketones
A: Introduction 30
B: Results and Discussion 33
C: Conclusions 41
D: Experimental data 42
Section 1.3: Asymmetric Suzuki Arylation of a-Bromo- and a-
Chloroamides
A: Introduction 74
B: Results and Discussion 77
C: Conclusions 90
D: Experimental data 92
Chapter 2: Borabenzene-containing Transition Metal Complexes
A: Introduction 119
B: Results and Discussion
1. A new route to DPB-containing transition metal complexes 122
2. The chemistry of di(ortho-tolyl)phosphido-2- 125
Methylboratabenzene
C. Conclusions 133
D. Experimental Data 135
Curriculum Vitae 187
Chapter 1
Cross-Coupling Strategies for the Asymmetric Arylation of a-
Halocarbonyl Compounds
Section 1.1
Precedents for a-Arylation of Carbonyl Compounds
A: Introduction
a-Aryl carbonyl compounds are an important class of molecules due to their
interesting biological properties. The subclass of a-aryl carboxylic acids are
particularly well-known due to their use as non-steroidal anti-inflammatory agents,
including naproxen and ibuprofen. 1 Other examples of such compounds include
2 androtenone, ketobemidone,3 and tropicamide.4
Arylation of carbonyl compounds to access such a-aryl carbonyl scaffolds is an
attractive strategy as it provides the opportunity to prepare these useful compounds
from simple precursors in one step. However, twenty years ago, the direct arylation of
a carbonyl compound or its enolate was limited to nucleophilic aromatic substitutions
or protocols employing stoichiometric quantities of metal reagents with preformed
enolates.5 The development of cross-coupling technology has greatly improved access
to a-aryl carbonyl compounds through the formation of a new bond between the a-
carbon of the carbonyl and an aryl ring. Thus, two strategies, opposing in polarity, are
possible: 1. the coupling of a metal enolate with an aryl halide or pseudo halide, and 2.
the coupling of an a-halocarbonyl compound with an aryl organometallic reagent
(Scheme 1).
(a) Shen, T. Y. Angew. Chem. Int. Ed. Eng. 1972, 11, 460-472. (b) Wright, W. B., Jr.; Press, J. B.;
Chan, P. S.; Marsico, J. W.; Haug, M. F.; Lucas, J.; Tauber, J.; Tomcufcik, A. S. J Med. Chem. 1986, 29,
523-530. (c) Landoni, M. F.; Soraci, A. Curr. Drug Metab. 2001, 2, 37-51.
2 For leading references, see: Caboni, P.; Sherer, T. B.; Zhang, N.; Taylor, G.; Na, H. M.; Greenamyre,
J. T.; Casida, J. E. Chem. Res. Toxicol. 2004, 17, 1540-1548.
3 For leading references, see: Jylli, L.; Lundeberg, S.; Langius-Ekl6f, Olsson, G. L. Acta Anaesthesiol.
Scand. 2004, 48, 1256-1259.
4 The Merck Index; O'Neil, M. J., Ed.; Merck: Whitehouse Station, N.J., 2006.
5 Johansson, C. C. C.; Colacot, T. J. Angew. Chem. Int. Ed. 2010, 49, 676-707.
M, 0 0
R1 ORR0
H catalyst R2 catalyst H XH No- R11I
+ H Ar +
X-Ar M-Ar
Scheme 1: Strategies for the a-arylation of carbonyl compounds
The former strategy, the coupling enolates with aryl halides, is by far the more
well developed. The groups of Miura,6 Buchwald,7 and Hartwig8 individually reported
the initial examples, which used palladium catalysts to arylate ketone enolates.
Subsequently, this field has rapidly expanded in scope to now encompass enolate
arylation of esters, amides, aldehydes, and other related compounds such as nitriles; this
topic has recently been reviewed.'' Of particular relevance to the contents of this
thesis are the examples of the asymmetric arylation of enolates, which will be the focus
of part B.10
Less work has been done on the umpolung approach, that is the coupling of an
a-halocarbonyl compound with an aryl organometallic reagent, and there have been no
specialized reviews of this area. Therefore, to contextualize the research presented in
sections 1.2 and 1.3 of this thesis chapter, the work in this area to date will be
summarized in part C.
6 Satoh, T.; Kawamura, Y.; Miura, M.; Nomura, M. Angew. Chem., Int. Ed. Eng. 1997, 36, 1740-1742.
7 Palucki, M.; Buchwald, S. L. J Am. Chem. Soc. 1997, 119, 11108-11109.
8 Hamann, B. C.; Hartwig, J. F. J. Am. Chem. Soc. 1997, 119, 12382-12383.
9 Bellina, F.; Rossi, R. Chem. Rev. 2010, 110, 1082-1146.
1 For a recent review, see: Burtoloso, A. C. B. Synlett 2009, 320-327.
B: Transition-Metal Catalyzed Asymmetric Arylations of Metal Enolates with
Aryl Halides
Buchwald was the first to report an asymmetric version of the enolate/aryl
halide coupling strategy, using a Pd(O)/BINAP catalyst to effect the coupling of cyclic
ketone enolates bearing a tertiary a-carbon with aryl bromides in good yield and
modest to good enantioselectivity.11 However, to control the site of enolate generation,
the substrate scope was limited to cyclic ketones containing one non-enolizable a-
carbon. A few years later, the same group published a second report that improved
upon some of the limitations of the earlier protocol. The reaction temperature and
catalyst loading were both lowered substantially, and an easily installed and removed
blocking group was now employed to control the arylation regioselectivity (Equation
1).12 Similar conditions have also been used for the asymmetric a-vinylation of
ketones.13
0 1% Pd2(dba) 3  0
Ph. Me / ~ 2.5% phosphine !lPh Me Br OMe Ph, O (1)N NaOt-Bu, toluene N / M
Me Me
OCH 2(1-naphth) 80% yield, 94% ee
P(i-Pr)2
Subsequent to these studies, similar protocols have been reported. Chan and
coworkers described a nickel/P-Phos catalyst that effects the asymmetric a-arylation of
a-substituted tetralones, 2-methyl-1-indanone, and 2-methyl-1-benzosuberoneone with
" Ahman, J.; Wolfe, J. P.; Troutman, M. V.; Palucki, M.; Buchwald, S. L. J. Am. Chem. Soc. 1998, 120,
1918-1919.
12 Hamada, T.; Chieffi, A.; Ahman, J.; Buchwald, S. L. J Am. Chem. Soc. 2002, 124, 1261-1268.
13 Chieffi, A.; Kamikawa, K.; Ahman, J.; Fox, J. M.; Buchwald, S. L. Org. Lett. 2001, 3, 1897-1900.
aryl halides.1 Hartwig and coworkers extended the electrophile scope of ketone
arylation to include aryl triflates, which offer the advantage of easy preparation from
phenols.15 The electronic properties of the aryl triflate heavily influence the optimal
reaction conditions and whether a nickel- or palladium-based catalyst is better suited to
perform the desired transformation. One limitation of all of the protocols for the
asymmetric arylation of ketones to date is that only cyclic ketones undergo a-arylation
with good selectivity.
Me Me
O Me
0 -- '
Me 
- PPh2PPh2
(R)-P-Phos
Asymmetric arylation of enolates has also been applied to carboxylic acid
derivatives. For amides, much of the work has focused on intramolecular arylations to
form oxindoles (Scheme 2, Method A), which was first reported by Hartwig et al. using
chiral N-heterocyclic carbene ligands for the palladium catalyst.16 Coupling was
feasible with aryl chlorides, bromides, and iodides, but the enantioselectivities were
only moderate. Following this report, this reaction was used to evaluate the
performance of several new carbene ligands,1 7 though, of these, only two articles show
14 Chen, G.; Kwong, F. Y.; Chan, H. 0.; Yu, W.-Y.; Chan, A. S. C. Chem. Commun. 2006, 1413-1415.
15 Liao, X.; Weng, Z.; Hartwig, J. F. J. Am. Chem. Soc. 2008, 130, 195-200.
16 Lee, S.; Hartwig, J. F. J. Org. Chem. 2001, 66, 3402-3415.
17 (a) Glorius, F.; Altenhoff, G.; Goddard, R.; Lehman, C. Chem. Commun. 2002, 2704-2705. (b) Arao,
T.; Kondo, K.; Aoyama, T. Tetrahedron Lett. 2006, 47, 1417-1420. (c) Arao, T.; Sato, K.; Kondo, K.;
Aoyama, T. Chem. Pharm. Bull. 2006, 54, 1576-1581. (d) Kundig, E. P.; Seidel, T. M.; Jia, Y.;
Bernardinelli, G. Angew. Chem., Int. Ed. 2007, 46, 8484-8447. (e) Malkov, A. V.; Stewart-Liddon, A. J.
P.; Teplf, F.; Kobr, L.; Muir, K. W.; Haigh, D.; Kodovsk , P. Tetrahedron 2008, 64, 4011-4025. (f)
Luan, X.; Mariz, R.; Rober, C.; Gatti, M.; Blumentritt, S.; Linden, A.; Dorta, R. Org. Lett. 2008, 10,
examples with high enantioselectivity.17d,17 Accessing these quaternary-center-bearing
oxindole products in a complementary fashion, Buchwald and co-workers recently
reported an intermolecular a-arylation (and a -vinylation) of oxindoles (Scheme 2,
Method B). 18 This work is the first example of a catalytic asymmetric intermolecular
arylation of a non-ketone enolate.
Method A
N C
N
R1
X = CI, B
Method B
)R 2 IR3  4% TMEDA.Pd Me2
R3  L*nPd 4% phosphineI NaOt-Bu
R2 base NR2 bse Ncyclohexane
~r, IN
____ ____ ____ ____ I!-Bu
L* = chiral N-heterocyclic FN1  Ph
carbene p Nhsie2
m 2e2
Scheme 2: Methods for generating aca' -substituted oxindoles
R2
0
N
+
Ar-Br
Ar = R3)
a-Substituted -y-lactones have also been reported by Buchwald and coworkers to
be competent reaction partners for coupling with aryl bromides and chlorides using a
nickel-BINAP catalyst (Equation 2).19 Interestingly, this method employs a zinc salt
additive to improve the reaction rate and efficiency; the authors postulate these effects
are due to zinc-promoted abstraction of the bromide from the oxidative addition adduct
to form a cationic species that undergoes transmetallation more easily than its precursor.
5569-5572. (g) Wirtz, S.; Lohre, C.; Fr6hlich, R.; Bergander, K.; Glorius, F. J. Am. Chem. Soc. 2009,
131, 8344-8345.
18 Taylor, A. M.; Altman, R. A.; Buchwald, S. L. J. Am. Chem. Soc. 2009, 131, 9900-9901.
19 Spielvogel, D. J.; Buchwald, S. L. J Am. Chem. Soc. 2002, 124, 3500-3501.
This methodology has since found employment in the preparation of chiral 4,4'-
disubstituted hexahydroazepines. 20
0 5% Ni(cod)2, 0 e8.5% (S)-BINAP
O Me Cl-Ph a Ph (2)
15% ZnBr2
NaHMDS
toluene/THF 86% yield, >97% ee
f-Ketoesters are another substrate class that have been proven competent in
catalytic asymmetric a-arylation. Ma and coworkers have shown that 2-
methylacetoacetate esters can be coupled with 2-iodotrifluoroacetanilides to give
enantioselectivity values ranging from 60-93% ee (Equation 3).21 This Ullmann-type
process utilizes a copper/trans-4-hydroxy-L-proline catalyst in contrast with the other
a-arylation procedures, which rely upon palladium and nickel catalysts. The electronic
parameters of the anilide coupling partner strongly influence the coupling yield and
enantioselectivity, and this method suffers from limited substrate scope. However, the
products can be converted to chiral a-hydroxyindoles, thus making this method
complementary to those methods of generating oxindoles discussed above.
0 CF3
O CF3  Me 20% CuI NH
S 0 40% trans-4-hydroxy-L-proline NH
NH Me- 1 O (3)
O NaOH, DMF/H 20 Me Ot-Bu
Me I t-BuO Me Ac
79% yield, 93% ee
20 Delhaye, L.; Merschaert, A.; Diker, K.; Houpis, I. N. Synthesis 2006, 1437-1442.
21 Xie, X.; Chen, Y.; Ma, D. J. Am. Chem. Soc. 2006, 128, 16050-16051.
Aldehydes have also recently been utilized in catalytic asymmetric a-arylation
by Buchwald and co-workers. Using a palladium catalyst bearing phosphanyl-
oxazoline ligands, in several cases the intramolecular arylation proceeded in good yield
and with enantioselectivity values over 90% ee (Equation 4). This methodology is
particularly remarkable in that the aldehyde enolate preferentially undergoes
transmetallation with the palladium catalyst rather than participation in an aldol
23reaction.
i-Pr 3% Pd(OAc) 2  F
F , CHO 9% pfox ligand (4)
Br Cs 2CO3, t-BuOH CHO
O. 82% yield, 95% ee
PR 2 N .
HBF 4  t-Bu
R = p-OMe-C6 H4
In addition to the catalytic enantioselective examples already discussed, a few
catalytic diastereoselective examples of a-arylation have also been reported. Hartwig
and coworkers appended both Evans and Ley chiral auxiliaries to silyl enolates for
palladium-catalyzed coupling with aryl bromides, which was mediated by zinc
additives. 24 The authors postulate that the presence of these zinc additives attenuate the
basicity of the reaction, thus allowing tertiary a-aryl stereocenters to be formed;
however the exact role of the zinc additive is unknown. More recently, Jansat and
22 Garcia-Fortanet, J.; Buchwald, S. L. Angew. Chem., Int. Ed. 2008, 47, 8108-8111.
23 For organocatalytic procedures for the a-arylation of aldehydes, see: (a) Conrad, J. C.; Kong, J.;
Laforteza, B. N.; MacMillan, D. W. C. J. Am. Chem. Soc. 2009, 131, 11640-11641. (b) Jensen, K. L.;
Franke, P. T.; Nielsen, L. T.; Daasbjerg, K.; Jorgensen, K. A. Angew. Chem., Int. Ed. 2010, 49, 129-133.
24 Liu, X.; Hartwig, J. F. J Am. Chem. Soc. 2004, 126, 5182-5191.
coworkers have also developed a diastereoselective a-arylation (and a-vinylation) by
using a chiral dioxolane derived from chiral mandelic acid and a palladium/phosphine
catalyst (Equation 5).
t-Bu
t-Bu Br 2% Pd(OAc)2  0 0
8% P(t-Bu) 3.HBF 4  Ph'0 0 0 (5)
LiHMDS, toluene
P SMe r.t.
SMe
95% yield, 98% ee
The catalytic asymmetric a-arylation of enolates has been applied to a variety of
carbonyl compounds to generate products containing enantioenriched a-aryl
stereocenters, which are difficult to access via other synthetic methods. This method is
especially good for generating quaternary centers, which remain a particular challenge
in synthetic chemistry. However, this approach does have its limitations. With the
exception of the report by Hartwig that employs zinc additives to arylate silyl enol
ethers, the basic reaction conditions required to generate the enolate preclude the
formation of tertiary a-aryl stereocenters, which are more acidic than their precursors
and thus are quickly racemized. Furthermore, the product scope of these arylations is
often limited to cyclic molecules, either through intermolecular couplings with cyclic
enolates, or by intramolecular couplings. In some cases of intermolecular couplings, a
large excess (2 or more equivalents) of the enolate precursor is often needed to offset
loss of reagent due to competitive aldol and Claisen condensation reactions.
2 Jiang, L.; Weist, S.; Jansat, S. Org. Lett. 2009, 11, 1543-1546.
Nevertheless, the protocols described represent substantial advances in the ability to
prepare enantiomerically enriched a-arylcarbonyl compounds.
C: Transition-Metal Catalyzed Cross-Couplings between a-Halocarbonyl
Compounds and Aryl Metal Reagents
The coupling of aryl metal reagents with a-halocarbonyl compounds is the
umpolung approach to a-arylation of enolates in the effort to generate enantioenriched
a -aryl stereocenters. This process has been much less explored due in part to the
challenges posed in the cross-coupling of fl-hydrogen-containing, sp 3-hybridized
electrophiles. The oxidative addition of these electrophiles may be slow in comparison
to sp2 -hybridized electrophiles, and once an oxidative addition adduct has been formed,
there is a strong propensity of this complex to undergo f-hydride elimination. 26
Recently, however, advances in cross-coupling methodology have overcome these
obstacles and the arylation of o'-halocarbonyl compounds has become a much more
feasible undertaking.
The first reports of this mode of coupling appeared in 1986 by Amano, Fujita,
and coworkers in which they effected nickel-catalyzed Kumada couplings of aryl
Grignard reagents with a-bromopropionates in moderate yields (Equation 6).27
26 (a) Cirdenas, D. J. Angew. Chem., Int. Ed. Eng. 1999, 38, 3018-3020. (b) Luh, T.-Y. L., M.-k.; Wong,
K.-T. Chem. Rev. 2000, 100, 3187-3204.27 Amano, T.; Yoshikawa, K.; Sano, T.; Ohuchi, Y.; Shiono, M.; Ishiguro, M.; Fujita, Y. Synth. Commun.
1986, 16, 499-507.
MgCI Me
O 1% NiCl 2  EtO (6
EtO Me (6)
Br
i-Bu
i-Bu
50% yield
In 1989, Suzuki and coworkers reported that they used a Pd(PPh3)4 catalyst to
couple ethyl bromoacetate with dibutyl phenylboronate; 28 because base alone did not
facilitate the transmetallation, the additive thallium carbonate was used. This chemistry
was revived in 2001 by GooBen, who reported a more practical Suzuki arylation that
did not require toxic thallium additives to couple a-bromoacetates (and one a-
bromoacetamide) with arylboronic acids and aryl pinacol boronates. This protocol used
a palladium/phosphine catalyst to give the products in modest to very good yields
(Equation 7; 1-Naphth = 1-naphthalene).29
3% Pd(OAc)2  OMe
O 9% P(1-Naphth) 3  O
EtO Br (HO) 2B - OMe K3PO4, H20 EtO (7)
THF 84% yield
This methodology was incorporated into two syntheses of novel molecules for
the purpose of probing biological problems. The first example used this coupling
procedure to prepare an isotopically labeled nonproteinogenic amino acid in order to
elucidate the biosynthetic pathway to make the angiotensin converting enzyme inhibitor
28 Sato, M.; Miyaura, N.; Suzuki, A. Chem. Lett. 1989, 1405-1408.
29 GooBen, L. Chem. Commun. 2001, 669-670.
K-26 (Scheme 3). 30 In the second synthesis, a novel bifunctional poly(amino
carboxylate) chelating agent was prepared that contained functionality for site-specific
labeling of biomolecules to be used in biodistribution studies.3
3% Pd(OAc) 2
O 9% P(1-Naphth) 3  0
I (HO)2B O / N. PhEtO' K3PO4, H20 EtO .'
THF
OH
H 0  H
- N N N PO 3H-
H0 s-Bu 0
radiolabeled K-26 OH
Scheme 3: Application of GooBen's Suzuki arylation of a-bromoacetates
Subsequent to GooBen's report, a similar procedure for the coupling of
arylboronic acids to ethyl bromoacetate was reported by Deng and coworkers. This
process used Pd(PPh3)4 as the pre-catalyst in combination with a copper(I) oxide co-
catalyst. The same group also reported a coupling procedure for NN-dibutyl
bromoacetamide with arylboronic acids, although this protocol did not require the
copper co-catalyst. 33
Concurrent with these studies, Lei and Zhang noted the presence of two
competing pathways in the catalytic cycle while studying the a-arylation of primary and
30 Ntai, I.; Phelan, V. V.; Bachmann, B. 0. Chem. Commun. 2006, 4518-4520.
31 Kn6r, S.; Modlinger, A.; Poethko, T.; Schottelius, M.; Wester, H.-J.; Kessler, H. Chem.-Eur. J. 2007,
13.
32 Liu, X.-X.; Deng, M.-Z. Chem. Commun. 2002, 622-623.
3 Duan, Y.-Z.; Deng, M.-Z. Tetrahedron Lett. 2003, 44, 3423-3426.
secondary a-bromoesters. 3 4  One pathway gave rise to the desired cross-coupling
product, while the second led to homocoupling of the nucleophile, presumably through
a double transmetallation of the oxidative addition adduct by the nucleophile. In the
case of a-bromoacetate, this group was able to obtain a 7:3 ratio of the cross-coupling
product to the homocoupling product. However, in the end, they decided to optimize
for the selective formation of the homocoupling product mediated by the a-bromoester
reagent (Equation 8).
Br 2.5% PdCI2(rac-BINAP)
PhB O e KF, dioxane/H 20 (8)
B(OH) 2  0
95% yield
The first example of selective a-arylation of a secondary a-halocarbonyl
compound following Amano and Fujita's 1986 report was in 2004 by Fnrstner and
coworkers. 35,36 Here they were able to use a well-defined iron catalyst to couple,
amongst other substrates, ethyl a-bromobutyrate with phenylmagnesium bromide in
high yield (Equation 9). However, this particular reaction was the only example of
such an a-arylation included.
34 Lei, A.; Zhang, X. Tetrahedron Lett. 2002, 43, 2525-2528.
* Martin, R.; Fiirstner, A. Angew. Chem., Int. Ed. 2004, 43, 3955-3957. For a more detailed report of
these experimental findings, see FUrstner, A.; Martin, R.; Krause, H.; Seidel, G.; Goddard, R.; Lehmann,
C. W. J. Am. Chem. Soc. 2008, 130, 8773-8787.
36 For a review of transition metal-catalyzed cross-couplings of secondary alkyl electrophiles, see:
Rudolph, A.; Lautens, M. Angew. Chem., Int. Ed. 2009, 48, 2656-2670.
O 5% [Li(tmeda)] 2[Fe(C 2H4)2] O
EtO Et BrMg THF EtO Et (9)
Br
87% yield
This transformation has been demonstrated to be facilitated by other metal
catalysts as well. Yorimitsu and Oshima have one example of the use of a
cobalt/diamine catalyst for the coupling of ethyl a-bromopropionate with
phenylmagnesium bromide (Equation 10).37
5% CoCl 2
NMe 2
O 6% "Ne 2 0
EtO Me BrMg 'e2 EtO Me (10)
Br THF
88% yield
Nickel-catalysis has also been used for the arylation of a-halocarbonyl
compounds. In the first such example, Strotman, Sommer and Fu demonstrated a
nickel/amino alcohol-mediated Hiyama arylation of a-chloro- and a-bromoketones,
esters, and amides, all in good yields (Equation 11).38 This method was also applicable
to a-chloro and a-bromonitriles and phosphonates.
37 Ohmiya, H.; Yorimitsu, H.; Oshima, K. J. Am. Chem. Soc. 2006, 128, 1886-1889.
38 Strotman, N. A.; Sommer, S.; Fu, G. C. Angew. Chem., Int. Ed. 2007, 46, 3556-3558.
10% NiCl 2 .glyme
0 15% norephedrine
R2 Ar-SiF3  12% LiHMDS, 8% H20 )2
X CsF, DMA Ar
X = Br, CI 78-86% yield
ketones, esters, amides
Lei and coworkers have also used nickel catalysis for the Suzuki arylation of a-
bromoesters and amides, and both a-bromo- and a-chloroketones. 39 The conditions
vary depending on the substrate pair; however, a representative coupling can be found
in Equation 12.
O 5% Ni(PPh3)4 O
EtO Me Ph-B(OH) 2  5 EtO Me (12)
Br K3PO 4, toluene Ph
78% yield
Recently, a-chlorohydrazones have been shown to be suitable electrophiles for
copper-catalyzed cross-coupling with Grignard reagents, including one example with
phenymagnesium bromide (Equation 13).40 After the coupling, the a-phenylhydrazone
can be hydrolyzed to give the a-phenylketone. This reaction is noteworthy in that it
generates an a-quatemary center, which is unique for this polarity of cross-coupling.
The mechanism is presumed to proceed through a conjugate addition to an azo-alkene
intermediate, whereas other a-arylations of a-halocarbonyls are supposed to occur
through radical-mediated or SN2-type oxidative addition processes. This mechanistic
difference may account for this divergency in reactivity.
39 Liu, C.; He, C.; Shi, W.; Chen, M.; Lei, A. Org. Lett. 2007, 9, 5601-5604.
40 Hatcher, J. M.; Coltart, D. M. J. Am. Chem. Soc. 2010, 132, 4546-4547.
N NTs
TsHNN TsHNN
Me 10%CuCI Me Me
CI Ph-MgBr 1 Ph (13)THF, -78 oC conjugate
addition
Ph-CuMgBr 64% yield
The arylation of secondary a-halocarbonyl compounds using catalysts bearing
chiral ligands under mild conditions provides the opportunity for generating
enantioenriched tertiary stereocenters, as the ability to use milder reaction conditions
may avoid the epimerization that hinders enolate arylation for these targets. Our group
has been very interested in stereoconvergent, asymmetric cross-coupling reactions of
41,42,4
racemic secondary alkyl electrophiles for a number of years, and we were
intrigued by the possibility of utilizing this methodology for the synthesis of these
difficult tertiary a-arylcarbonyl stereocenters.
The first success in this area was Dai and Strotman's development of an
asymmetric Hiyama arylation protocol for use with a-bromoesters.44 It was found that
bulky esters gave the higher levels of enantioselectivity, with a 2,6-di-tert-butyl-4-
methylphenyl (BHT) ester being optimal (Equation 14). The reaction was sensitive to
the steric demand of the a-alkyl substituent, but was fairly tolerant of various functional
groups. Interestingly, this methodology was also applicable to asymmetric couplings
with alkenylsilanes under the same reaction conditions to afford f,'-unsaturated ester
4 1 (a) Fischer, C.; Fu, G. C. J. Am. Chem. Soc. 2005, 127, 4594-4595. (b) Arp, F. 0.; Fu, G. C. J Am.
Chem. Soc. 2005, 127, 10482-10483. (c) Son, S.; Fu, G. C. J Am. Chem. Soc. 2008, 130, 2756-2757.
(d) Saito, B.; Fu, G. C. J. Am. Chem. Soc. 2008, 130, 6694-6695. (e) Smith, S. W.; Fu, G. C. J. Am.
Chem. Soc. 2008, 130, 12645-12647. (f) Lou, S.; Fu, G. C. J. Am. Chem. Soc. 2010, 132, 5010-5011.
(g) Owston, N. A.; Fu, G. C. J. Am. Chem. Soc. 2010, 132, ASAP.
42 For an example of a nickel-catalyzed asymmetric alkynylation with trialkynylindium reagents, see:
Caeiro, J.; Sestelo, J. P.; Sarandeses, L. A. Chem.-Eur. J 2008, 14, 741-746.
43 For a review on asymmetric cross-couplings of secondary alkyl electrophiles, see: Glorius, F. Angew.
Chem., Int. Ed. 2008, 47, 8347-8349.
44 Dai, X.; Strotman, N. A.; Fu, G. C. J. Am. Chem. Soc. 2008, 130, 3302-3303.
products bearing a tertiary a-stereocenter. These ester products are easily converted
into other molecules; if an a-aryl carboxylic acid is desired, an oxidatively cleavable
2,6-di-tert-butyl-4-methoxyphenyl ester can also be used with only a modest decrease
in enantioselectivity.
10% NiCl2.glyme
Ph Ph
Me t-Bu 12% Me t-BuOMeHN NHMe0
O Et Ph-Si(OMe)3  TBAT d Et (14)TBAT, dioxane, r.t.
t-Bu Br t-Bu Ph
racemic 80% yield, 99% ee
Following the development of the Hiyama a-arylation methodology, our group
has sought to expand this strategy to other classes of carbonyl compounds and other
organometallic reagents. The enantioselective Negishi arylation of a-bromoketones is
the subject of section 1.2 of this thesis, and the enantioselective Suzuki arylation of a-
haloamides is the subject of section 1.3. In addition to these three reports, Lou has
developed an asymmetric Kumada arylation of both aryl-alkyl and dialkyl a-
bromoketones (Equations 15 and 16). Despite the strong basicity of the Grignard
nucleophiles, racemization of the enantiomerically enriched products is not observed
under the reaction conditions. This reaction is also quite tolerant of a number of
functional groups, including esters, nitriles, and aromatic heterocycles.
4 Lou, S.; Fu, G. C. J. Am. Chem. Soc. 2010, 132, 1264-1266.
0
Me Ph-MgX
CT Br
racemic
7% NiCl2-glyme
Me Me
0 0
9%
N N
Ph Ph
DME, -60 oC
(15)
, Ph
81% yield, 92% ee
7% NiCI2-glyme
9%
0
Me Me Ph-MgX
Me Br
racemic
PH ~ hPh Ph ,
DME, --400C
0
Me Me
Me Ph
83% yield, 84% ee
Kinetic studies were undertaken to elucidate the mechanism of this reaction. It
was found that the reaction is first order in both catalyst and nucleophile, and zero order
in electrophile. If the resting state is assumed to be the free catalyst, this data seems to
support a pathway in which transmetallation occurs before oxidative addition (Scheme
4). However, to more clearly define the mechanism of this coupling, more information
must be gathered. At this point, the exact nature of the stereochemistry-determining
step remains unclear; the stereochemistry may be set in the course of initial carbon-
nickel bond formation, or it may be determined by reductive elimination after
interconversion of the intermediate nickel enolate. Which of these pathways is the
most likely would depend on the rate of reductive elimination relative to enolate
interconversion. If it is fast, then the former scenario is more likely, but if it is slow,
(16)
then the latter pathway is more plausible. However, at this point, the relative rates of
the steps in this postulated catalytic cycle are unknown.
X-M
Transmetallation
Ar-M
LnNi-X
free catalyst
0
R, 1- R2
Ar
Reductive
Elimination
LnNi-Ar
0
Ridt, R2
X
Oxidative Addition
LnNi-Ar
R1 R2 L
neutral radical pair
0
R1 R2
LnNi-ArIX
R1 R 1 R2
O R2 O R0)
LnNi-Ar LnNi-Ar
I IX X
Potential Stereoconvergence
Pathway
Scheme 4: Postulated mechanism for the nickel-catalyzed Kumada coupling of a-
bromoketones
D: Conclusions
In the last fifteen years, advances in transition metal-catalyzed cross-coupling
technology have made possible remarkable progress in the ability to synthesize a-
arylcarbonyl compounds. Within this class of new reactions, methods to generate
enantioenriched a-carbonyl compounds are especially promising and exciting. Two
transition-metal catalyzed cross-coupling approaches exist to prepare these products:
(1) the arylation of enolates with aryl halides, and (2) the arylation of a-halocarbonyls
with aryl organometallic reagents. Each of these strategies has been applied to a
number of carbonyl subclasses and offers its own advantages and disadvantages (Figure
1); however, together, these complementary methods combine to considerably
strengthen the synthetic chemist's ability to prepare novel and potentially biologically
significant molecules.
R1 R2 O R4 R2
H __R_ _R H X
+ H Ar +
X-Ar M-Ar
* Enolates are prepared in situ and e a-Halocarbonyls (and sometimes
commercially available aryl halides aryl metal reagents) must be
can be used. prepared beforehand.
* Asymmetric variants are limited to * Asymmetric variants are limited to
the generation of quaternary the generation of tertiary
stereocenters. stereocenters.
* Products are typically cyclic e Most examples generate acyclic
products.
Figure 1: Comparison of strategies for asymmetric arylation of carbonyls
Section 1.2
Asymmetric Negishi Arylation of ot-Bromoketones
A: Introduction
The Negishi coupling of organozinc nucleophiles is a functional-group tolerant
procedure that proceeds under mild conditions, generally without the use of additives,
46
making it more straightforward than many other cross-coupling reactions. It is not
surprising, therefore, that Negishi coupling reactions have played a pivotal role in the
Fu group's development of strategies for cross-coupling secondary alkyl electrophiles.
The first such example from the group was a Negishi coupling of unactivated secondary
and primary alkyl bromides and iodides with a variety of primary alkylzinc iodides
developed by Zhou in 2003 (Equation 17).47 This paper is notable in that it is this
group's initial foray into the field of nickel-catalyzed cross-coupling reactions.
Me 4% Ni(cod) 28% (s-Bu)-Pybox
Br Me Znl Me (17)
DMA, r.t. \
Me
1.6 equiv 68% yield
N N
s-Bu (s-Bu)-pybox s-Bu
More recently, Smith reported the coupling of secondary alkylzinc iodides and
bromides with secondary propargyl bromides and chlorides (Equation 18).48 This
46 For a review of the Negishi reaction, see: Negishi, E.-i.; Hu, Q.; Huang, Z.; Wang, G.; Yin, N. In The
Chemistry of Organozinc Compounds; Rappopport, Z., Marek, I., Eds.; Wiley: New York, 2006; Chapter
11.
47 Zhou, J.; Fu, G. C. J Am. Chem. Soc. 2003, 125, 14726-14727.
48 Smith, S. W.; Fu, G. C. Angew. Chem., Int. Ed. 2008, 47, 9334-9336.
report is the first example of a nickel-catalyzed cross-coupling of a secondary alkyl
nucleophile of any type with a secondary alkyl electrophile.49
TIPS TIPS
10% NiCl 2-glyme
10% terpyridine
Br IZn (18)
n-Bu DMA, r.t. n-Bu
1.6 equiv 88% yield
In 2005, Fischer disclosed the asymmetric Negishi coupling of a-bromoamides
and primary alkylzinc bromide and iodide nucleophiles, again with a nickel/Pybox
catalyst (Equation 19), which is the first example of an asymmetric cross-coupling
reaction wherein a racemic secondary alkyl electrophile is converted to a highly
enantioenriched coupling product.4 1a To expand the scope of this novel transformation,
the competency of many new electrophile classes in such transformations were
evaluated. Soon afterwards, Arp reported the second example of an asymmetric
Negishi alkylation, in this case with benzylic bromides and chlorides as the
electrophilic coupling partner.41b Subsequently, Son developed a method for Negishi
alkylation of allylic chlorides and bromides.4 14
10% NiCl 2.glyme OO 13% (S)-(i-Pr)-Pybox
Bn'N Et n-Hex-Znl , Bn'N .. Et (19)
N | DMI/THF I
Ph Br 0 0C Ph -Hex
1.3 equiv 90% yield, 95% ee
O 0
N N
i-Pr (S)-(i-Pr)-Pybox i-Pr
49 For a copper-catalyzed cross-coupling of secondary alkylzinc halides with a-chloroketones, see:
Malosh, C. F.; Ready, J. M. J. Am. Chem. Soc. 2004, 126, 10240-10241.
Given the success these asymmetric Negishi reactions with alkylzinc
nucleophiles, we were interested in whether we could extend this methodology to
arylzinc nucleophiles. Jorge Esquivias initially explored this question, finding that
diphenylzinc could indeed be coupled with 2-bromo-a-tetralone using a nickel/Pybox
catalyst to give the product with 87% yield and 82% ee. Upon cooling of the reaction
to -30 *C, these results were improved to 94% yield and 89% ee (Equation 20). It was
with this result in hand that the optimization process described in section B was begun
to further improve the scope, yield, and enantioselectivity.
0 10% NiCI2.glyme 0
Br 13% (S)-(i-Pr)-pybox Ph
+ Ph2Zn diIme (20)
C& diglyme (
racemic 1.5 equiv r.t.: 87% yield, 82% ee
-30 *C: 94% yield, 89% ee
Concurrent with the studies detailed in this thesis section, Smith developed the
asymmetric Negishi arylation of secondary propargylic halides, using ethylphenylzinc
as the arylating agent and a nickel/Pybox catalyst (Equation 21).41,
TMS 3% NiCl2.glyme TMS
Br Ph-ZnEt 3.9% indanyl pybox Ph (21)
n-Bu glyme, -20 OC n-Bu
racemic 2.0 equiv 90% yield, 92% ee
t O O HN
N N
H H
indanyl-Pybox
B: Results and Discussion 50
Although the conditions found by Esquivias were very good for coupling 2-
bromo-a-tetralone, other classes of ketones did not give comparably high yield and ee,
including acyclic ketones. Thus the utility of this method to the synthetic community
was very limited. We therefore decided our efforts were best concentrated on
optimizing reaction conditions for a more general family of electrophiles, namely, an
acyclic scaffold. Under the conditions in Equation 20, 2-bromopropiophenone was
found to couple in 59% yield and 74% ee; a simple switch of solvent from diglyme to
glyme improved the enantiomeric excess to 79% although the yield decreased to 55%.
At this point, a number of Pybox ligands were evaluated in the reaction due to their
success in our other asymmetric cross-coupling procedures (Figure 2).41a-41c Although a
number of these species gave ee values greater or equal to that obtained with (i-Pr)-
Pybox, the trans-4-methoxymethyl-5-phenyl-substituted Pybox ligand, 1, stood out
with the highest ee (93%).
50 Portions of the work described in this section are published in: Lundin, P. M.; Esquivias, J.; Fu, G. C.
Angew. Chem., Int. Ed. 2009, 48, 154-156.
0
Me
Br
racemic
0 E- 0
N NJ
Et E
+ Ph 2Zn
1.5 equiv
10% NiCI2.glyme
13% Pybox ligand
glyme
0
Me
Ph
i-Bu i-Bu
37% yield, 57% ee
34% yield, 75% ee
32% yield, 59% ee
66% yield, 79% ee
11% yield, 65% ee
0 N- 0
N
SMe MeS
73% yield, 83% ee
61% yield, 87% ee
Figure 2: Ligand screen
SBn BnS
68% yield, 88% ee
N N
OMe MeO(S, S)-1
65% yield, 93% ee
We continued reaction optimization with ligand 1 and were able to improve the
system with the conditions in equation 22, which gave the coupling product in 88%
yield and 95% ee.
0
Me
racemic
Ph 2Zn
10% NiCI2*glyme
13% (S,S)-11
DME, -30 00
1.3 equiv
hMe
88% yield, 95% ee
i-Bu
(22)
However, the diphenylzinc powder that had been used up to this point as the
arylating agent posed two problems to the development of a general coupling procedure.
First, diarylzinc solids are air-sensitive compounds and thus are not amenable to
handling on the bench top. Secondly, diphenylzinc is one of only two such species that
are commercially available. Therefore, to expand the nucleophile scope, it was
imperative to find another arylzinc source, and a variety of potential species were tested
(Table 1). Ethylphenylzinc5 1 and phenylzinc bromide did not provide any coupling
product (entries 1 and 2). While phenylzinc chloride gave the desired product with high
enantioselectivity, the yield was low (entry 3). A commercially available phenylzinc
iodide solution gave only 79% ee (entry 4). The use of phenylzinc iodide generated
from phenylmagnesium bromide and zinc iodide led to high yield and ee of the
coupling product (entry 5), whereas s phenylzinc iodide synthesized by zinc insertion
into iodobenzene gave even higher yield and ee (entry 6). Diphenylzinc generated from
phenyl Grignard and of zinc chloride also gave high ee but the yield was lower (entry
7). However, filtration of the nucleophile solution to remove the magnesium salts prior
to addition to the reaction significantly improved the yield (entry 8).
5 Bolm, C.; Rudolph, J. J. Am. Chem. Soc. 2002, 124, 14850-14851.
Table 1: Arylzine reagents tested in reaction
0 10% NiCl 2-glyme O
Me 13% (S,S)-1 MeN. Ph-ZnX _______M
Br glyme, -30 *C Ph
racemic 1.3 equiv
entry Nucleophile % yielda % ee
1 Ph-ZnEt 0
2 Ph-ZnBr -- > PhMgBr + ZnBr 2  0 -
3 Ph-ZnCl -> PhMgBr + ZnC 2  14 88
4 Ph-Znl (0.5 M solution, Aldrich) 51 79
5 Ph-Znl -> PhMgBr + Zn12  84 90
6 Ph-Znl -> Phi + Zn (dioxane/DMA) 82 95
7 Ph-ZnPh - PhMgBr + ZnCl 2  58 94
8b Ph-ZnPh -- PhMgBr + ZnCl 2  92 96
aYields were determined by GC versus n-tetradecane as an internal
standard. bThe nucleophile solution was filtered through an Acrodisc
prior to use in the reaction.
Reaction optimization was therefore continued using in situ-generated
diarylzinc reagents. Testing with a variety of different nucleophile substitution patterns
identified the conditions specified in Table 2 as optimal. These reactions can be set up
without the use of an inert atmosphere glovebox, as the commercially available nickel
salt can be handled in air.52 Both meta- (entries 2 and 3) and para-substituted (entries
4-7) nucleophiles coupled well. Electron-donating groups in both these positions (entry
3 and entries 5-7) were suitable for coupling.
52 Ligand 1 is not commercially available, but it can be prepared in 2-3 steps using commercially
available amino alcohols and a commercially available pyridine derivative. For experimental
information, see part D.
Table 2: Nucleophile scope with diarylzinc reagents
O 5% NiC12-glyme 0
Ph Me Ar2Zn 6.5% (S,S)1 Ph - Me
Br glyme/THF (2.8:1.0) Ar
racemic 1.1 equiv -30 *C, 1.5 h
entry aryl % yield % ee
1 Ph 83 (88a) 93 (95a)
2 3-Me-C 6H4  87 92
3 3-OMe-C 6H4  87 94
4 4-F-C6H4  79 95
5 4-OMe-C6H4  80 91
6 4-NMe 2-C6H4  88 89
7 4-SMe-C6H4  82 92
All data are the average of two runs. a Diphenylzinc
powder was used rather than diphenylzinc generated
in situ.
Variations on the electrophile were also tested in the reaction (Table 3). A
variety of aryl alkyl ketones53 couple efficiently with moderate to high ee. Functional
groups are tolerated on the alkyl chain (entries 2-3), and branching at the fl-position
relative to the reaction center does not hinder the reaction (entry 4). Substitution at the
ortho position of the aryl ring does result in a decrease in yield and ee (entries 5 and 6).
In the para position, the aryl ring can bear either electron-rich (entry 7) or electron-poor
(entry 8) substituents. A heteroaromatic ketone is also tolerated in this reaction (entry
9).
" 2-Bromocyclohexanone was found to couple with Ph 2Zn powder in 68% yield and 72% ee. However,
in general, dialkyl ketones were found to only couple in low yields and enantioselectivities.
Table 3: Electrophile
0
Ar R Ph2Zn
Br
racemic 1.1 equiv
entry aryl
1 Ph
2 Ph
3 Ph
4 Ph
5 2-F-C 6H4
6 2-Et-C 6H4
7 4-OMe-C 6H4
8 4-CF 3-C6H4
ga 2-thienyl
All data are the average
rather than 1.5 h.
g with diarylzinc nucleophiles
5% NiCl2'glyme
6.5% (S,S)-1
*Ar
glyme/THF (2.8:1.0)
-30 0C, 1.5 h
0
R
Ph
R % yield % ee
Et 91 88
CH2Ph 86 87
CH2CH2CI 82 86
i-Bu 89 95
Me 68 70
Me 43 76
Me 91 94
Me 82 89
Me 87 93
of two runs. a Reaction time of 6 h
With these results in hand, the reaction with phenylzinc iodide in place of
diphenylzinc was again tested. Whereas phenylzinc iodide was previously a slightly
inferior coupling partner with respect to enantioselectivity (Table 1, entry 5 versus
entry 8), under the current reaction conditions it was found that it gave slightly
improved enantioselectivity as compared to diphenylzinc (Equation 23 versus Table 2
entry 1).
0
Me
Br
racemic
5 mol% NiCl2-glyme
6.5 mol% (S,S)-1
Ph-Znl
DME/THF (2.8:1.0)
-30 *C
1.1 equiv
0
I N :Me (23)h
87% yield, 95% ee
scope in couplin
A variety of other arylzinc iodides were tested under these conditions, and the
improvement in enantioselectivity was indeed found to be general. Arylzine iodides
offer an advantage over diarylzinc reagents in that they require one equivalent of
Grignard reagent to zinc salt, whereas the diarylzinc reagents require two equivalents.
Therefore, the reaction parameters for coupling with arylzinc iodides were optimized,
and the couplings analogous to those performed in Tables 2 and 3 were performed with
arylzinc iodide nucleophiles (Table 4). Two couplings did not proceed well with the
arylzinc iodide nucleophile. In the case of 3-methoxyphenylzinc iodide, the
nucleophile solution turned to a thick slurry that was difficult to syringe into the
reaction solution. For 2-bromo-4-methyl-1 -phenylpentan-1-one, the reaction with
phenylzinc iodide was more sluggish as compared to the coupling with diphenylzinc.
The ee values obtained in Table 4 are either comparable to or higher than the
corresponding entries in Tables 2 and 3; the yields vary from being lower, higher, or
comparable.
54 We preferred to generate arylzinc iodides through transmetalation rather than zinc insertion, as we
found the transmetalation procedure to be more reliable.
Table 4. Coupling with arylzi
0
Ar R Ar'
Br
racemic 1.3
entry Ar
1 Ph
2 Ph
3 Ph
4 Ph
5 Ph
6 Ph
7 Ph
8 Ph
ga Ph
10 2-F-C 6H4
11 2-Et-C6H4
12 4-OMe-C6H4
13 4-CF 3-C6H4
14 2-thienyl
nc iodide reagents
5% NiCl2-glyme
6.5% (S,S)-1
-Znl
glyme/THF (2.1:1.0)
-30 0C
equiv
R
Me
Me
Me
Me
Me
Me
Et
CH2Ph
CH2CH2CI
Me
Me
Me
Me
Me
Ar'
Ph
3-Me-C 6H4
4-F-C6H4
4-OMe-C6H4
4-NMe 2-C6H4
4-SMe-C 6H4
Ph
Ph
Ph
Ph
Ph
Ph
Ph
Ph
0
Ar R
Ar
% yield
86
88
74
93
85
71
86
76
90
80
79
90
76
81
All data are the average
C rather than -30 OC.
of two runs. a The reaction temperature was -20
A few other notes should be made regarding this coupling system. Ortho-
substituted nucleophiles were not successful in the coupling of either diarylzinc or
arylzinc iodide reagents due to low yields. a-Branching on the alkyl side chain was
also not tolerated. On a gram-scale at -30 0C, the reaction is sluggish, but at -10 *C the
% ee
96
94
96
96
93
96
94
95
92
72
75
96
87
96
product (same as Table 4, entry 1) was obtained in 81% yield and 93% ee. In all
reactions, the ee of the starting electrophile remains less than 5% over the course of the
reaction; therefore, the oxidative addition of the a-bromoketone seems unlikely to
proceed through a kinetic resolution. The ee of the product remains essentially constant
during the reaction.
C. Conclusions
In conclusion, the first asymmetric cross-coupling of secondary a-haloketones
has been developed, specifically, a Negishi arylation of a-bromoketones. This process
is a new procedure for the synthesis of enantioenriched a-arylketones, a motif that is
difficult to access via other methods. Both diaryl zinc and arylzinc iodide reagents are
suitable coupling partners in this stereoconvergent process, which occurs under very
mild conditions without the presence of any activators.
D. Experimental
1. General Information 41
2. Preparation of a-Bromoketones 41
3. Preparation of Ligand 2 45
4. Asymmetric a-Arylations of Ketones 46
5. Assignment of Absolute Configuration 55
6. Selected 1H NMR Spectra 56
1. General Information
All reactions were carried out in oven-dried glassware under an atmosphere of
argon.
The following reagents were purchased and used without purification: ZnI2(Alfa), ZnPh 2 (Alfa), NiCl2-glyme (Strem), glyme (Fluka), THF (anhydrous; Aldrich),
(1S,2S)-(+)-2-amino-3-methoxy-1-phenyl-l-propanol (Aldrich), and (lR,2R)-(+)-2-
amino-1 -phenyl-1,3-propanediol (TCI).
HPLC analyses were carried out on an Agilent 1100 series system with Daicel
Chiralpak@ columns.
2. Preparation of a-Bromoketones
General Procedure: Bromine (1.0 equiv) was added to a solution of the ketone
in Et20. The solution was stirred for 30 min, and then the reaction was quenched with
10% aqueous potassium carbonate (10 mL). The organic layer was washed with
sodium thiosulfate (10 mL) and brine (10 mL), dried over sodium sulfate, and
concentrated. The a-bromoketone was purified by flash chromatography.
These procedures have not been optimized.
0
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-Br
2-Bromo-1-phenylbutan-1-one [877-35-0]. Prepared from butyrophenone
(1.49 g, 10 mmol) and bromine (0.51 mL, 10 mmol) in Et20 (25 mL). Solvent system
for chromatography: 3:1-+2:1 hexanes:dichloromethane. The product was isolated as a
yellow oil in 70% yield (1.6 g).
1H NMR (400 MHz, CDCl3): 3 8.04-8.02 (m, 2H), 7.62-7.59 (m, 1H), 7.52-7.48
(m, 2H), 5.09 (dd, J= 7.2, 7.6 Hz, 1H), 2.29-2.11 (m, 2H), 1.10 (t, J= 7.6 Hz, 3H);
13C NMR (100 MHz, CDCl 3): 3 193.4, 134.7 133.9, 129.0, 128.0, 49.3, 27.1,
12.4;
JR (film): 1683, 1597, 1448, 1226, 1002, 899, 802, 703 cm-';
LRMS (EI) for CioH 10 (M-Br): caled 147, found 147.
0
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2-Bromo-1,3-diphenylpropan-1-one [51012-66-9]. Prepared from 3-
phenylpropiophenone (2.3 g, 10 mmol) and bromine (0.51 mL, 10 mmol) in Et2O (20
mL). Solvent system for chromatography: 4:1-+2:1 hexanes:dichloromethane. The
product was isolated as a white solid in 79% yield (2.3 g).
IH NMR (400 MHz, CDCl 3): a 8.00-7.97 (m, 2H), 7.61-7.57 (m, 1H), 7.49-7.45
(m, 2H), 7.33-7.24 (m, 5H), 5.34 (t, J= 7.2 Hz, 1H), 3.69 (dd, J= 7.6, 14 Hz, 1H), 3.38
(dd, J= 7.4, 14 Hz, 1H);
13C NMR (100 MHz, CDCl 3): a 193.0, 137.7, 134.6, 134.0, 129.7, 129.04,
128.97, 128.8, 127.3, 46.8, 39.7;
LRMS (El) for C15H130 (M-Br): calcd 209, found 209.
0
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2-Bromo-4-chloro-1-phenylbutan-1-one [52868-15-2]. Prepared from 4-
chlorobutyrophenone (1.81 g, 10 mmol) and bromine (0.51 mL, 10 mmol) in Et20 (20
mL). Solvent system for chromatography: 3:1-+2:1 hexanes:dichloromethane. The
product was isolated as a yellow oil in 89% yield (1.8 g).
1H NMR (400 MHz, CDCl 3): a 8.14-8.07 (m, 2H), 7.68-7.64 (m, 1H), 7.58-7.54
(m, 2H), 5.55 (dd, J= 2.4, 7.6 Hz, 1H), 3.85-3.78 (m, 2H), 2.76-2.57 (m, 2H);
13C NMR (100 MHz, CDCl 3): a 192.7, 134.20, 134.17, 129.2, 129.1, 43.9, 42.6,
35.9;
IR (film): 1685, 1596, 1449, 1257, 1178, 851, 707 cm-1;
LRMS (EI) for CioH 1oBrO (M-Cl): calcd 225, found 225.
0
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2-Bromo-4-methyl-1-phenylpentan-1-one [33809-96-0]. Prepared from 4-
methylvalerophenone (2.3 g, 13.1 mmol), which was prepared according to a literature
procedure,5 5 and bromine (0.67 mL, 13.1 mmol) in Et20 (30 mL). Solvent system for
chromatography: 3:1 hexanes:dichloromethane. The product was isolated as a clear,
colorless oil in 30% yield (1.0 g).
5 Cho, C. S. J. Mo. Catal. A: Chem. 2005, 240, 55-60.
'H NMR (400 MHz, CDCl 3): d 8.05-8.02 (m, 2H), 7.63-7.59 (m, 1H), 7.53-7.49
(m, 2H), 5.23 (dd, J= 6.4, 8.0 Hz, 1H), 2.12-1.99 (m, 2H), 1.91-1.81 (m, 1H), 0.98 (dd,
J= 3.6, 6.8 Hz, 6H);
13C NMR (100 MHz, CDC 3): 6 193.5, 134.7, 133.9, 129.03, 129.00, 45.9, 42.2,
26.5, 22.9, 22.0;
IR (film): 1687, 1597, 1448, 1369, 1278, 705, 686 cm';
LRMS (EI) for C12H150 (M-Br): calcd 175, found 175.
0
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2-Bromo-1-(4-methoxyphenyl)propan-1-one [21086-33-9]. Prepared from 4-
methoxypropiophenone (1.64 g, 10 mmol) and bromine (0.51 mL, 10 mmol) in Et20(20 mL). Solvent system for chromatography: 1:1 hexanes:dichloromethane. The
product was isolated as a white solid in 61% yield (1.5 g).
'H NMR (400 MHz, CDCl 3): 6 8.02 (dd, J= 2.4, 8.8 Hz, 2H), 6.96 (dd, J= 2.4,
8.8 Hz, 2H), 5.27 (q, J= 6.8 Hz, 1H), 3.88 (s, 3H), 1.89 (d, J= 6.8 Hz, 3H);
13C NMR (100 MHz, CDCl 3): 6 192.2, 164.1, 131.5, 127.0, 114.1, 55.7, 41.7,
20.4.
0
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2-Bromo-1-(4-(trifluoromethyl)phenyl)propan-1-one [95728-57-7].
Prepared from 4-(trifluoromethyl)propiophenone (2.02 g, 10 mmol) and bromine (0.51
mL, 10 mmol) in Et2O (25 mL). Solvent system for chromatography: 3:1->2:1
hexanes:dichloromethane. The product was isolated as a white solid in 64% yield (1.8
g).
'H NMR (400 MHz, CDC3 ): 6 8.14 (d, J= 8.4 Hz, 2H), 7.76 (d, J= 8.4 Hz,
2H), 5.27 (q, J= 6.4 Hz, 1H), 1.93 (d, J= 6.4 Hz, 3H);
1 3C NMR (100 MHz, CDC 3): d 192.3, 136.8, 134.8 (q, J = 132 Hz), 129.3,
125.8 (t, J= 16 Hz), 123.5 (q, J= 1088 Hz), 41.4, 19.8;
IR (film): 1694, 1446, 1410, 1154, 1119, 1056, 999, 861, 768, 701 cm;
LRMS (EI) for C1oH8BrF30: calcd 280, found 280.
F 0
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2-Bromo-1-(2-fluorophenyl)propan-1-one [186036-09-9]. Prepared from 2'-
fluoropropiophenone (1.51 g, 10 mmol) and bromine (0.51 mL, 10 mmol) in Et20 (20
mL). Solvent system for chromatography: 3:1 hexanes:dichloromethane. The product
was isolated as a clear, colorless oil in 75% yield (1.7 g).
H NMR (400 MHz, CDCl3): a 7.91-7.87 (m, 1H), 7.55-7.53 (m, 1H), 7.27-7.24
(m, 1H), 7.12 (ddd, J= 0.8, 8.0, 11.2 Hz, 1H), 5.30 (dq, J= 1.2, 6.8 Hz, 1H), 1.89 (dd,
J= 0.8, 6.8 Hz, 3H).
Et 0
-Br
2-Bromo-1-(2-ethylphenyl)propan-1-one. Prepared from 2'-
ethylpropiophenone (0.97 g, 6.3 mmol) and bromine (0.32 mL, 6.3 mmol) in Et 20 (12
mL). Solvent system for chromatography: 3:1->2:1 hexanes:dichloromethane. The
product was isolated as a yellow oil in 75% yield (1.1 g).
H NMR (400 MHz, CDCl3 ): 6 7.60-7.58 (m, 1H), 7.47-7.43 (m, 1H), 7.34 (d, J
= 7.6 Hz, 1H), 7.30-7.26 (m, 1H), 5.20 (q, J= 6.4 Hz, 1H), 2.88-2.77 (m, 2H), 1.90 (d,
J= 6.4 Hz, 3H), 1.27 (t, J= 7.6 Hz, 3H);
13C NMR (100 MHz, CDCl3): a 197.4, 145.4, 135.8, 132.1, 130.7 127.7, 125.8,
45.5, 27.1, 20.6, 16.1;
IR (film): 1688, 1444, 1331, 1222, 941, 754 cm-;
LRMS (EI) for CIIH 3 0 (M-Br): calcd 161, found 161.
0
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2-Bromo-1-(thiophen-2-yl)propan-1-one [75815-46-2]. Prepared from 2-
propionylthiophene (1.94 g, 13.9 mmol) and bromine (0.71 mL, 13.9 mmol) in Et2 0
(20 mL). Solvent system for chromatography: 3:1 hexanes:dichloromethane. The
product was isolated as an orange oil in 40% yield (0.88 g).
'H NMR (400 MHz, CDCl 3): a 7.85 (dd, J= 1.0, 4.0 Hz, 1H), 7.70 (dd, J= 1.0,
5.2 Hz, 1H), 7.17 (dd, J= 4.0, 5.2 Hz, 1H), 5.15 (q, J= 6.8 Hz, 1H), 1.90 (d, J= 6.8 Hz,
3H);
13C NMR (100 MHz, CDCl 3): a 187.1, 141.0, 135.2, 133.3, 128.6, 42.7, 20.6;
IR (film): 1666, 1519, 1413, 1246, 1167, 1065, 855, 723, 648 cm;
LRMS (EI) for C7H8BrOS (M+H): calcd 219, found 219.
11. Preparation of Ligand 2
11N OHPh..00 hMeO NJ OMe H2N HPh ,_Ph_ N Ph
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,6 -Bis((4S,5S)-4-(methoxymethyl)-5-phenyl-4,5-dihydrooxazol-2-
yl)pyridine ((+)-2). A solution of (1S,2S)-(+)-2-amino-3-methoxy-1-phenyl-1-
propanol (1.0 g, 5.5 mmol) and 2,6-pyridinedicarboximidic acid, dimethyl ester (531
mg, 2.75 mmol; 0.50 equiv) prepared according to a literature procedure56 in
dichloromethane (10 mL) was heated to reflux in a Schlenk tube for two days. The
solvent was then removed, and the residue was purified by flash chromatography (2%
triethylamine in ethyl acetate), which afforded the product as a white solid in 60% yield
(761 mg; not optimized).
IH NMR (400 MHz, CDCl 3): 6 8.24 (d, J= 8.0 Hz, 2H), 7.92 (t, J= 8.0 Hz, 1H),
7.33-7.26 (m, 1OH), 5.58 (d, J = 7.6 Hz, 2H), 4.42-4.37 (m, 2H), 3.74-3.70 (in, 2H),
3.63-3.59 (m, 2H), 3.42 (s, 6H);
13C NMR (100 MHz, CDCl 3): 6 163.1, 147.2, 140.5, 137.5, 128.9, 128.5, 126.4,
126.2, 84.9, 75.2, 74.3, 59.5;
IR (film): 1645, 1575, 1457, 1385, 1193, 1132, 964, 733, 699 cm;
HRMS (ESI) for C27H27N30 4 (M+H): calcd 458.2074, found 258.2063;
[a]2 2 D +90 (c 1.03, CDC 3).
OH
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2 ,6-Bis((4R,5R)-4-(methoxymethyl)-5-phenyl-4,5-dihydrooxazol-2-
yl)pyridine ((-)-2). A solution of (1R,2R)-2-amino-1-phenyl-1,3-propanediol (2.00 g,
12 mmol) and 2,6-pyridinedicarboximidic acid, dimethyl ester (1.16 g, 6.0 mmol; 0.5
equiv) in dichloromethane (30 mL) was heated to 80 *C in a Schlenk tube for 40 h.
The solvent was then removed, and the residue was washed with ethyl acetate to give
the Pybox diol (1.8 g), which was dissolved in THF (45 mL) and cooled to 0 'C. NaH
(351 mg, 14.7 mmol; 3.5 equiv) was added, and the solution was stirred for 1 h. Next,
iodomethane (5.2 mL, 83.5 mmol; 20 equiv) was added. The reaction mixture was
stirred overnight at room temperature, and then the reaction was quenched with
saturated ammonium chloride (10 mL). The mixture was washed with brine (10 mL),
dried over sodium sulfate, and concentrated. The resulting residue was passed through
a column of silica gel (eluant: 2% triethylamine in ethyl acetate). The residue was
56 MUller, P.; Bolka, C. Helv. Chim. Acta 2001, 84, 1093-1111.
recrystallized from ethyl acetate to give 400 mg of the product as a white solid (15%
yield; not optimized).
H NMR (400 MHz, CDCl 3): 6 8.24 (d, J= 8.0 Hz, 2H), 7.92 (t, J= 8.0 Hz, 1H),
7.33-7.26 (m, 10H), 5.58 (d, J = 7.6 Hz, 2H), 4.42-4.37 (in, 2H), 3.74-3.70 (m, 2H),
3.63-3.59 (im, 2H), 3.42 (s, 6H);
[a]2 2D-95 (c 1.01, CDCl3).
IV. Asymmetric a-Arylations of Ketones
General Procedure A: Asymmetric a-arylation with ArZnI: A solution of
the arylmagnesium bromide (1.6 mmol; 1.6 equiv) was added to a solution of ZnI2 (510
mg, 1.6 mmol; 1.6 equiv) in THF (final concentration of ArZnI = 0.20 M) under argon.
The mixture was stirred for 40 min at room temperature (a precipitate is immediately
observed), and then it was cooled to -30 *C. NiCl 2 -glyme (11.0 mg, 0.050 mmol; 0.050
equiv) and (+)-2 (29.9 mg, 0.065 mmol; 0.065 equiv) were added to an oven-dried 50-
mL flask. The flask was purged with argon, and the a-bromoketone (1.0 mmol; 1.0
equiv) was added, followed by glyme (13.5 mL). This solution was allowed to stir at
room temperature for 20 min, and then it was cooled to -30 'C. The suspension of
ArZnI (6.5 mL, 1.3 mmol; 1.3 equiv) was added dropwise over 3 min, and the reaction
mixture was stirred at -30 'C for 4 h. Then, the reaction was quenched with saturated
ammonium chloride (10 mL). The reaction mixture was diluted with Et20 (50 mL),
washed with distilled water (10 mL) and brine (10 mL), dried over magnesium sulfate,
and concentrated. The product was purified by flash chromatography.
The second run was conducted with (-)-2.
General Procedure B: Asymmetric a-arylation with Ar 2Zn: A solution of
ZnCl 2 in Et2O (1.0 M; 1.3 mL, 1.3 mmol; 1.3 equiv) under argon was diluted with THF
(5.2 mL) to provide a solution that was 0.20 M in zinc. A solution of the
arylmagnesium bromide (2.6 mmol; 2.6 equiv) was added (if a suspension formed, the
mixture was filtered through an acrodisc), and the solution was stirred for 20 min at r.t.
Then, the reaction mixture was cooled to -30 *C. NiCl2-glyme (11.0 mg, 0.050 mmol;
0.050 equiv) and (+)-2 (29.9 mg, 0.065 mmol; 0.065 equiv) were added to an oven-
dried 50-mL flask. The flask was purged with argon, and the a-bromoketone (1.00
mmol; 1.00 equiv) was added, followed by glyme (14.5 mL). This solution was
allowed to stir at room temperature for 20 min, and then it was cooled to -30 *C. The
solution of Ar2Zn (5.5 mL, 1.1 mmol; 1.1 equiv) was added dropwise over ~5 min, and
the reaction mixture was stirred at -30 'C for 90 min. Then, the reaction was quenched
with saturated ammonium chloride (10 mL). The reaction mixture was diluted with
Et20 (50 mL), washed with distilled water (10 mL) and brine (10 mL), dried over
magnesium sulfate, and concentrated. The product was purified by flash
chromatography.
The second run was conducted with (-)-2.
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1,2-Diphenylpropan-1-one (Table 2, entry 1; Table 4, entry 1). 2-
Bromopropiophenone (213 mg, 1.0 mmol) and an arylzinc reagent prepared from
phenylmagnesium bromide were used. Solvent system for chromatography: 3:1-+2:1
hexanes:dichloromethane. The product was isolated as a clear, colorless oil.
PhZnI: Run 1, 172 mg (82% yield, 96% ee). Run 2, 189 mg (90% yield, 96%
ee).
Ph2Zn (in situ): Run 1, 170 mg (81% yield, 93% ee). Run 2, 178 mg (85% yield,
93% ee).
Ph2Zn (solid): Run 1, 176 mg (84% yield, 95% ee). Run 2, 191 mg (91% yield,
95% ee).
The ee was determined on an OJ-H column (hexanes:isopropanol 99:1, flow 1.0
mL/min), with enantiomers eluting at 14.7 (minor) and 16.8 (major) min.
H NMR (400 MHz, CDCl 3): 6 7.98-7.96 (m, 2H), 7.51-7.47 (m, 1H), 7.41-7.37
(m, 2H), 7.31-7.26 (m, 4H), 7.24-7.20 (m, 1H), 4.71 (q, J= 6.8 Hz, 1H), 1.55 (d, J=
6.8 Hz, 3H);
[a]22 D +190 (C 1.08, CHCl3); 96% ee, from (-)-2.
0
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1-Phenyl-2-m-tolylpropan-1-one (Table 2, entry 2; Table 4, entry 2). 2-
Bromopropiophenone (213 mg, 1.0 mmol) and an arylzinc iodide reagent prepared
from m-tolylmagnesium bromide were used. Solvent system for chromatography:
3:1-.2:1 hexanes:dichloromethane. The product was isolated as a yellow oil.
Ar2Zn: Run 1, 201 mg (90% yield, 94% ee). Run 2 192 mg (85% yield, 91%
ee).
ArZnI: Run 1, 197 mg (88% yield, 95% ee). Run 2, 195 mg (87% yield, 93%
ee).
The ee was determined on an OJ-H column (hexanes:isopropanol 99:1, flow 1.0
mL/min), with enantiomers eluting at 12.6 (major) and 13.7 (minor) min.
H NMR (400 MHz, CDCl 3): a 7.99-7.97 (m, 2H), 7.49-7.47 (m, 1H), 7.41-7.37
(m, 2H), 7.22-7.18 (m, 1H), 7.12 (br s, 2H), 7.04-7.02 (m, 1H), 4.67 (q, J= 6.8 Hz, 1H),
2.32 (s, 3H), 1.54 (d, J= 6.8 Hz, 3H);
13C NMR (100 MHz, CDC13): a 200.6, 141.6, 138.9, 136.7, 133.0, 129.04,
129.98, 128.7, 128.5, 127.9, 125.1, 48.0, 21.6, 19.8;
IR (film): 1682, 1597, 1449, 1208, 95.7, 734, 693 cm-;
LRMS (EI) for C16H170 (M+H): calcd 225, found 225;
[a]2 2 D +182 (c 1.13, CHCl 3); 93% ee, from (-)-2.
0Phl Me
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2-(3-Methoxyphenyl)-1-phenylpropan-1-one (Table 2, entry 4). 2-
Bromopropiophenone (213 mg, 1.0 mmol) and a diarylzine reagent prepared from 3-
methoxyphenylmagnesium bromide were used. Solvent system for chromatography:
1:1 hexanes:dichloromethane. The product was isolated as a clear, colorless oil.
Ar2Zn (in situ): Run 1, 206 mg (86% yield, 96% ee). Run 2, 211 mg (88% yield,
93% ee).
The ee was determined on an OD-H column (hexanes:isopropanol 99:1, flow
1.0 mL/min), with enantiomers eluting at 7.3 (minor) and 8.8 (major) min.
'H NMR (400 MHz, CDCl 3): 6 7.95-7.93 (m, 2H), 7.46-7.42 (m, 1H), 7.37-7.33
(m, 2H), 7.21-7.17 (m, 1H), 6.87-6.85 (m, 1H), 6.82-6.81 (m, 1H), 6.73-6.71 (m, 1H),
4.64 (q, J= 6.8 Hz, 1H), 3.73 (s, 3H), 1.51 (d, J= 6.8 Hz, 3H);
13C NMR (100 MHz, CDCl3): 6 200.3, 160.2, 143.2, 136.7, 133.0, 130.2, 129.0,
128.7, 120.4, 113.7, 112.3, 55.4, 48.1, 19.7;
IR (film): 1682, 1598, 1485, 1448, 1264, 1045, 957, 693 cm~;
LRMS (EI) for C16H17 0 2 (M+H): calcd 241, found 241;
[a]22 D +166 (c 1.04, CHC 3); 93% ee, from (-)-2.
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2-(4-Fluorophenyl)-1-phenylpropan-1-one (Table 2, entry 4; Table 4, entry
3). 2-Bromopropiophenone (213 mg, 1.0 mmol) and an arylzinc iodide reagent
prepared from p-fluorophenylmagnesium bromide were used. Solvent system for
chromatography: 3:1-+2:1 hexanes:dichloromethane. The product was isolated as a
yellow oil.
Ar2Zn: Run 1, 171 mg (75% yield, 95% ee). Run 2, 190 mg (83% yield, 95%
ee).
ArZnI: Run 1, 162 mg (71% yield, 96% ee). Run 2, 173 mg (76% yield, 96%
ee).
The ee was determined on an OJ-H column (hexanes:isopropanol 99:1, flow 1.0
mL/min), with enantiomers eluting at 12.5 (major) and 14.2 (minor) min.
H NMR (400 MHz, CDCl3): 6 7.96-7.94 (m, 2H), 7.53-7.48 (m, 1H), 7.42-7.39
(m, 2H), 7.28-7.25 (m, 2H), 7.02-6.97 (m, 2H), 4.71 (q, J= 6.8 Hz, 1H), 1.54 (d, J=
6.8 Hz, 3H);
13C NMR (100 MHz, CDCl 3): 6 200.4, 162.0, 137.3, 136.4, 133.1, 129.5, 128.9,
128.8, 116.0, 47.1, 19.8;
IR (film): 1684, 1507, 1448, 1223, 840, 738 cm-1;
LRMS (EI) for C15H14 FO (M+H): caled 229, found 229;
[a]2D +159 (c 1.02, CHCl3 ); 96% ee, from (-)-2.
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2
-(4-Methoxyphenyl)-1-phenylpropan-1-one (Table 2, entry 5; Table 4,
entry 4) [(S) enantiomer: 35572-39-5]. 2-Bromopropiophenone (213 mg, 1.0 mmol)
and an arylzine iodide reagent prepared from 4-methoxyphenylmagnesium bromide
were used. Solvent system for chromatography: 1:1 hexanes:dichloromethane. The
product was isolated as a yellow oil.
Ar2Zn: Run 1, 199 mg (83% yield, 93% ee). Run 2, 182 mg (76% yield, 90%
ee).
ArZnI: Run 1, 230 mg (96% yield, 96% ee). Run 2, 214 mg (89% yield, 95%
ee).
The ee was determined on an AD-H column (hexanes:isopropanol 99:1, flow
1.0 mL/min), with enantiomers eluting at 11.2 (minor) and 14.4 (major) min.
1H NMR (400 MHz, CDCl 3): 6 7.94-7.91 (m, 2H), 7.47-7.43 (m, lH), 7.37-7.33
(m, 2H), 7.24-7.15 (m, 2H), 6.83-6.79 (m, 2H), 4.65 (q, J= 6.8 Hz, 1H), 3.76 (s, 3H),
1.51 (d, J= 6.8 Hz, 3H);
[a]22D +161 (c 1.00, CHCl3); 95% ee, from (-)-2.
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2-(4-(Dimethylamino)phenyl)-1-phenylpropan-1-one (Table 2, entry 6;
Table 4, entry 5) [740843-43-0]. 2-Bromopropiophenone (213 mg, 1.0 mmol) and an
arylzinc iodide reagent prepared from p-(NN-dimethylamino)phenylmagnesium
bromide were used. Solvent system for chromatography: 49:49:2
hexanes:dichloromethane:triethylamine. The product was isolated as a white solid.
Ar2Zn: Run 1, 231 mg (91% yield, 88% ee). Run 2, 219 mg (86% yield, 89%
ee).
ArZnI: Run 1, 218 mg (86% yield, 93% ee). Run 2, 213 mg (84% yield, 92%
ee).
The ee was determined on an AD-H column (hexanes:isopropanol 95:5, flow
1.0 mL/min), with enantiomers eluting at 7.5 (minor) and 10.9 (major) min.
'H NMR (400 MHz, CDCl 3): 6 8.03-8.01 (m, 2H), 7.47-7.46 (m, 1H), 7.41-7.37
(m, 2H), 7.21-7.19 (m, 2H), 6.71-6.69 (m, 2H), 4.65 (q, J= 6.8 Hz, 1H), 2.91 (s, 6H),
1.55 (d, J= 6.8 Hz, 3H);
IR (film): 1684, 1653, 1559, 1521, 1507, 1228 cm;
[a]22D -162 (c 0.98, CHCl3); 93% ee, from (+)-2.
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2-(4-(Methylthio)phenyl)-1-phenylpropan-1-one (Table 2, entry 7; Table 4,
entry 6). 2-Bromopropiophenone (213 mg, 1.0 mmol) and an arylzinc iodide reagent
prepared from 4-(methylthio)phenylmagnesium bromide were used. Solvent system for
chromatography: 1:1 hexanes:dichloromethane. The product was isolated as a white
solid.
Ar2Zn: Run 1, 217 mg (85% yield, 93% ee). Run 2, 201 mg (78% yield, 91%
ee).
ArZnI: Run 1, 182 mg (71% yield, 96% ee). Run 2, 182 mg (71% yield, 95%
ee).
The ee was determined on an AS-H column (hexanes:isopropanol 99:1, flow 1.0
mL/min), with enantiomers eluting at 7.7 (minor) and 8.9 (major) min.
1H NMR (400 MHz, CDC 3): 6 7.96-7.94 (m, 2H), 7.51-7.47 (m, 1H), 7.41-7.37
(m, 2H), 7.23-7.17 (m, 4H), 4.66 (q, J= 6.8 Hz, 1H), 2.44 (s, 3H), 1.52 (d, J= 6.8 Hz,
3H);
13 C NMR (100 MHz, CDCl 3): 6 200.4, 138.4, 137.1, 136.6, 133.1, 128.9, 128.7,
128.5, 127.3, 47.5, 19.6, 16.0;
IR (film): 2927, 2361, 1653, 1457, 1131, 971, 699 cm-;
LRMS (EI) for C16H 170S (M+H): calcd 257, found 257;
[a] D +125 (c 1.00, CHCl3 ); 95% ee, from (-)-2.
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1,2-Diphenylbutan-1-one (Table 3, entry 1; Table 4, entry 7) [(S)
enantiomer: 175274-19-8; (R) enantiomer: 175274-18-7]. 2-Bromo-1-phenylbutan-
1-one (227 mg, 1.0 mmol) and an arylzinc reagent prepared from phenylmagnesium
bromide were used. Solvent system for chromatography: 3:1 ->2:1
hexanes:dichloromethane. The product was isolated as a white solid.
Ph 2Zn (in situ): Run 1, 202 mg (90% yield, 88% ee). Run 2, 209 mg (93%
yield, 88% ee).
PhZnI: Run 1, 186 mg (83% yield, 94% ee). Run 2, 197 mg (88% yield, 93%
ee).
The ee was determined on an OD-H column (hexanes:isopropanol 99:1, flow
1.0 mL/min), with enantiomers eluting at 5.2 (minor) and 5.8 (major) min.
H NMR (400 MHz, CDCl 3): 6 8.00-7.98 (m, 2H), 7.50-7.47 (m, 1H), 7.42-7.38
(m, 2H), 7.35-7.30 (m, 4H), 7.24-7.22 (m, 1H), 4.47 (t, J= 7.0 Hz, 1H), 2.26-2.19 (m,
1H), 1.92-1.85 (m, 1H), 0.93 (t, J= 7.4 Hz, 3H);
[a]2 2 D +155 (c 1.01, CHCl3); 88% ee, from (-)-2.
0
Ph - Ph
Ph
1,2,3-Triphenylpropan-1-one (Table 3, entry 2; Table 4, entry 8). 2-Bromo-
1,3-diphenylpropan-1-one (289 mg, 1.0 mmol) and an arylzinc iodide reagent prepared
from phenylmagnesium bromide were used. Solvent system for chromatography:
3:1->2:1 hexanes:dichloromethane. The product was isolated as a white solid.
Ph2Zn (in situ): Run 1, 257 mg (90% yield, 86% ee). Run 2, 237 mg (83%
yield, 89% ee).
PhZnI: Run 1, 206 mg (72% yield, 95% ee). Run 2, 229 mg (80% yield, 94%
ee).
The ee was determined on an OJ-H column (hexanes:isopropanol 99:1, flow 1.0
mL/min), with enantiomers eluting at 17.2 (major) and 20.0 (minor) min.
'H NMR (400 MHz, CDCl 3): 6 7.93-7.89 (m, 2H), 7.48-7.44 (m, 1H), 7.38-7.34
(m, 2H), 7.30-7.19 (m, 7H), 7.17-7.13 (m, 1H), 7.11-7.08 (m, 2H), 4.83 (t, J= 7.2 Hz,
1H), 3.58 (dd, J= 7.2, 13.6 Hz, 1H), 3.08 (dd, J= 7.2, 13.6 Hz, 1H);
"C NMR (100 MHz, CDCl 3): 6 199.4, 140.0, 139.3, 136.9, 133.1, 129.3, 129.1,
128.9, 128.7, 128.5, 128.4, 127.4, 126.3, 56.1, 40.3;
IR (film): 1675, 1596, 1447, 1244, 950, 757, 736, 695 cm~;
LRMS (EI) for C21Hi 80: calcd 286, found 286;
[a]2 2 D +215 (c 1.00, CHCl3); 94% ee, from (-)-2.
0
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4-Chloro-1,2-diphenylbutan-1-one (Table 3, entry 3; Table 4, entry 9). 2-
Bromo-4-chloro-1-phenylbutan-1-one (262 mg, 1.0 mmol) and an arylzinc reagent
prepared from phenylmagnesium bromide were used. The reaction was run at -20 'C.
Solvent system for chromatography: 3:1->2:1 hexanes:dichloromethane. The product
was isolated as a yellow oil.
Ph 2Zn (in situ): Run 1, 203 mg (78% yield, 87% ee). Run 2, 219 mg (83%
yield, 89% ee).
PhZnI: Run 1, 225 mg (87% yield, 93% ee). Run 2, 240 mg (93% yield, 91%
ee).
IThe ee was determined on an OJ-H column (hexanes:isopropanol 99:1, flow 1.0
mL/min), with enantiomers eluting at 16.0 (minor) and 16.9 (major) min.
'H NMR (400 MHz, CDCl 3): 6 8.00-7.97 (m, 2H), 7.52-7.49 (m, 1H), 7.42-7.38
(m, 2H), 7.34-7.31 (m, 4H), 7.26-7.22 (m, 1H), 4.47 (dd, , J= 6.8, 7.6 Hz, 1H), 3.63-
3.58 (m, 1H), 3.47-3.41 (m, 1H), 2.64-2.56 (m, 1H), 2.35-2.27 (m, 1H);
13C NMR (100 MHz, CDC 3): 6 199.2, 138.3, 136.5, 133.3, 129.4, 129.0, 128.8,
128.5, 127.7, 50.3, 43.3, 36.2;
IR (film): 1684, 1653, 1559, 1540, 1507, 1448, 756, 698 cm;
LRMS (EI) for C16H15C1O: calcd 258, found 258;
[a]22 D +233 (c 1.02, CHCl3); 91% ee, from (-)-2.
0
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4-Methyl-1,2-diphenylpentan-1-one (Table 3, entry 4). 2-Bromo-4-methyl-1-
phenylpentan-1-one (191 mg, 0.75 mmol) and an arylzine reagent prepared from
phenylmagnesium bromide were used. Solvent system for chromatography: 3:1->2:1
hexanes:dichloromethane. The product was isolated as a white solid.
Ph 2Zn (in situ): Run 1, 168 mg (89% yield, 94% ee). Run 2, 166 mg (88% yield,
95% ee).
The ee was determined on an IA-H column (hexanes:isopropanol 99:1, flow 1.0
mL/min), with enantiomers eluting at 5.2 (minor) and 6.2 (major) min.
1H NMR (400 MHz, CDCl 3): 6 7.99 (d, J= 7.2 Hz, 2H), 7.50 (t, J= 7.2 Hz, 1H),
7.43-7.39 (m, 2H), 7.34-7.27 (m, 4H), 7.23-7.19 (m, 1H), 4.69 (t, J= 7.2 Hz, 1H), 2.13-
2.069 (m, 1H), 1.75 (q, J= 6.8 Hz, 1H), 1.51 (s, J= 6.8 Hz, 1H), 0.96 (d, J= 6.8 Hz,
3H), 0.91 (d, J= 6.8 Hz, 3H);
13C NMR (100 MHz, CDCl 3): 8 200.4, 140.0, 137.1, 133.0, 129.1, 128.8, 128.7,
128.4, 127.1, 51.5, 43.2, 26.0, 23.1, 22.7;
IR (film): 1682, 1597, 1448, 1208, 757, 698 cm;
LRMS (EI) for C18H2 10 (M+H): calcd 253, found 253;
[a]2 2D +144 (c 0.98, CHCl3); 95% ee, from (-)-2.
F 0
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1-(2-Fluorophenyl)-2-phenylpropan-1-one (Table 3, entry 5; Table 4, entry
10). 2-Bromo-1-(2-fluorophenyl)propan-1-one (231 mg, 1.0 mmol) and an arylzinc
reagent prepared from phenylmagnesium bromide were used. Solvent system for
chromatography: 3:1 hexanes:dichloromethane. The product was isolated as a yellow
oil.
Ph2Zn (in situ): Run 1, 151 mg (66% yield, 70% ee). Run 2, 157 mg (69%
yield, 71% ee).
PhZnI: Run 1, 182 mg (80% yield, 73% ee). Run 2, 180 mg (79% yield, 70%
ee).
The ee was determined on an OJ-H column (hexanes:isopropanol 99:1, flow 1.0
mL/min), with enantiomers eluting at 12.5 (minor) and 16.3 (major) min.
H NMR (400 MHz, CDCl3): 6 7.75 (td, J= 2.0, 7.6 Hz, 1H), 7.43-7.37 (m, 1H),
7.29-7.27 (m, 4H), 7.22-7.18 (m, 1H), 7.14 (td, J= 1.2, 7.6 Hz, 1H), 7.03 (ddd, J= 1.2,
8.4, 11.2 Hz, 1H), 4.65 (m, 1H), 1.56 (dd, J= 0.8, 6.8 Hz, 3H);
13C NMR (100 MHz, CDCl3): 6 199.8 (d, J= 16 Hz), 161.1 (d, J= 1000 Hz),
140.7, 134.2 (d, J= 36 Hz), 131.2 (d, J= 12 Hz), 128.9, 128.4, 127.2, 126.3 (d, J= 52
Hz), 124.6 (d, J= 16 Hz), 116.7 (d, J= 96 Hz), 52.1 (d, J= 28 Hz), 19.1;
IR (film): 1687, 1609, 1480, 1450, 1273, 1212, 762, 700 cm-1;
LRMS (EI) for C15HI3FO: calcd 228, found 228;
[a]2 2 D +175 (c 1.04, CHCl3); 70% ee, from (-)-2.
Et 0
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1-(2-Ethylphenyl)-2-phenylpropan-1-one (Table 3, entry 6; Table 4, entry
11). 2-Bromo-1-(2-ethylphenyl)propan-1-one (241 mg, 1.0 mmol) and an arylzinc
iodide reagent prepared from phenylmagnesium bromide were used. The reaction was
run at -20 'C, with a large stir bar. Solvent system for chromatography: 3:1-+2:1
hexanes:dichloromethane. The product was isolated as a yellow oil.
Ph2Zn (in situ): Run 1, 110 mg (46% yield, 74% ee). Run 2, 93 mg (39% yield,
78% ee).
PhZnI: Run 1, 195 mg (82% yield, 75% ee). Run 2, 181 mg (76% yield, 70%
ee).
The ee was determined on an OJ-H column (hexanes:isopropanol 99:1, flow 1.0
mL/min), with enantiomers eluting at 11.6 (major) and 20.1 (minor) min.
1H NMR (400 MHz, CDCl 3): 6 7.54 (dd, J = 1.2, 7.6 Hz, 1H), 7.34-7.21 (m,
8H), 4.58 (q, J= 6.8 Hz, 1H), 2.69-2.59 (m, 2H), 1.63 (d, J= 7.2 Hz, 3H), 1.17 (t, J=
7.6 Hz, 3H);
13C NMR (100 MHz, CDCl 3): 8 205.3, 144.0. 140.5, 138.9, 131.0, 130.3, 129.0,
128.3, 127.8, 127.2, 125.5, 51.3, 26.9, 18.7, 16.2;
IR (film): 1687, 1600, 1453, 1250, 943, 756, 700 cm;
LRMS (EI) for C17HI80: calcd 238, found 238;
[a]2 2 D -79 (c 1.03, CHC 3); 71% ee, from (+)-2.
0
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1-(4-Methoxyphenyl)-2-phenylpropan-1-one (Table 3, entry 7; Table 4,
entry 12) [(S) enantiomer: 36065-28-8 ; (R) enantiomer: 28968-16-3]. 2-Bromo-1-
(4-methoxyphenyl)propan-1-one (243 mg, 1.0 mmol) and an arylzinc iodide reagent
prepared from phenylmagnesium bromide were used. Solvent system for
chromatography: 1:1 dichloromethane:hexanes. The product was isolated as a white
solid.
Ph2Zn (in situ): Run 1, 219 mg (91% yield, 94% ee). Run 2, 221 mg (92%
yield, 95% ee).
Run 1, 206 mg (86% yield, 97% ee). Run 2, 223 mg (93% yield, 95% ee).
The ee was determined on an AS-H column (hexanes:isopropanol 99:1, flow 1.0
mL/min), with enantiomers eluting at 9.8 (minor) and 11.1 (major) min.
H NMR (400 MHz, CDCl 3): 6 7.95-7.91 (m, 2H), 7.27-7.26 (m, 4H), 7.19-7.16
(m, 1H), 6.86 (d, J= 8.8 Hz, 2H), 4.67 (q, J= 6.8 Hz, 1H), 3.80 (s, 3H), 1.54 (d, J= 6.8
Hz, 3H);
1 3C NMR (100 MHz, CDCl 3): 6 199.1, 163.4, 142.1, 131.3, 129.6, 129.1, 127.9,
127.0, 113.9, 55.6, 47.7, 19.8;
IR (film): 1674, 1600, 1510, 1251, 1170, 1029, 701 cm-;
LRMS (EI) for C16H17 0 2 (M+H): calcd 241, found 241;
[a]22 D +117 (c 1.03, CHC 3); 95% ee, from (-)-2.
0
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Ph
F3C h e
2-Phenyl-1-(4-(trifluoromethyl)phenyl)propan-1-one (Table 3, entry 8;
Table 4, entry 13). 2-Bromo-1-(4-(trifluoromethyl)phenyl)propan-1-one (281 mg, 1.0
mmol) and an arylzinc reagent prepared from phenylmagnesium bromide were used.
Solvent system for chromatography: 3:1-+2:1 hexanes:dichloromethane. The product
was isolated as a white solid.
Ph2Zn (in situ): Run 1, 220 mg (79% yield, 89% ee). Run 2, 234 mg (84% yield,
88% ee).
PhZnI: Run 1, 203 mg (73% yield, 87% ee). Run 2, 217 mg (78% yield, 86%
ee).
The ee was determined on an OJ-H column (hexanes:isopropanol 99:1, flow 1.0
mL/min), with enantiomers eluting at 7.1 (minor) and 8.3 (major) min.
1H NMR (400 MHz, CDCl 3): 6 8.04 (d, J = 8.0 Hz, 2H), 7.64 (d, J = 8.0 Hz,
2H), 7.28-7.21 (m, 5H), 4.67 (q, J= 6.8 Hz, 1H), 1.56 (d, J= 6.8 Hz, 3H);
13C NMR (100 MHz, CDCl3 ): 6 199.4, 141.0, 139.4, 134.2 (q, J = 128 Hz),
129.4, 129.3, 127.9, 127.4, 125.7 (q, J= 16 Hz), 123.8 (q, J= 1084 Hz), 48.7, 19.6;
IR (film): 1690, 1409, 1323, 1170, 1130, 1067, 700 cm~;
LRMS (EI) for C16H13F 30: calcd 278, found 278;
[a]22D +145 (c 1.05, CHC 3); 86% ee, from (-)-2.
0
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2-Phenyl-1-(thiophen-2-yl)propan-1-one (Table 3, entry 9; Table 4, entry
14). 2-Bromo-1-(thiophen-2-yl)propan-1-one (219 mg, 1.0 mmol) and an arylzinc
reagent prepared from phenylmagnesium bromide were used. The reaction was run for
six hours. Solvent system for chromatography: 3:1-2:1 hexanes:dichloromethane.
The product was isolated as a white solid.
Ph 2Zn (in situ): Run 1, 192 mg (89% yield, 92% ee). Run 2, 186 mg (86%
yield, 93% ee).
Run 1, 171 mg (79% yield, 95% ee). Run 2, 179 mg (83% yield, 96% ee).
The ee was determined on an OJ-H column (hexanes:isopropanol 99:1, flow 1.0
mL/min), with enantiomers eluting at 24.5 (minor) and 37.0 (major) min.
H NMR (400 MHz, CDCl 3): 6 7.68 (d, J= 3.6 Hz, 1H), 7.57 (dd, J= 0.8, 4.8
Hz, 1H), 7.35-7.30 (m, 4H), 7.27-7.22 (m, 1H), 7.05 (dd, J= 4.0, 4.4 Hz, 1H), 4.52 (s, J
= 6.8 Hz, 1H), 1.55 (d, J= 6.8 Hz, 3H);
1C NMR (100 MHz, CDCl 3): 6 193.5, 143.9, 141.5, 133.8, 132.6, 129.1, 128.2,
127.9, 127.3, 49.5, 19.4;
IR (film): 1661, 1414, 1323, 1235, 856, 699 cm-1;
LRMS (EI) for C13H1 30S (M+H): calcd 217, found 217;
[a]22 D +161 (c 1.00, CHCl3); 96% ee, from (-)-2.
Gram-scale asymmetric a-arylation of ketones: Negishi reaction of 2-
bromopropiophenone with phenylzinc iodide. Because the reaction mixture is
heterogeneous, we decided to determine if General Procedure A can be applied without
modification to a cross-coupling that is carried out on a larger scale. In a gram-scale
experiment, we found that the ee remains the same, but that the reaction is much slower.
However, if the cross-coupling is conducted at -10 'C, the desired product is obtained
in 93% ee and 81% yield.
V. Assignment of Absolute Configuration
The optical rotations were measured of the products generated in the presence of (-)-2.
0
Me
.-
Ph
Table 4, entry 1.
[a]22 D +190 (C 1.08, CHCl3); 96% ee, from (-)-2. Lit. 57 [a]' 9D +196 (c 1.10, CHCl3).
E Et3SiH Et
Ph AYEt , Ph-"P TFA PhPh
Table 4, entry 7.
[a] 22D -75 (c 1.01, CHCl3); 94% ee, from (-)-2. Lit.58 [a] 20D -102 (c 1, CHC 3).
57 Shionhara, T.; Suzuki, K. Synthesis 2003, 141-146.
58 Ruano, J. L. G.; Aranda, M. T.; Puente, M. Tetrahedron 2005, 61, 10099-10104.
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Section 1.3
Asymmetric Suzuki Arylation of a-Haloamides
A: Introduction
The Suzuki cross-coupling is a heavily utilized method for carbon-carbon bond
formation due to its functional-group tolerance and the low toxicity of the reaction
components. 59 However, the vast majority of these protocols have employed aryl
electrophiles. Our group's interest in the development of cross-coupling procedures for
secondary alkyl electrophiles plus the attractive qualities of Suzuki cross-couplings
have led us to consider Suzuki couplings of secondary alkyl electrophiles as highly
desirable goals. 0
Our first success in this area came in 2004 with Zhou's development of a
coupling protocol for arylboronic acids with secondary alkyl bromides and iodides
(Equation 24).61 This nickel-catalyzed process worked with bathophenanthroline as a
ligand, and it was applicable to couplings of primary alkyl iodides as well.
4% Ni(cod) 2
Ph Ph
8% -
Br (HO)2BN N-(4
Br (HO) 2 B 1.6 equiv KOt-Bu / (24)
cI s-BuOH, 60 OC Cl
1.2 equiv 75% yield
In 2006, Gonzilez-Bobes reported a more active catalyst system that could
couple secondary alkyl chlorides, bromides, and iodides with arylboronic acids, using a
59 Miyaura, N. In Metal-Catalyzed Cross-Coupling Reactions; de Meijere, A., Diederich, F., Eds.;
Wiley-VCH: New York, 2004; Chapter 2.
60 For references regarding Suzuki coupling and other cross-coupling methodologies of primary alkyl
electrophiles, see: Netherton, M. R.; Fu, G. C. In Topics in Organometallic Chemistry: Palladium in
Organic Synthesis; Tsuji, J., Ed.; Springer: New York, 2005, p 85-108.
61 Zhou, J.; Fu, G. C. J Am. Chem. Soc. 2004, 126, 1340-1341.
nickel/chiral amino alcohol catalyst (Equation 25).62 This catalyst system was the first
in our group to employ an amino alcohol ligand, and it led to increased interest in the
ability of this family of compounds (as well as diamines) to effect other nickel-
catalyzed couplings, especially asymmetric transformations.
Cl (HO)2B-Ph
1.5 equiv
6% Ni(cod) 2
12% N
H OH
2.0 equiv KHMDS
i-PrOH, 60 OC
Ph
80% yield
(25)
In addition to these Suzuki arylation protocols, our group has made advances in
the nickel-catalyzed Suzuki couplings of alkyl nucleophiles with secondary alkyl
electrophiles. In 2007, Saito reported that a nickel/diamine catalyst can couple alkyl 9-
borabicyclo[3.3.1]nonane (9-BBN) reagents with secondary alkyl bromides under the
conditions in Equation 26.63 Recently, Lu has extended this methodology to include
secondary alkyl chlorides (Equation 27).64
Br (9-BBN) "-- Ph
1.8 equiv
6% NiCI2'glyme
8%
MeHN NHMe
1.2 equiv KOt-Bu
2.0 equiv i-BuOH
dioxane, r.t.
(26)
Ph
75% yield
62 Gonzilez-Bobes, F.; Fu, G. C. J. Am. Chem. Soc. 2006, 128, 5360-5361.
63 Saito, B.; Fu, G. C. J. Am. Chem. Soc. 2007, 129, 9602-9603.
" Lu, Z.; Fu, G. C. Angew. Chem., Int. Ed. 2010, Early View.
6% NiBr 2-diglyme
Ph Ph
8%
MeHN NHMe
Cl (9-BBN Ph -Ph
1.2 equiv KOt-Bu
2.0 equiv i-BuOH
1.8 equiv 4 A molec. sieves
i-Pr20, r.t.
(27)
Ph
80% yield
An asymmetric variant of this chemistry has been developed using unactivated
homobenzylic electrophiles (Equation 2 8 ).41d In contrast to previous asymmetric
couplings in which the putative radical intermediate is in conjugation with a 7r-system
to facilitate stereoconvergence of the racemic electrophile (for an example, see Scheme
4 in section 1.1C), in this case it is believed that coordination between the phenyl ring
and the catalyst produces a more rigid geometry during the stereochemistry-
determining step, thus allowing for a high level of enantioselectivity. This class of
asymmetric cross-coupling reactions of unactivated secondary alkyl halides has
recently been expanded by Owston to include the Suzuki alkylation of acylated
halohydrins using alkyl-(9-BBN) reagents and a nickel/diamine catalyst. 41
' 
n-Bu
.; Br
(9-BBN)-"- Ph
1.8 equiv
10% NiBr 2diglyme
12%F 3C 
CF3
MeHN NHMe
1.2 equiv KOt-Bu
2.0 equiv i-BuOH
i-Pr20, 5 00
n-Bu
Ph
84% yield, 94% ee
As was previously mentioned, the chirality of the catalyst system in Equation 25
presented an intriguing opportunity for the development of an asymmetric Suzuki
arylation of secondary alkyl electrophiles. Preliminary results conducted by Gonzailez-
(28)
Bobes identified a-bromoamides as good candidates for such a process. Optimization
of reaction parameters resulted in the conditions summarized in Figure 3, and these
conditions serve as the starting point for the studies of this section of the thesis, which
are detailed in section B.
M 8% NiCl 2-glyme O16% ligand
Ph N Me Ph-B(OH) 2  , Ph'N Me
Me Br1.6 equiv KHMDS M
Me Br i-PrOH, 40 "C Me Ph
racemic 1.2 equiv
lNH2 OH
H H 'NH2 NH
66% yield, 52% ee 52% yield, -32% ee 77% yield, 40% ee 46% yield, 40% ee
Figure 3: Initial results for the coupling of arylboronic acids with a-bromoamides
B: Results and Discussion 6
With the results summarized in Figure 3, one strategy for increasing the yield
and enantioselectivity was to vary the N-substituents of the amide. Therefore, a range
of amide electrophiles was synthesized and screened, including N-alkyl-N-aryl, NN-
diaryl, NN-dialkyl, secondary, and Weinreb amide species (Figure 4).66 However,
none of these new electrophiles was able to produce enantioselectivity above 55% (1-
indolinyl amide), and of the amides capable of this level of selectivity, the yields, too,
remained moderate. Although the screening was focused primarily on a-bromoamides,
it is notable that a-chloroamides were able to couple with equal or greater efficiency
than the a-bromo counterparts (top versus bottom row of Figure 4), despite the lower
65 Portions of the work described in this section are published in: Lundin, P. M.; Fu, G. C. J Am. Chem.
Soc. 2010, 132, 11027-11029.
66 It was found that the identiy of the alkyl a-substituent had a small enough impact on the yield and
enantioselectivity. Therefore, in screening N-substituents, an a-methyl group was used as the standard.
reactivity of alkyl chlorides in oxidative addition reactions with transition metal
complexes. 62,63
0
R" N Me
R2 X
racemic
0
Ph, Me
Me Br
64% yield, 51% ee
0
Ph, L Me
N
Bn Br
63% yield, 35% ee
0
Ph.. Me
N
n-Bu Br
52% yield, 53% ee
0
Ph.. Me
H Br
68% yield, 4% ee
0
Ph.. Me
Me Cl
68% yield, 46% ee
Ph-B(OH)2
8% NiCI 2-glyme
16%
N
H NH,
1.6 equiv KHMDS
i-PrOH, 40 *C
0
R" N Me
R2 Ph
1.2 equiv
0
MeO.. Me
N
Me Br
62% yield, 45% ee
0
Ph.. Me
N
Ph Br
61% yield, 51% ee
0
Ph. Me
N
i-Pr Br
52% yield, 53% ee
0
Me
Me Me Br
58% yield, 20% ee
0
MeO.. Me
Me C1
71% yield, 35% ee
0
Me
Br
62% yield, 55% ee
0
N ' Me
% 
Br
0% yield
0
n-BuN Me
n-Bu Br
96% yield, 26% ee
"N 0
N iMe
Br
46% yield, 40% ee
0
Me
Cl
>99% yield, 45% ee
Figure 4: Electrophile screening
A second strategy for improving the reaction yield and ee was to identify a
ligand that would allow higher coupling efficiency and selectivity. Previously,
extensive screening of commercially available and easily accessible chiral amino
alcohols and diamines had been done to reach the conditions in Figure 3. Therefore,
effort was directed toward the synthesis of ligands that were variations on the best
ligand, the proline diamine (Figure 5). The effects of both larger and smaller ring sizes
were investigated, as well as the effects of incorporating substituents at both nitrogen
positions. However, these changes only produced inferior results in terms of yield and
enantioselectivity. Concurrent with these studies, the family of 1,2-diaryldiamines was
gaining prominence in our group due to their success in other coupling systems.41d' 44
However, they too gave lower yields and enantioselectivities.
(N
H NH2
65% yield, 52% ee
N
H NHi-Pr
18% yield, 23% ee
N OHH
27% yield, 42%ee
H OH
52% yield, 32% ee
N
Et NH2
5% yield, 0% ee
Me
H NH2
9% yield, 8% ee
Ph Ph Ph Ph
H2N NH2  MeHN NHMe
18% yield, 39% ee 73% yield, 19% ee
Figure 5: Ligand effects (for conditions, see
N N-
H NHPh H NHMe
10% yield, 0% ee 51% yield, 24% ee
(N N NH-1
NH2  H
46% yield, 17% ee 7% yield, 15%ee
Me ,HMe
N '4N
H OH H OH
28% yield, 36% ee 22% yield, 0% ee
F3C CF3
Ph Ph
BnHN NHBn BnHN NHBn
6% yield 86% yield, 10% ee
Figure 4)
As optimization of the electrophile, ligand, and other reaction parameters
(solvent, additives, etc.) had not produced fruitful results, we decided to turn to other
nucleophile classes with the hope that a suitable reaction partner for this coupling could
be found. A variety of B-phenyl boronate esters was explored, as well as potassium
phenyltrifluoroborate, triphenylboroxin, and Ph-(9-BBN) (Figure 6).67 Although most
species gave inferior results in comparison to those obtained with phenylboronic acid
(62% yield, 55% ee, Figure 3), triphenylboroxin did give an ee value of 60%. However,
the active nucleophile in this case is thought to be the in situ generated boronic acid
which lacks the impurities included in phenylboronic acid powder. It was therefore
postulated that the increase in ee was most likely due to this absence of impurities and
consequently that further improvement in yield and enantioselectivity would be as
difficult as it had been for phenylboronic acid powder.
67 At this stage, the indolinyl amide was employed, as it was found to be more stable upon storage during
long periods of time than the N-phenyl-N-methyl amide, besides offering a modest increase in
enantioselectivity (see Figure 4).
0N Et
Br
racemic
Ph-BR2
1.2 equiv
8% NiCl2.glyme
16%N
H NH2
ON
1.6 equiv KHMDS
i-PrOH, 40 OC, 24 h
Ph-Bj Ph-Bj
40% yield, 50% ee 35% yield, 30% ee 52% yield, 21% ee 17% yield, 39% ee
,O Ph-BF3 K 0.4 equiv (PhBO) 3Ph-B
with 5.6 equiv H20 with 1.2 equiv H20
30% yield, 34% ee 0% yield 44% yield, 60% ee
Figure 6: Scope of B-phenyl Suzuki nucleophiles
Ph-(9-BBN)
23% yield, 32% ee
Due to the substantial difference between the standard conditions used up to this
point and the best conditions for coupling with alkyl-(9-BBN) reagents, 41d,63,64 it was
decided to try Ph-(9-BBN) again as a reaction partner under conditions more similar to
those employed with alkyl-(9-BBN) nucleophiles. While the yield was lower, the
enantioselectivity was among the highest of what had been observed previously
(Equation 29).
0
Et
Ph
0
Ph-B
0
Ph-B'
o 8% NiCl2-glyme 0
N Et Ph-(9-BBN) 12%(S,S)-2 N Et (29)
Br 1.6 equiv KOt-Bu Ph1.6 equiv i-BuOH
racemic 1.2 equiv dioxane, r.t., 24 h 37% yield, 59% ee
Ph Ph
MeHN NHMe
(S,S)-2
Because these new reaction conditions offered many parameters to be optimized,
we decided to pursue coupling with Ph-(9-BBN). Table 5 contains a concise summary
of the optimization process. Ethereal solvents were found to be good, but toluene
seemed to offer a slight advantage in terms of enantioselectivity of the reaction (entry 3
versus entries 1 and 2). A change of the alcohol additive from i-BuOH to MeOH
increased the ee (entry 4), whereas increasing the equivalents of nucleophile improved
the yield (entry 5). Decreasing the reaction temperature to -10 'C further improved the
ee value obtained (entry 6). Variations on the N,N'-dimethyl-1,2-diarylethylene-
diamine scaffold of 2 led to the identification of 3, which is commercially available, as
the best ligand in this coupling reaction (entry 7). At this juncture, however,
reproducibility problems hindered further optimization. Upon switching the alcohol
additive back to i-BuOH, the reaction mixture was much more homogeneous and the
yield dramatically improved (entry 8). Thus, after some additional modifications to the
reaction parameters such as slight modifications to the equivalents of base and alcohol
additive used, the conditions in Equation 30 were identified as the best for both yield
and enantioselectivity.
Table 5: Initial optimization of the coupling conditions employing Ph-(9-BBN)
Ph-(9-BBN)
1.2 equiv
8% NiCl2.glyme
12% (S,S)-2
1.6 equiv KOt-Bu
1.6 equiv i-BuOH
dioxane, r.t.
"standard conditions"
sequential variations from the "standard"
entry conditions yield (%)a ee (%)
1 none 37 59
2 i-Pr20 instead of dioxane 21 64
3 toluene instead of i-Pr2O 36 70
4 MeOH instead of i-BuOH 22 83
5 2.0 equiv instead of 1.2 equiv of 72 80
Ph-(9-BBN)
6 -10 0C instead of r.t. 57 84
7 (S,S)-3 instead of (S,S)-2 44 91
8 i-BuOH instead of MeOH 67 92
a Yields were determined by GC analysis versus an internal standard.
F3C O/\CF 3
MeHN NHMe
(S,S)-3
Et
Br
racemic
Ph-(9-BBN)
2.0 equiv
8% NiCl2-glyme
10% (S,S)-3
1.4 equiv KOt-Bu
1.6 equiv i-BuOH
toluene, -10 "C, 24h
0
Et
Ph
74% yield, 92% ee
0
N Et
Br
racemic
0
Et
Ph
(30)
N
N
Under these optimal conditions, the use of other amide electrophiles was tested
in the coupling reaction (Table 6). N-Methyl-N-phenyl-2-bromobutyramide coupled in
higher yield but lower enantioselectivity than 1-indolinyl-2-bromobutyramide (entry 1
versus Equation 29). The N-benzyl-N-phenyl-2-bromobutyramide which was most
successful in the Negishi alkylation of a-bromoamides4la gave low yield and only
moderate ee (entry 2). The Weinreb amide, which would be a very useful synthetic
handle for further functionalizations of the product, unfortunately showed very low
enantioselectivity in coupling (entry 3).
Table 6: Other a-bromobutyramides in the coupling reaction
0 8% NiCl2-glyme
R Et Ph-(9-BBN) 10% (,S)-3
R2  Br 1.4 equiv KOt-Bu
1.6 equiv i-BuOH
racemic 2.0 equiv toluene, -10 *C
0
Ri'N Et
R2 Ph
entry RN % yielda % ee
R 2
1 Ph'N 87 74
Me
2 Bn' N 30 60
Ph
3 MeO'N 85 9
Me
a Yields were determined by GC
internal standard
versus an n-tetradecane
At this stage, we tested a-chloro-l-indolinylpropionamide in the coupling
reaction and found the product was obtained in 75% yield and 92% ee. This result is
important as it is the first asymmetric example of the coupling of an a-chlorocarbonyl
reagent with high enantioselectivity. The reaction parameters were refined for this new
substrate class, as summarized in Table 7. The equivalents of nucleophile, alcohol
additive, and base were lowered without diminishing the yield (entry 2). The reaction
temperature was slightly raised to -5 *C to avoid reproducibility problems with other,
more sluggish coupling substrates; the enantioselectivity appeared unaffected by this
change (entry 3). A change of nickel pre-catalyst from NiCl 2-glyme to NiBr2-diglyme
improved the yield (entry 4).
Optimization of reaction parameters for a-chloroamide
O 8% NiCl 2 glyme o
N Me Ph-(9-BBN) 10%(S,S)-3 N
Cl 1.4 equiv KOt-Bu
1.6 equiv i-BuOH
racemic 2.0 equiv toluene, -100C
"standard conditions"
entry variation from the "standard" conditions yield (%)a ee (%)
1 none 75 92
2 1.5 equiv Ph-(9-BBN), 1.5 equiv i-BuOH, 74 92
1.3 equiv KOt-Bu
3 -5 C, instead of -10 OC 75 92
4 8% NiBr 2-glyme, instead of 8% 84 85
NiCl2-glyme
a Yields were determined by GC analysis versus n-tetradecane as an
internal standard.
Me
P)h
Table 7:
The NiBr2-diglyme pre-catalyst and both enantiomers of the diamine ligand 3
are all commercially available. The pre-catalyst and ligand components are both
necessary for coupling. In the absence of the nickel salt, <2% of the coupling product
is obtained; if the ligand is omitted, the coupling proceeds in only 8% yield.
Furthermore, if the catalyst loading is lowered, the reaction proceeds in lower yield
(78% yield, 92% ee) and is more unreliable.
With these conditions in hand, the electrophile and nucleophile scope were
examined, and the results are summarized in Table 8. The reaction is tolerant of
functional groups such as an olefin or a silyl ether on the alkyl side chain (entries 3 and
4), as well as fl-branching (entry 5). The aryl-(9-BBN) nucleophile may bear meta-
(entries 6 and 7) or para-substituents (entries 8 and 9). This substituent may be either
electron-withdrawing (entry 6) or electron-donating (entries 7 and 8). The reaction can
be run on a 5.0 mmol scale, and enantioenrichment to >99% ee of the product is
possible through recrystallization (Table 8, entry 2 on a 5.0 mmol scale: 88% yield,
92% ee before recryallization; 70% yield, >99% ee after).68,69 These conditions can
also be applied to the analogous a-bromoamide with comparable results. For example,
starting from the c-bromoamide, the product of Table 8, entry 1 was obtained in 88%
yield and 91% ee.
68 In these studies, the aryl-(9-BBN) reagent was purified by distillation. However, when non-distilled
Ph-(9-BBN) was used under the conditions of Table 2 entry 1 (1.8 equiv of nucleophile was used to
compensate for impurities), the product was obtained in comparable yield (83%) and the same ee (92%).
69 The following species were not found to be competent reaction partners: alkyl-(9-BBN) reagents,
alkenyl-(9-BBN) reagents, a-isopropyl substituted amide, Ph-B(OH)2, and a pinacol boronate ester.
Table 8: Electrophile and nucleophile scope
0
N R
Cl
racemic
Ar-(9-BBN)
1.5 equiv
8% NiBr 2-diglyme
10% (S,S)-3
1.3 equiv KOt-Bu
1.5 equiv i-BuOH
toluene, -5 *C, 24h
Entry R Ar % yielda ee
Me
CH2CH=CH 2
CH2CH2OTBS
i-Bu
Et
Cl
Me
MeO / 1
F
RN AR
Ar
All entries are the average of two runs. a Isolated yields. b Requires 10%
NiBr 2-diglyme, 12.5% ligand, and 48 h reaction time.
The amide moiety of these products provides a useful handle for manipulation
of the product into other species. For example, the product can be reduced to the
primary alcohol (Equation 31) or converted to the free carboxylic acid (Equation 32).
Both reactions proceed without racemization.
0
/ N Me Li[NH 2BH3] HO Me (31)
Ph Ph
>99% ee >99% ee
/ N
N, Me 
DD
Ph
N Me LIOH, H20 2
Ph Ph
>99% ee >99% ee
As in other examples of asymmetric nickel-catalyzed cross-coupling reactions
of secondary alkyl halides, this reaction is stereoconvergent, in that the racemic starting
material is converted preferentially into one enantiomer of product.41 42 44 455 o However,
in contrast to these earlier reports in which the electrophile remains racemic over the
course of the reaction, in this reaction the initially racemic a-chloroamide electrophile
undergoes enantioenrichment. For example, at 86% conversion, the ee of the unreacted
electrophile is 54% and that of the product is 90% (Equation 33).
Ph-(9-BBN)
+
0
N IIMe
C1
racemic
8% NiBr 2-diglyme
F3C CF3
10%
MeHN NHMe
1.3 equiv KOt-Bu
1.5 equiv i-BuOH
toluene, -5 *C
86% conversion
O. 0
N kMe
CI
54% ee
0
N Me (33)
Ph
90% ee
(32)
This enhancement in the enantiomeric ratio of the electrophile must arise from
discrimination by the chiral catalyst between the two enantiomers. However, from this
data, it is unclear whether the moderate ee value of the electrophile is due to modest
enantiomeric discrimination by the chiral catalyst or to a high level of discrimination
that is counteracted by a reversible oxidative addition.
To gain insight into this question, enantioenriched electrophiles were subjected
to the reaction conditions. It was found that the ee of each electrophile remains
essentially unchanged throughout the course of the reaction (Equations 34 and 35),
implying that oxidative addition is irreversible, and the enantioenrichment, therefore,
must be due to a modest kinetic resolution with a selectivity factor of -1.8.
Furthermore, the reaction operates under complete catalyst control; regardless of the
starting enantiomer of electrophile, the obtained coupling product has both the same
sense and degree of enantioenrichment with a given enantiomer of catalyst.
Ph-(9-BBN)
+
S0
N "YMeCI
95% ee
Ph-(9-BBN)
+
0
N e
95% ee
8% NiBr 2ediglyme
F3C CF3
10%
MeHN NHMe
1.3 equiv KOt-Bu
1.5 equiv i-BuOH
toluene, -5 OC
67% conversion
8% NiBr 2-diglyme
F3C CF3
10% -
MeHN NHMe
1.3 equiv KOt-Bu
1.5 equiv i-BuOH
toluene, -5 oC
69% conversion
0
NMe
CIl
95% ee
S0
N, Me
OI
95% ee
q 0N Me (34)
Ph
88% ee
0
N Me (35)
Ph
88% ee
C. Conclusions
In conclusion, a nickel-catalyzed a-arylation of a-haloamides has been
developed that represents, to the best of our knowledge, the first asymmetric arylation
of an a-haloamide, the first enantioselective cross-coupling of an a-chlorocarbonyl, and
the first asymmetric cross-coupling of an aryl boron reagent. The catalyst components
are both commercially available, and the reaction is applicable to coupling of al-
bromoamides as well. This coupling procedure has been performed on scales up to 5.0
mmol. The products can be recrystallized to enhance the enantiomeric ratio and
transformed into primary alcohols or carboxylic acids without racemization. Although
this process is stereoconvergent like our other asymmetric cross-coupling procedures, it
differs in that kinetic resolution is at play during the oxidative addition. Mechanistic
studies have been conducted to further elucidate information regarding this kinetic
resolution, which indicate that the resolution occurs through modest differentiation
between the two enantiomers of the electrophile in an irreversible oxidative addition
step.
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1. General Information
The following reagents were purchased and used without purification:
NiBr2-diglyme (Strem), (-)-(SS)-3, (+)-(R,R)-3 (Acros), KOt-Bu (Alfa), i-BuOH
(Aldrich), toluene (Aldrich; anhydrous), and B-methoxy-(9-BBN) (Aldrich; 1.0 M
solution in hexanes). Indoline (Alfa) was distilled prior to use.
All reactions were carried out in oven-dried glassware under an atmosphere of
argon or nitrogen.
HPLC analyses were carried out on an Agilent 1100 series system with Daicel
Chiralpak@ columns.
2. Preparation of a-Chloroamides
The procedures and yields have not been optimized.
0
N Et
2-Chloro-1-(indolin-1-yl)butan-1-one. 2-Chlorobutyric acid (2.06 mL, 20.0
mmol) and anhydrous CH 2Cl 2 (45 mL) were added to an oven-dried flask under argon.
This solution was cooled to 0 *C, and then oxalyl chloride (2.5 mL, 30 mmol, 1.5
equiv) and dimethylformamide (0.15 mL, 1.9 mmol, 0.097 equiv) were added. The
reaction mixture was stirred at 0 0C for 1.5 h, and then it was transferred via cannula to
an oven-dried flask that contained a solution of indoline (3.4 mL, 30 mmol, 1.5 equiv)
and triethylamine (4.18 mL, 30 mmol, 1.5 equiv) in anhydrous CH2Cl2 (30 mL) at 0 0C.
The reaction mixture was stirred for 1.5 h as it was allowed to warm to room
temperature. The reaction was then quenched by the addition of aqueous HCl (1 M; 45
mL), and the resulting mixture was extracted with CH2C12 (50 mL x 2). The combined
organic layers were washed with brine (30 mL), dried over Na2SO 4, and concentrated.
The residue was purified by flash chromatography (5%-+10% EtOAc in pentane),
which furnished the product as a white crystalline solid (1.5 g, 34%).
IH NMR (400 MHz, CDC13): 5 8.26 (d, 1H, J = 8.0 Hz), 7.25-7.19 (m, 2H),
7.09-7.04 (m, 1H), 4.41-4.30 (m, 2H), 4.11 (dt, 1H, J= 7.1, 9.9 Hz), 3.32-3.17 (m, 2H),
2.27-2.16 (m, 1H), 2.10-1.99 (m, 1H), 1.08 (t, 3H, J= 7.3 Hz);
13C NMR (100 MHz, CDC13): 6 166.5, 142.8, 131.6, 127.9, 124.8, 124.6, 117.8,
58.4, 48.0, 28.3, 27.7, 11.3;
IR (film): 1655, 1598, 1484, 1423, 1342, 1310, 761 cm';
LRMS (EI) for C12H15CNO (M+H): caled 224, found 224.
0
N Me
CI
2-Chloro-1-(indolin-1-yl)propan-1-one [107236-27-1]. 2-Chloropropionyl
chloride (3.17 g, 25.0 mmol) was added to a flask that contained indoline (3.08 mL,
27.5 mmol, 1.1 equiv), triethylamine (3.83 mL, 27.5 mmol, 1.1 equiv), and THF (30
mL). The solution immediately turned into a thick slurry, which was stirred for 45 min
before the reaction was quenched by the addition of HCl (1 M; 30 mL). EtOAc (30
mL) was added, and the phases were separated. The aqueous layer was extracted
EtOAc (30 mL x 2), and the combined organic layers, washed with brine (30 mL),
dried over Na 2SO 4, and concentrated. The residue was purified by flash
chromatography (10% EtOAc in pentane), which furnished the product as a white
crystalline solid (2.32 g, 44%).
1H NMR (400 MHz, CDCl 3): 6 8.24 (d, 1H, J = 8.0 Hz), 7.25-7.18 (m, 2H),
7.07 (t, 1H, J= 7.4 Hz), 4.59 (q, 1H, J= 6.5 Hz), 4.48-4.36 (m, 1H), 4.14-4.05 (m, 1H),
3.32-3.16 (m, 2H), 1.75 (d, 3H, J= 6.6 Hz);
13C NMR (100 MHz, CDCl 3): 6 166.8, 142.8, 131.6, 127.9, 124.8, 124.6, 117.7,
52.2, 47.9 28.3, 20.7;
IR (film): 1652, 1595, 1482, 1417, 1060, 1004, 755 cm;
LRMS (EI) for CIIH1ClNO (M+H): calcd 210, found 210.
0
HO
C1
2-Chloropent-4-enoic acid [909778-25-2]. A solution of sodium nitrite (1.30 g,
18.9 mmol, 1.6 equiv) in water (3.5 mL) was added to a solution of DL-allylglycine
(1.36 g, 11.8 mmol, 1.0 equiv) in HCl (5 N; 20 mL) at 0 'C under argon. The reaction
mixture was stirred at 0 'C for 5 h, and then it was allowed to warm to room
temperature overnight. Sodium carbonate (800 mg) was added, and then the reaction
mixture was extracted with Et20 (10 mL x 4). The organic layers were combined and
washed with brine (10 mL). The brine was extracted with Et20 (10 mL x 3). The
organic layers were combined, dried over Na2 SO 4 , and concentrated to give a yellow oil
(683 mg, 62%), which was used in the next step without further purification.
'H NMR (400 MHz, CDCl 3): a 7.31 (br s, 1H), 5.81 (tdd, 1H, J= 6.9, 10.2,
17.1 Hz), 5.25-5.18 (in, 2H), 4.39-4.34 (in, 1H), 2.86-2.77 (in, 1H), 2.75-2.66 (m, 1H);
13C NMR (100 MHz, CDCl 3): 6 174.6, 131.6, 119.8, 56.0, 38.9;
IR (film): 1734, 1653, 1559, 1507, 1436, 1279, 668 cm'.
0
N 
_1
2-Chloro-1-(indolin-1-yl)pent-4-en-1-one. Oxalyl chloride (0.46 mL, 5.42
mmol, 1.1 equiv) and DMF (0.1 mL) were added to a solution of 2-chloropent-4-enoic
acid (663 mg, 4.93 mmol) in CH 2Cl 2 (10 mL) at 0 'C. The solution was stirred for 2 h
as it warmed to room temperature. Then, it was added via cannula to a solution of
indoline (0.61 mL, 5.42 mmol, 1.1 equiv) and triethylamine (0.71 mL, 5.42 mmol, 1.1
equiv) in CH 2Cl 2 (10 mL) at 0 'C. The reaction mixture was stirred for 15 min, and
then the reaction was quenched with HCl (1 M; 20 mL) and the phases were separated.
The aqueous layer was extracted with CH2Cl 2 (20 mL x 2). The organic layers were
combined, washed with brine (10 mL), dried over Na2 SO 4 , and concentrated. The
residue was purified by flash chromatography (5% EtOAc in pentane), which furnished
2-chloro-1-(indolin-1-yl)pent-4-en-1-one (360 mg, 31%) as a white solid.
IH NMR (400 MHz, CDCl 3): 6 8.25 (d, 1H, J = 8.0 Hz), 7.25-7.19 (in, 2H),
7.10-7.04 (m, 1H), 5.86 (tdd, 1H, J= 6.9, 10.2, 17.1 Hz), 5.25 (dd, 1H, J= 1.4, 17.1
Hz), 5.17 (d, 1H, J= 10.1 Hz), 4.38-4.31 (in, 2H), 4.15-4.06 (in, 1H), 3.31-3.16 (in,
2H), 2.96 (td, 1H, J= 6.8, 13.7 Hz), 2.75 (td, 1H, J= 7.3, 14.5 Hz);
13C NMR (100 MHz, CDC 3): 6 166.0, 142.7, 133.3, 131.7, 127.9, 124.8, 124.7,
119.3, 117.8, 55.7, 48.0, 38.5, 28.3;
IR (film): 1664, 1600, 1483, 1418, 1341, 1318, 924, 756 cm-1;
LRMS (EI) for C13H15ClNO (M+H): calcd 236, found 236.
0
0 C1
a'-Chloro-y-butyrolactone [31167-90-5]. A cold solution of NaNO2 (3.45 g,
50 mmol, 1.63 equiv) was added by pipette over 5 min to a solution of D,L-homoserine
(3.64 g, 30.6 mmol) in HCl (5 N; 50 mL) at 0 'C. The reaction mixture was allowed to
warm to room temperature overnight. Next, Na2CO 3 (1.33 g) was added, and the
reaction mixture was extracted with Et20 (75 mL x 3). The combined organic layers
were washed with brine (50 mL), which was then extracted with Et20 (75 mL x 4).
The organic layers were combined, dried over Na2 SO 4, and concentrated. The residue
was purified by flash chromatography (30% EtOAc in pentane), which furnished the
product (1.82 g, 50%) as a yellow oil.
1H NMR (400 MHz, CDCl 3): 6 4.53 (td, 1H, J= 6.9, 9.1 Hz), 4.49-4.36 (in, 2H),
2.78 (dt, 1H, J= 7.2, 14.3 Hz), 2.48 (tdd, 1H, J= 5.1, 6.9 Hz, 13.9 Hz);
13C NMR (100 MHz, CDCl 3): 6 66.6, 50.4, 33.4;
IR (film): 1785, 1376, 1213, 1168, 1020, 896 cm.
0
N fOH
C1
2-Chloro-4-hydroxy-1-(indolin-1-yl)butan-1-one. Indoline (4.1 mL, 36.4
mmol, 2.6 equiv) was added to an oven-dried flask containing AIC13 (2.43 g, 18.2 mmol,
1.3 equiv) in anhydrous CH2Cl 2 (15 mL) at 0 'C. The solution was stirred for 5 min at
0 'C, and then a-chloro-y-butyrolactone (1.68 g, 13.9 mmol, 1.0 equiv) was added. The
solution was stirred for 2 h at room temperature, and then the reaction was quenched
with water and stirred overnight. The reaction mixture was filtered through celite and
concentrated. CH 2C12 and water were added to the residue, and the organic layer was
separated and concentrated. The residue was purified by flash chromatography
(2:3->2:1 EtOAc:pentane, followed by 1:3->1:1 EtOAc:pentane), which provided the
product (750 mg, 20%) as a yellow oil.
H NMR (400 MHz, CDCl 3): 6 8.22 (d, 1H, J = 7.9 Hz), 7.25-7.20 (m, 2H),
7.10-7.05 (m, 1H), 4.80-4.74 (m, 1H), 4.39 (dt, 1H, J= 7.3, 9.8 Hz), 4.17 (dt, 1H, J=
7.2, 10.0 Hz), 3.88 (dd, 2H, J= 4.9, 11.0 Hz), 3.32-3.17 (m, 2H), 2.47-2.38 (m, 1H),
2.31-2.22 (m, 1H), 1.80 (t, 1H, J= 4.9 Hz);
13C NMR (100 MHz, CDCl3): 6 166.7, 142.5, 131.7, 127.6, 124.73, 124.66,
117.6, 58.7, 53.8, 47.9, 36.7, 28.0;
IR (film): 1660, 1598, 1483, 1418, 1263, 1054, 756 cm';
LRMS (EI) for C12H 15ClN0 2 (M+H): caled 240, found 240.
0
N OTBS
j C1
4-(tert-Butyldimethylsilyloxy)-2-chloro-1-(indolin-1-yl)butan-1-one. TBSCl
(0.82 g, 5.33 mmol, 1.25 equiv), imidazole (732 mg, 10.7 mmol, 2.5 equiv), and DMAP
(60 mg) were added in turn to a solution of 2-chloro-4-hydroxy-1-(indolin-1-yl)butan-
1-one (1.02 g, 4.26 mmol) in DMF (5 mL) at 0 'C. The resulting solution was allowed
to warm to room temperature with stirring overnight. Next, the reaction mixture was
diluted with EtOAc (15 mL) and poured into saturated NaHCO 3 (20 mL). The phases
were separated, and the aqueous layer was extracted with EtOAc (15 mL x 2). The
organic layers were combined and washed with brine (20 mL), dried over Na2 SO 4, and
concentrated. The residue was purified by flash chromatography (7% EtOAc in
pentane), followed by recrystallization from EtOAc, which furnished the product as a
white solid (720 mg, 43%).
H NMR (400 MHz, CDCl 3): 6 8.26 (d, 1H, J = 8.0 Hz), 7.25-7.19 (m, 2H),
7.09-7.04 (m, 1H), 4.77 (dd, 1H, J= 5.6, 8.2 Hz), 4.36 (dt, 1H, J= 7.2, 9.9 Hz), 4.12
(dt, 1H, J= 7.0, 10.0 Hz), 3.84 (ddd, 1H, J= 3.8, 8.0, 11.7 Hz), 3.76 (ddd, 1H, J= 4.6,
5.3, 10.3 Hz), 3.32-3.17 (m, 2H), 2.34 (dddd, 1H, J= 4.5, 5.5, 8.0, 12.5 Hz), 2.19 (dddd,
1H, J= 3.8, 5.6, 9.3, 11.0 Hz), 0.89 (s, 9H), 0.06 (d, 6H, J= 11.6 Hz);
13C NMR (100 MHz, CDCl 3): 6 166.7, 142.8, 131.7, 127.8, 124.8, 124.6, 117.8,
59.2, 53.6, 47.9, 37.3, 28.2, 26.1, 18.4 -5.2 -5.3;
IR (film): 1668, 1600, 1483, 1413, 1257, 1103, 937, 834, 778, 755 cm~1;
LRMS (EI) for C1 H 28ClNO 2Si: calcd 353, found 353.
0
/ N i-Bu
CI
2-Chloro-1-(indolin-1-yl)-4-methylpentan-1-one. Oxalyl chloride (1.18 mL,
13.4 mmol, 1.1 equiv) and DMF (0.1 mL, 1.3 mmol, 0.11 equiv) were added to a 0 'C
solution of a-chloroisocaproic acid70 (1.84 g, 12.2 mmol) in anhydrous CH 2Cl2 (36 mL)
in an oven-dried flask under argon. The reaction mixture was allowed to warm to room
temperature with stirring overnight. The solution was then transferred by cannula to a
solution of indoline (1.50 mL, 13.4 mmol, 1.1 equiv) and triethylamine (1.87 mL, 13.4
mmol, 1.1 equiv) in anhydrous CH 2Cl2 (30 mL) at 0 *C under argon. The suspension
was stirred for 4 h, and then the reaction was quenched by the addition of HCl (1 M; 20
mL). The reaction mixture was extracted with CH 2Cl 2 (20 mL x 2), and the combined
organic layers were washed with brine (20 mL), dried over Na2SO 4 , and concentrated.
The residue was purified by flash chromatography (5% EtOAc in hexanes), which
furnished the product (2.20 g, 72%) as a white solid.
1H NMR (400 MHz, CDCl 3): 6 8.25 (d, 1H, J = 8.0 Hz), 7.27-7.19 (m, 2H),
7.06 (t, 1H, J= 7.4 Hz), 4.49 (t, 1H, J= 7.2 Hz), 4.42-4.34 (m, 1H), 4.16-4.07 (m, 1H),
3.32-3.17 (m, 2H), 2.01-1.95 (m, 2H), 1.91-1.80 (m, 1H), 1.00-0.94 (m, 6H);
"C NMR (100 MHz, CDCl3 ): 5 166.7, 142.9, 131.6, 127.9, 124.8, 124.6, 117.8,
55.2, 48.0, 42.8, 28.3, 25.3, 22.9, 22.1;
IR (film): 1668, 1600, 1482, 1413, 1262, 1107, 755 cm-;
LRMS (EI) for C14H19ClNO (M+H): calcd 252, found 252.
0
N k Et
Br
2-Bromo-1-(indolin-1-yl)butan-1-one. Triethylamine (2.77 g, 27.5 mmol, 1.1
equiv) and then 2-bromo-n-butyryl bromide were added to an oven-dried flask under
argon that contained a solution of indoline (3.28 g, 27.5 mmol, 1.1 equiv) in THF (50
mL) at 0 "C. The reaction mixture was stirred at 0 "C for 1 h, and then the reaction was
quenched by the addition of HCI (1 M; 30 mL) and EtOAc (30 mL). The phases were
separated, and the aqueous layer was extracted EtOAc (2 x 30 mL). The organic layers
were combined, washed with brine (30 mL), and dried over Na2SO 4 . The residue was
70 Koppenhoefer, B.; Schurig, V. Org. Syntheses 1988, 66, 151-155.
purified by flash chromatography (10% EtOAc in pentane), which furnished the
product (4.22 g, 63%) as a white crystalline solid.
H NMR (400 MHz, CDCl 3): 5 8.27 (d, 1H, J= 8.0 Hz), 7.24-7.17 (m, 2H),
7.09-7.03 (m, 1H), 4.37-4.29 (m, 2H), 4.07 (dt, 1H, J= 7.1, 10.0 Hz), 3.30-3.15 (m,
2H), 2.27 (pentet d, 1H, J= 7.2, 14.3 Hz), 2.12 (pentet d, 1H, J= 7.4, 14.7 Hz), 1.06 (t,
3H, J= 7.3 Hz);
13C NMR (400 MHz, CDCl 3): 6 166.6, 142.7, 131.5, 127.7, 124.7, 124.4, 117.6,
48.3, 47.9, 28.1, 27.9, 12.3;
IR (film): 1653, 1576, 1457, 1419, 1161, 755, 668 cm~';
LRMS (EI) for C12HI4BrNO: calcd 267, found 267.
3. Preparation of Aryl-(9-BBN) Reagents
General Procedure. All aryl-(9-BBN) reagents were prepared by following a
literature procedure for the synthesis of Ph-(9-BBN) via the reaction of
phenylmagnesium chloride with B-methoxy-(9-BBN). 71 Although we routinely
purified the aryl-(9-BBN) reagents by distillation, we have obtained comparable results
when the aryl-(9-BBN) reagent (1.8 equiv) was not distilled prior to use in the
asymmetric Suzuki reaction.
B
9-Phenyl-9-borabicyclo[3.3.1]nonane [23418-91-9]. Prepared from B-
methoxy-(9-BBN) and phenylmagnesium bromide. Distilled at 95 *C at 240 mTorr.
'H NMR (400 MHz, CDCl 3): ( 7.98 (d, 2H, J = 7.0 Hz), 7.58-7.53 (m, 1H),
7.50-7.45 (m, 2H), 2.29-2.24 (m, 2H), 2.06-1.96 (m, 6H), 1.87-1.76 (m, 4H), 1.31 (ddd,
2H);
B
C1
9-(3-Chlorophenyl)-9-borabicyclo[3.3.1]nonane. Prepared from B-methoxy-
(9-BBN) and 3-chlorophenylmagnesium bromide. Distilled at 150 *C at 400 mTorr.
'H NMR (400 MHz, CDCl3): 5 7.91-7.89 (m, 1H), 7.84-7.80 (m, 1H), 7.52 (ddd,
1H, J = 1.2, 2.3, 8.0 Hz), 7.43-7.38 (m, 1H), 2.29-2.22 (m, 2H), 2.06-1.96 (m, 6H),
1.85-1.75 (m, 4H), 1.35-1.25 (m, 2H);
13C NMR (100 MHz, CDCl 3): ( 134.7, 134.5, 132.72, 132.67, 129.7, 34.3, 29.8,
23.6;
"B NMR (128 MHz, CDC 3): ( 61.
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9-(3-Methylphenyl)-9-borabicyclo[3.3.1]nonane. Prepared from B-methoxy-
(9-BBN) and 3-methylphenylmagnesium bromide. Distilled at 110 *C at 290 mTorr.
'H NMR (400 MHz, CDCl3): 6 7.85-7.80 (m, 2H), 7.44-7.40 (m, 2H), 2.46 (s,
3H), 2.35-2.30 (m, 2H), 2.09-2.00 (m, 6H), 1.92-1.81 (m, 4H), 1.40-1.29 (m, 2H);
13C NMR (100 MHz, CDCl 3): 6 138.7, 137.5, 135.5, 133.8, 131.9, 128.2, 34.3,
29.3, 23.7, 21.7;
"B NMR (128 MHz, CDCl 3): 6 81.
MeO / \ B
9-(4-Methoxyphenyl)-9-borabicyclo[3.3.lnonane. Prepared from B-
methoxy-(9-BBN) and 4-methoxyphenylmagnesium bromide. After filtration and
concentration, the aryl-(9-BBN) reagent was used without further purification.
'H NMR (400 MHz, CDCl 3): 6 8.01-7.96 (m, 2H), 7.03-6.98 (m, 2H), 3.89 (s,
3H), 2.27 (br s, 2H), 2.05-1.95 (m, 6H), 1.86-1.74 (m, 4H), 1.37-1.27 (m, 2H);
13C NMR (100 MHz, CDCl3): 6 163.7, 137.0, 130.9, 113.5, 55.2, 34.1, 28.4,
23.5;
"B NMR (128 MHz, CDCl3): 6 78.
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9-(4-Fluorophenyl)-9-borabicyclo[3.3.1]nonane. Prepared from B-methoxy-
(9-BBN) and 4-fluorophenylmagnesium bromide. Distilled at 76 *C at 200 mTorr.
'H NMR (400 MHz, CDCl 3): 6 8.01-7.95 (m, 2H), 7.17-7.10 (m, 2H), 2.29-2.22 (m,
2H), 2.05-1.91 (m, 6H), 1.85-1.74 (m, 4H), 1.35-1.25 (m, 2H);
13C NMR (100 MHz, CDCl3): 6 167.7, 165.2, 137.4, 115.3, 34.3, 29.2 23.6;
"B NMR (128 MHz, CDCl3): 6 80.
4. Asymmetric Suzuki Arylations of a-Chloroamides
General Procedure. In a nitrogen-filled glovebox, NiBr2'diglyme (14.1 mg,
0.040 mmol, 8.0%), ligand 3 (18.8 mg, 0.050 mmol, 10%; Run 1: (SS)-3; Run 2: (R,R)-
3), the electrophile (0.50 mmol), and toluene (2.5 mL) were added to a 10-mL flask.
The following materials were added in turn to a 4-mL vial: KOt-Bu (73 mg, 0.65 mmol,
1.3 equiv), i-BuOH (69 IL, 0.75 mmol, 1.5 equiv), the aryl-(9-BBN) reagent (0.75
mmol, 1.5 equiv), and toluene (2.5 mL). The flask and the vial were each capped with
a rubber septum, and the two mixtures were stirred for 10 min. Next, the vessels were
removed from the glovebox and placed in a -5 'C bath, and the mixtures were stirred
for 10 min. The solution in the vial was then transferred by syringe to the slurry in the
1 0-mL flask, which was attached to a nitrogen-filled balloon. The reaction mixture was
stirred at -5 *C for 24 h (it turned orange after a few min). Next, the mixture was
poured into a separatory funnel and washed with a saturated solution of sodium
carbonate (5 mL; if the aqueous layer is very viscous, then distilled water (3 mL) was
added). The aqueous phase was extracted with EtOAc (5 mL x 2), and the organic
layers were combined and washed with brine (5 mL), dried over Na2SO 4 , and
concentrated. The resulting residue was purified by flash chromatography.
Run 1: (SS)-3. Run 2: (R,R)-3.
Practical note: For the cross-couplings illustrated in Table 2, flash
chromatography was used to purify the products. However, it was sometimes difficult
to remove a 9-BBN-derived impurity by flash chromatography, necessitating the use of
more than one chromatography. It is more practical to run a preliminary flash
chromatography and then a recrystallization; this effectively removes the impurity and
simultaneously enriches the ee of the product.
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1-(Indolin-1-yl)-2-phenylbutan-1-one (Table 8, entry 1). 2-Chloro-1-
(indolin-1-yl)butan-1-one (112 mg, 0.50 mmol) and 9-phenyl-9-
borabicyclo[3.3.1]nonane (149 mg, 0.75 mmol) were used. Solvent system for
chromatography: 7.5% EtOAc in pentane, then 1:1 CH 2Cl2:pentane->CH 2Cl2. The
product was isolated as a white solid.
Run 1: 108 mg (81% yield, 93% ee). Run 2: 101 mg (76% yield, 90% ee).
The ee was determined on an AS-H column (hexanes:isopropanol 99:1, flow 1.0
mL/min), with enantiomers eluting at 8.5 (major) and 10.1 (minor) min.
'H NMR (400 MHz, CDCl 3): 5 8.33 (d, 1H, J = 8.1 Hz), 7.38-7.29 (m, 4H),
7.26-7.21 (m, 1H), 7.19 (t, 1H, J= 7.8 Hz), 7.12 (d, 1H, J= 7.3 Hz), 6.99 (t, 1H, J= 7.4
Hz), 4.15 (dt, 1H, J= 6.6, 10.3 Hz), 3.84 (dt, 1H, J= 6.6, 10.3 Hz), 3.58 (t, 1H, J= 7.2
Hz), 3.19-3.09 (m, 1H), 3.07-2.96 (m, 1H), 2.28-2.16 (m, 1H), 1.87-1.74 (m, 1H), 0.93
(t, 3H, J= 7.3 Hz);
13C NMR (100 MHz, CDCl 3): 6 171.7, 143.5, 139.6, 131.3, 129.0, 128.3, 127.7,
127.3, 124.7, 123.8, 117.4, 54.1, 47.9, 28.22, 28.16, 12.7;
IR (film): 1646, 1559, 1540, 1457, 1406, 757, 668 cm~1;
LRMS (EI) for Ci8H20NO (M+H): calcd 266, found 266;
[a]2 3 D +123 (c 1.20, CHC 3); 93% ee, from (SS)-3.
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1-(Indolin-1-yl)-2-phenylpropan-1-one (Table 8, entry 2). 2-Chloro- 1-
(indolin-1-yl)propan-1-one (105 mg, 0.50 mmol) and 9-phenyl-9-
borabicyclo[3.3.1]nonane (149 mg, 0.75 mmol) were used. Solvent system for
chromatography: (1) 10% EtOAc in pentane; (2) 1:1 CH2Cl2:pentane->CH 2Cl2. The
product was isolated as a white solid.
Run 1: 113 mg (90% yield, 88% ee). Run 2: 109 mg (87% yield, 86% ee).
The ee was determined on an AS-H column (hexanes:isopropanol 99:1, flow 1.0
mL/min), with enantiomers eluting at 13.0 (major) and 16.9 (minor) min.
H NMR (400 MHz, CDCl 3): 6 8.33 (d, 1H, J = 8.1 Hz), 7.34-7.30 (m, 4H),
7.26-7.22 (m, 1H), 7.20 (t, 1H, J= 7.8 Hz), 7.13 (d, 1H, J= 7.2 Hz), 7.00 (t, 1H, J= 7.4
Hz), 4.10 (dt, 1H, J= 6.6, 10.3 Hz), 3.87 (q, 1H, J= 6.8 Hz), 3.77 (dt, 1H, J= 6.6, 10.3
Hz), 3.17-3.06 (m, 1H), 3.04-2.94 (m, 1H), 1.53 (d, 3H, J= 6.8 Hz);
13C NMR (100 MHz, CDCl 3): 6 172.2, 143.5, 141.3, 131.3, 129.2, 127.7 (2),
127.2, 124.7, 123.9, 117.4, 47.8, 46.5, 28.2, 20.7;
IR (film): 1653, 1599, 1482, 1403, 1286, 755, 701 cm-l;
LRMS (EI) for C17H18NO (M+H): calcd 252, found 252;
[']2 3D -160 (c 1.06, CHCl3); 86% ee, from (R,R)-3.
Reaction on a gram scale (Table 8, entry 2). The reaction was carried out on
a 5.0 mmol, rather than a 0.5 mmol, scale. In a nitrogen-filled glovebox, NiBr2'diglyme
(141 mg, 0.400 mmol, 8.0%), ligand (SS)-3 (189 mg, 0.500 mmol, 10%), 1.048 g 2-
Chloro-1-(indolin-1-yl)propan-1-one (5.00 mmol), and toluene (25.0 mL) were added
to a 100-mL Schlenk flask. The following materials were added in turn to a 50-mL
pear-shaped flask: KOt-Bu (729 mg, 6.50 mmol, 1.30 equiv), i-BuOH (556 mg, 7.50
mmol, 1.5 equiv), Ph-(9-BBN) (1.486 mg, 7.50 mmol, 1.5 equiv), and toluene (25.0
mL). The flasks were capped with rubber septa, and the two mixtures were stirred for
10 min. Next, the vessels were removed from the glovebox and placed in a -5 *C bath,
and the mixtures were stirred for 10 min. The nucleophile solution was then transferred
by syringe to the slurry in the 10-mL flask, which was attached to a nitrogen-filled
balloon. The reaction mixture was stirred at low temperature for 24 h (it turned orange
after a few min); the reaction temperature ranged from -20 *C to -5 *C for 20 h, and
then it was maintained at -5 'C for the remaining 4 h. After purification by flash
chromatography (7.5% EtOAc in pentane), the product was obtained in 88% yield, as
determined by 1H NMR spectroscopy (vs. Ph3CH as a standard), and 92% ee. The
internal standard was removed by flash chromatography (1%->15% EtOAc in pentane),
and the product was recrystallized from MTBE and hexanes to give the desired
compound as white crystals (0.882 g, 70%; >99% ee).
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1-(Indolin-1-yl)-2-phenylpent-4-en-1-one (Table 8, entry 3). 2-Chloro-1-
(indolin-1-yl)pent-4-en-1-one (118 mg, 0.50 mmol) and 9-phenyl-9-
borabicyclo[3.3.1]nonane (149 mg, 0.75 mmol) were used. Solvent system for
chromatography: (1) 5% EtOAc in pentane; (2) 3:1 CH 2Cl2:pentane-+CH 2Cl2. The
product was isolated as a white solid.
Run 1: 115 mg (83% yield, 91% ee). Run 2:105 mg (76% yield, 90% ee).
The ee was determined on an AS-H column (hexanes:isopropanol 99:1, flow 1.0
mL/min), with enantiomers eluting at 11.0 (major) and 13.2 (minor) min.
H NMR (400 MHz, CDCl 3): 6 8.33 (d, 1H, J = 8.1 Hz), 7.37-7.29 (m, 4H),
7.27-7.22 (m, 1H), 7.19 (t, 1H, J= 7.8 Hz), 7.13 (d, 1H, J= 7.3 Hz), 6.99 (dt, 1H, J=
0.8, 7.4 Hz), 5.81 (tdd, 1H, J= 6.9, 10.2, 17.1 Hz), 5.07 (ddd, 1H, J= 1.4, 3.1, 17.1 Hz),
5.01-4.97 (m, 1H), 4.14 (dt, 1H, J= 6.5, 10.3 Hz), 3.83 (dt, 1H, J= 6.5, 10.4 Hz), 3.78-
3.73 (m, 1H), 3.14 (ddd, 1H, J= 6.5, 10.4, 16.6 Hz), 3.06-2.92 (m, 2H), 2.54-2.45 (td,
1H, J= 6.9, 14.0 Hz);
13C NMR (100 MHz, CDCl 3): ( 170.8, 143.3, 138.8, 136.3, 131.1, 128.9, 128.1,
127.5, 127.2, 124.5, 123.7, 117.3, 116.7, 52.1, 47.7, 39.1, 28.0;
IR (film): 1646, 1597, 1479, 1407, 922, 757, 705 cm';
LRMS (EI) for C19H2 0NO (M+H): calcd 278, found 278;
[a]2 3 D -144 (c 1.03, CHCl3 ); 90% ee, from (R,R)-3.
OTBS
0Ph
4-(tert-Butyldimethylsilyloxy)-1-(indolin-1-yl)-2-phenylbutan-1-one (Table
8, entry 4). 4-(tert-Butyldimethylsilyloxy)-2-chloro-1 -(indolin-1 -yl)butan-1 -one (179
mg, 0.50 mmol) and 9-phenyl-9-borabicyclo[3.3.1]nonane (149 mg, 0.75 mmol) were
used. Solvent system for chromatography: (1) 2%-+5% EtOAc in pentane; (2) passage
through a plug of reverse-phase silica with 8:2 H20:MeCN, followed by 2:8
H20:MeCN. The product was isolated as a yellow solid.
Run 1: 152 mg (77% yield, 85% ee). Run 2: 162 mg (82% yield, 83% ee).
The ee was determined on an IC column (hexanes:isopropanol 99:1, flow 1.0 mL/min),
with enantiomers eluting at 18.0 (major) and 14.7 (minor) min.
H NMR (400 MHz, CDCl 3): ( 8.32 (d, 1H, J = 8.1 Hz), 7.38-7.28 (m, 4H),
7.26-7.22 (m, 1H), 7.19 (t, 1H, J= 7.8 Hz), 7.13 (d, 1H, J= 7.1 Hz), 6.99 (dt, 1H, J=
0.8, 7.4 Hz), 4.18 (dt, 1H, J= 6.4, 10.4 Hz), 4.08 (t, 1H, J= 7.2 Hz), 3.86 (dt, 1H, J=
6.6, 10.4 Hz), 3.69-3.62 (m, 1H,), 3.58-3.51 (m, 1H), 3.19-3.09 (m, 1H), 3.07-2.97 (m,
1H), 2.45-2.35 (m, 1H), 1.99-1.89 (m, 1H), 0.91 (s, 9H), 0.02 (d, 6H, J= 4.9 Hz);
13C NMR (100 MHz, CDCl 3): 6 171.6, 143.5, 139.4, 131.4, 129.0, 128.5, 127.7,
127.3, 124.6, 123.8, 117.4, 60.5, 47.9, 47.6, 37.8, 28.1, 26.1, 18.4, -5.2;
IR (film): 1654, 1482, 1401, 1258, 1101, 834, 754 cm;
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LRMS (EI) for C24H33NO2Si (M): calcd 395, found 395;
[a] D -82 (c 1.06, CHCl 3); 83% ee, from (R,R)-1.
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1-(Indolin-1-yl)-4-methyl-2-phenylpentan-1-one (Table 8, entry 5). 2-
Chloro-1-(indolin-1-yl)-4-methylpentan-1-one (112 mg, 0.50 mmol) and 9-phenyl-9-
borabicyclo[3.3.1]nonane (149 mg, 0.75 mmol) were used. Solvent system for
chromatography: (1) 5% EtOAc in pentane; (2) 1:1 CH2Cl2:pentane-+CH 2Cl2. The
product was isolated as a white solid.
Run 1: 128 mg (87% yield, 86% ee). Run 2: 119 mg (81% yield, 84% ee).
The ee was determined on an AS-H column (hexanes:isopropanol 99:1, flow 1.0
mL/min), with enantiomers eluting at 8.9 (major) and 11.3 (minor) min.
1H NMR (400 MHz, CDCl 3): 6 8.32 (d, 1H, J= 8.1 Hz), 7.38-7.29 (m, 4H),
7.26-7.22 (m, 1H), 7.19 (t, 1H, J= 7.8 Hz), 7.13 (d, 1H, J= 7.3 Hz), 6.99 (t, 1H, J= 7.4
Hz), 4.17 (dt, 1H, J= 6.7, 10.3 Hz), 3.90 (dt, 1H, J= 6.5, 10.3 Hz), 3.80 (t, 1H, J= 7.2
Hz), 3.21-3.11 (m, 1H), 3.09-2.99 (m, 1H), 2.13 (td, 1H, J= 6.7, 13.8 Hz), 1.68-1.51
(m, 2H), 0.94 (dd, 6H, J= 6.4, 15.7 Hz);
"C NMR (100 MHz, CDCl 3): 6 171.7, 143.5, 139.8, 131.3, 129.0, 128.3, 127.7,
127.2, 124.6, 123.8, 117.5, 49.8, 47.9, 44.2, 28.2, 25.9, 22.9;
IR (film): 2955, 1658, 1600, 1481, 1402, 754, 701 cm~1;
LRMS (El) for C20H24NO (M+H): calcd 294, found 294;
[a]23D +123 (c 1.00, CHC 3); 86% ee, from (SS)-3.
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2-(3-Chlorophenyl)-1-(indolin-1-yl)butan-1-one (Table 8, entry 6). 2-
Chloro-1-(indolin-1 -yl)butan-1-one (112 mg, 0.50 mmol) and 9-(3-chlorophenyl)-9-
borabicyclo[3.3.1]nonane (149 mg, 0.75 mmol) were used, as well as 10 mol%
NiBr2-diglyme (17.6 mg, 0.050 mmol) and 12.5 mol% diamine ligand (23.5 mg, 0.062
mmol). Solvent system for chromatography: (1) 7.5% EtOAc in pentane; (2) 2:1
CH2Cl2:pentane to CH2Cl 2. The product was isolated as a white solid.
Run 1: 118 mg (79% yield, 93% ee). Run 2: 111 mg (74% yield, 91% ee).
The ee was determined on an AD-H column (hexanes:isopropanol 99:1, flow 1.0
mL/min), with enantiomers eluting at 19.8 (major) and 17.3 (minor) min.
1H NMR (400 MHz, CDCl3): 6 8.32 (d, 1H, J = 8.1 Hz), 7.36-7.34 (m, 1H),
7.26-7.17 (m, 4H), 7.16-7.12 (d, 1H, J= 7.2 Hz), 7.00 (dt, 1H, J= 1.0, 7.4 Hz), 4.15 (dt,
1H, J= 6.6, 10.3 Hz), 3.86 (dt, 1H, J= 6.5, 10.3 Hz), 3.56 (t, 1H, J= 7.3 Hz), 3.21-3.11
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(m, 1H), 3.11-3.01 (m, 1H), 2.26-2.14 (m, 1H), 1.85-1.73 (m, 1H), 0.93 (t, 3H, J= 7.4
Hz);
"C NMR (100 MHz, CDCl 3): 6 170.8, 143.2, 141.4, 134.6, 131.1, 130.1, 128.3,
127.6, 127.4, 126.3, 124.5, 123.9, 117.3, 53.5, 47.8, 28.04, 27.98, 12.4;
IR (film): 1646, 1596, 1479, 1407, 1258, 756, 668 cm;
LRMS (EI) for C18H19CNO (M+H): caled 300, found 300;
[a]23 D +136 (c 1.00, CHCl3); 93% ee, from (SS)-3.
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1-(Indolin-1-yl)-2-m-tolylbutan-1-one (Table 8, entry 7). 2-Chloro-1-
(indolin-1-yl)butan-1-one (112 mg, 0.50 mmol) and 9-(3-methylphenyl)-9-
borabicyclo[3.3.1]nonane (159 mg, 0.75 mmol) were used. Solvent system for
chromatography: (1) 7.5% EtOAc in pentane; (2) 1:1 CH 2Cl2:pentane to CH 2Cl 2. The
product was isolated as a white solid.
Run 1: 112 mg (80% yield, 93% ee). Run 2: 121 mg (87% yield, 92% ee).
The ee was determined on an AS-H column (hexanes:isopropanol 99:1, flow 1.0
mL/min), with enantiomers eluting at 9.4 (major) and 10.9 (minor) min.
1H NMR (400 MHz, CDC13): 6 8.34 (d, 1H, J = 8.1 Hz), 7.23-7.17 (m, 2H),
7.17-7.10 (m, 3H), 7.05 (d, 1H, J= 7.4 Hz), 6.99 (t, 1H, J= 7.4 Hz), 4.14 (dt, 1H, J=
6.6, 10.3 Hz), 3.86 (dt, 1H, J= 6.4, 10.4 Hz), 3.54 (t, 1H, J= 7.3 Hz), 3.19-3.09 (m,
1H), 3.07-2.97 (m, 1H), 2.33 (s, 3H), 2.26-2.14 (m, 1H), 1.84-1.72 (m, 1H), 0.93 (t, 3H,
J= 7.3 Hz);
13C NMR (100 MHz, CDC 3): a 171.6, 143.4, 139.3, 138.6, 131.2, 128.59,
128.57, 127.9, 127.5, 125.4, 124.5, 123.6, 117.3, 53.9, 47.7, 28.1, 28.0, 21.5, 12.6;
IR (film): 1653, 1600, 1481, 1401, 1339, 755 cm'1;
LRMS (EI) for C19H22NO (M+H): calcd 280, found 280;
[a]23D -136 (c 1.11, CHC 3); 92% ee, from (R,R)-3.
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1-(Indolin-1-yl)-2-(4-methoxyphenyl)butan-1-one (Table 8, entry 8). 2-
Chloro- 1 -(indolin- 1 -yl)butan- 1-one (112 mg, 0.50 mmol) and 9-(4-methoxyphenyl)-9-
borabicyclo[3.3.1]nonane (172 mg, 0.75 mmol) were used. Solvent system for
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chromatography: (1) 10% EtOAc in pentane; (2) 1:1 CH2Cl2:pentane->CH 2Cl2 (twice).
The product was isolated as a white solid.
Run 1: 116 mg (79% yield, 91% ee). Run 2: 120 mg (81% yield, 90% ee).
The ee was determined on an AS-H column (hexanes:isopropanol 99:1, flow 1.0
mL/min), with enantiomers eluting at 18.8 (major) and 21.7 (minor) min.
H NMR (400 MHz, CDCl 3): 8 8.32 (m, 1H), 7.27-7.23 (m, 2H), 7.21-7.16 (m,
1H), 7.12 (d, 1H, J= 7.3 Hz), 6.98 (dt, 1H, J= 0.9, 7.4 Hz), 6.87-6.83 (m, 2H), 4.13 (dt,
1H, J= 6.6, 10.3 Hz), 3.90-3.82 (m, 1H), 3.78 (s, 3H), 3.52 (t, 1H, J= 7.3 Hz), 3.19-
3.09 (m, 1H), 3.07-2.97 (m, 1H), 2.23-2.12 (m, 1H), 1.82-1.71 (m, 1H), 0.92 (t, 3H, J=
7.3 Hz);
13C NMR (100 MHz, CDCl 3): 6 172.0, 158.8, 143.6, 131.6, 131.3, 129.3, 127.7,
124.6, 123.8, 117.4, 114.3, 55.5, 53.1, 47.9, 28.20, 28.16, 12.6;
IR (film): 1653, 1511, 1481, 1401, 1252, 1178, 1033, 756 cm;
LRMS (EI) for C19H22NO2 (M+H): calcd 296, found 296;
[a]23D +126 (c 1.15, CHCl3); 91% ee, from (SS)-3.
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2-(4-Fluorophenyl)-1-(indolin-1-yl)butan-1-one (Table 8, entry 9). 2-
Chloro-1 -(indolin-1 -yl)butan-1-one (112 mg, 0.50 mmol) and 9-(4-fluorophenyl)-9-
borabicyclo[3.3.1]nonane (166 mg, 0.75 mmol) were used. Solvent system for
chromatography: (1) 7.5% EtOAc in pentane; (2) 1:1 CH 2Cl2:pentane-+CH 2Cl2 (three
times). The product was isolated as a white solid.
Run 1: 101 mg (71% yield, 94% ee). Run 2: 99 mg (70% yield, 93% ee).
The ee was determined on an AS-H column (hexanes:isopropanol 99:1, flow 1.0
mL/min), with enantiomers eluting at 10.7 (major) and 13.1 (minor) min.
'H NMR (400 MHz, CDCl 3): 6 8.31 (d, 1H, J = 8.1 Hz), 7.34-7.28 (m, 2H),
7.23-7.17 (m, 1H), 7.15-7.11 (m, 1H), 7.04-6.97 (m, 3H), 4.15 (dt, 1H, J= 6.6 Hz, J=
10.3 Hz), 3.85 (dt, 1H, J= 6.5 Hz, 10.3 Hz), 3.57 (t, 1H, J= 7.3 Hz), 3.20-3.10 (m, 1H),
3.09-2.99 (m, 1H) 2.24-2.13 (m, 1H), 1.83-1.71 (m, 1H), 0.92 (t, 3H, J= 7.3 Hz);
13C NMR (100 MHz, CDCl 3): 6 171.4, 161.9 (d, J= 244 Hz), 143.2, 135.1 (d, J
= 3.3 Hz), 131.1, 129.7, 127.6, 124.5, 123.8, 117.3, 115.7 (d, J= 21 Hz), 53.0, 47.7,
28.1, 28.0, 12.4;
IR (film): 1653, 1600, 1501, 1482, 1401, 1223, 756;
LRMS (El) for C18H1 9FNO (M+H): calcd 284, found 284;
[a]2 D +131 (c 0.99, CHCl3 ); 94% ee, from (SS)-3.
Eq 32. In a nitrogen-filled glovebox, NiBr 2' diglyme (7.0 mg, 0.032 mmol,
8.0%), ligand (R,R)-1 (15.1 mg, 0.040 mmol, 10%), 2-chloro-1-(indolin-1-yl)propan-1-
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one (83.4 mg, 0.40 mmol), n-tetradecane (60.9 mg, 0.31 mmol, 0.77 equiv; internal
standard), and toluene (2.0 mL) were added to a 10-mL flask. The following materials
were added in turn to a 4-mL vial: KOt-Bu (58.3 mg, 0.52 mmol, 1.3 equiv), i-BuOH
(44.6 mg, 0.60 mmol, 1.5 equiv), Ph-(9-BBN) (119 mg, 0.60 mmol, 1.5 equiv), and
toluene (2.0 mL). The flask and the vial were each capped with a rubber septum, and
the two mixtures were stirred for 10 min. Next, the vessels were removed from the
glovebox and placed in a -5 'C bath, and the mixtures were stirred for 10 min. The
solution in the vial was then transferred by syringe to the slurry in the 10-mL flask,
which was attached to an argon-filled manifold. The reaction mixture was stirred at -
5 'C for 11 h, at which time an aliquot was removed and passed through a plug of silica
(washed with Et 20).
GC analysis showed 86% conversion of the starting material, and HPLC analysis
showed a starting-material ee of 54% and a product ee of 90% (AS-H column
(hexanes:isopropanol 99:1, flow 1.0 mL/min); starting material: 21.5 (major) and 30.4
(minor) min; product: 14.1 (minor) and 18.2 (major) min).
Eq 33 and 34. In a nitrogen-filled glovebox, NiBr2-diglyme (8.8 mg, 0.040
mmol, 8.0%), ligand (SS)-3 (18.8 mg, 0.050 mmol, 10%), 2-chloro-1-(indolin-1-
yl)propan-1-one (105 mg; 0.50 mmol; eq 6: R enantiomer, 95% ee, eq 7: S enantiomer,
95% ee), n-tetradecane (99 mg, 0.50 mmol, 1.0 equiv), and toluene (2.5 mL) were
added to a 10-mL flask. The following materials were added in turn to a 4-mL vial:
KOt-Bu (73 mg, 0.65 mmol, 1.3 equiv), i-BuOH (55.5 mg, 0.75 mmol, 1.5 equiv), Ph-
(9-BBN) (149 mg, 0.75 mmol, 1.5 equiv), and toluene (2.5 mL). The flask and the vial
were each capped with a rubber septum, and the two mixtures were stirred for 10 min.
Next, the vessels were removed from the glovebox and placed in a -5 *C bath, and the
mixtures were stirred for 10 min. The solution in the vial was then transferred by
syringe to the slurry in the 10-mL flask, which was attached to an argon-filled manifold.
The reaction mixture was stirred at -5 'C for 12 h, at which time an aliquot was
removed and passed through a plug of silica (washed with Et 20).
Eq 33: GC analysis showed 67% conversion of the starting material, and HPLC
analysis showed a starting-material ee of 95% and a product ee of 88% (AS-H column
(hexanes:isopropanol 99:1, flow 1.0 mL/min); starting material: 20.7 (major) and 28.3
(minor) min; product: 13.6 (major) and 17.1 (minor) min).
Eq 34: GC analysis showed 67% conversion of the starting material, and HPLC
analysis showed a starting-material ee of 95% and a product ee of 88% (AS-H column
(hexanes:isopropanol 99:1, flow 1.0 mL/min); starting material: 20.7 (minor) and 28.3
(major) min; product: 13.6 (major) and 17.1 (minor) min).
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5. Functionalization Reactions (eq 30 and eq 31) and Assignment of Absolute
Configuration
HO""- Me
Ph
(S)-(-)-2-Phenyl-1-propanol [37778-99-7] (eq 30).72 A solution of n-BuLi
(1.6 M solution in hexanes; 2.44 mL, 3.9 mmol, 3.9 equiv) was added dropwise to a
solution of of diisopropylamine (580 pL, 4.1 mmol, 4.1 equiv) in THF (15 mL) at 0 *C.
The mixture was stirred for 15 min, then ammonia-borane (123 mg, 4.0 mmol, 4.0
equiv) was added. The resulting mixture was stirred at 0 *C for 15 min, and then it was
warmed to room temperature. A solution of (S)- 1 -(indolin- 1 -yl)-2-phenylpropan- 1-one
(recrystallized; >99% ee; 251 mg, 1.0 mmol, 1.0 equiv) in THF (15 mL) was added,
and then the reaction mixture was heated to reflux for 24 h. Next, the mixture was
cooled to 0 *C, and the reaction was quenched by the addition of aqueous HCl (1 M; 20
mL). The layers were separated, and the aqueous layer was extracted with Et2O (10 mL
x 4). The combined organic layers were washed with HCl (1 M; 5 mL), NaOH (3 M; 5
mL), and brine (10 mL). The organic layer was dried over Na2SO 4 and concentrated.
The residue was purified by flash chromatography (10%-+80% Et2O in hexanes),
which furnished the product as a clear, colorless oil.
Run 1: 109 mg (80% yield, >99% ee); Run 2: 116 mg (85% yield, >99% ee).
The ee was determined on an AS-H column (hexanes:isopropanol 99:1, flow 1.0
mL/min), with enantiomers eluting at 17.0 (major) and 18.6 (minor) min.
1H NMR (400 MHz, CDCl3): 6 7.36-7.31 (m, 2H), 7.25-7.22 (m, 3H), 3.74-3.69
(m, 2H), 3.01-2.91 (m, 1H), 1.28 (d, 3H, J= 7.0 Hz);
[a]24 D-13.6 (c 1.00, CHCl3); >99% ee. Lit.44 [a]D -12 (c 1.00, CHCl3 ), 89%
ee (S).
0
Nk hMe
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(S)-1-(1H-Indol-1-yl)-2-phenylpropan-1-one (eq 34). Toluene (7.5 mL) and
DDQ (460 mg, 2.03 mmol, 1.30 equiv) were added to a Schlenk flask that contained
(S)- 1 -(indolin- 1 -yl)-2-phenylpropan-1-one (recrystallized; >99% ee; 392 mg, 1.56
mmol) under argon. The resulting solution was heated to reflux overnight. The
solution was then diluted with EtOAc (15 mL) and washed with water (10 mL). The
aqueous layer was extracted with EtOAc (15 mL), and the combined organic layers
were washed with brine (12 mL), dried over MgSO 4, and concentrated. The residue
was purified by flash chromatography (2%->20% EtOAc in hexanes), which furnished
the product as a white solid (351 mg, 90%).
72 Myers, A. G.; Yang, B. H.; Chen, H.; McKinstry, L.; Kopecky, D. J.; Gleason, J. L. J. Am.
Chem. Soc. 1997, 119, 6496-6511.
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'H NMR (400 MHz, CDC13): 6 8.53 (d, 1H, J = 8.3 Hz), 7.43 (d, 1H, J = 7.8
Hz), 7.34 (d, 1H, J= 3.8 Hz), 7.32-7.22 (m, 5H), 7.21-7.14 (m, 2H), 6.42 (d, 1H, J=
3.8 Hz), 4.35 (q, 1H, J= 6.9 Hz), 1.57 (d, 3H, J= 6.8 Hz);
13C NMR (100 MHz, CDCl 3): 6 172.5, 141.1, 136.1, 130.4, 129.5, 127.6, 127.4,
125.4, 125.1, 124.0, 120.9, 117.1, 109.3, 46.5, 20.5;
IR (film): 1701, 1540, 1451, 1352, 1292, 1208, 910, 750, 700 cm';
LRMS (EI) for C17H15NO (M): caled 249, found 249;
[a] lD +101 (c 0.87, (CH3)2CO); >99% ee, based on the ee of the acid (after
hydrolysis).
0
HO
HO'K Me
Ph
(S)-2-Phenylpropionic acid [7782-24-3] (eq 34). A solution of aqueous H2 0 2
(30% w/w; 1 mL) and LiOH-H20 (192 mg, 4.58 mmol, 3.25 equiv) were added to a
solution of (S)-1-(1H-indol-1-yl)-2-phenylpropan-1-one (351 mg, 1.41 mmol) in THF
(14 mL) and H20 (4 mL) at 0 'C. The resulting suspension was allowed to warm to
room temperature and stirred overnight. Next, the reaction was quenched by the
addition of saturated sodium thiosulfate (8 mL) and saturated sodium bicarbonate (10
mL). The mixture was stirred for 15 min, and then the THF was removed by rotary
evaporation, and the aqueous layer was extracted with CH 2Cl 2 (10 mL). Next, the
aqueous layer was acidified (pH<5) with HCl (1 M) and extracted with EtOAc (15 mL
x 4). The combined organic layers were dried over Na2 SO 4 and concentrated. The
residue was purified by flash chromatography (2%->20% EtOAc in hexanes), which
furnished the product (161 mg, 76%) as a brown oil.
The ee was determined on an AD-H column (hexanes:isopropanol 97:3, flow 1.0
mL/min), with enantiomers eluting at 29.9 (minor) and 34.2 (major) min.
1H NMR (400 MHz, CDCl 3): 6 12.01 (br s, 1H), 7.41-7.36 (m, 4H), 7.36-7.29
(m, 1H), 3.74 (q, 1H, J= 7.2 Hz), 1.52 (d, 3H, J= 7.2 Hz);
[a]'8 D +59 (c 1.01, CHCl3); >99% ee. Lit.73 [a]2 D +72 (c 1.0, CHC13), 96% ee
(S).
HO Et
Ph
(R)-(-)-2-Phenyl-1-butanol [16460-75-6].72 A solution of n-BuLi (1.6 M
solution in hexanes; 0.83 mL, 1.33 mmol, 3.9 equiv) was added dropwise to a solution
of diisopropylamine (200 ptL, 1.43 mmol, 4.2 equiv) in THF (5 mL) at 0 *C. The
mixture was stirred for 15 min, then ammonia-borane (44 mg, 1.2 mmol, 3.5 equiv) was
added. The resulting mixture was stirred at 0 'C for 15 min, and then it was warmed to
room temperature. A solution of (R)- 1 -(indolin- 1 -yl)-2-phenylbutan- 1-one (90% ee; 89
mg, 0.34 mmol, 1.0 equiv) in THF (5 mL) was added, and then the reaction mixture
was heated to reflux for 22 h. Next, the mixture was cooled to 0 *C, and the reaction
was quenched by the addition of aqueous HCl (1 M; 5 mL). The layers were separated,
73 Coulbeck, E.; Eames, J. Tetrahedron: Asymmetry 2008, 19, 2223-2233.
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and the aqueous layer was extracted with Et20 (3 mL x 4). The combined organic
layers were washed with HCl (1 M; 3 mL), NaOH (2 M; 4 mL), and brine (3 mL). The
organic layer was dried over Na2 SO 4 and concentrated. The residue was purified by
flash chromatography (8%-+60% Et2O in hexanes), then washed with HCl (1 M; 3 mL;
to remove an indoline impurity), thereby producing the alcohol as a yellow oil (25 mg,
49%).
The ee was determined to be 90% on an AD-H column (hexanes:isopropanol 99:1, flow
1.0 mL/min), with enantiomers eluting at 14.3 (major) and 15.7 (minor) min.
H NMR (400 MHz, CDCl 3): 3 7.32-7.27 (m, 2H), 7.22-7.16 (m, 3H), 3.75-3.65
(m, 2H), 2.67-2.62 (m, 1H), 1.76-1.68 (m, 1H), 1.62-1.50 (m, 2H), 0.80 (t, 3H, J= 7.4
Hz);
[a]2 D -15.1 (c 0.95, CHCl 3); 90% ee. Lit. [a]2 3D -15.0±2.5 (c 1.00, CHCl3),
92% ee (R);74 [a] 2 2D +18 (c 1.50, CHCl 3), 99% ee (S).44
74 Matsubara, S.; Yamamoto, H.; Oshima, K. Angew. Chem., Int. Ed. 2002, 41, 2837-2840
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Chapter 2
Studies of Boratabenzene-Containing Transition Metal Complexes
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A. Introduction
Phosphines are ubiquitous ligands in homogenous catalysis, and the structural
diversity of this family of compounds spans a wide spectrum of steric and electronic
properties. Various metrics have been established to assess these properties, such as
Tolman's definition of the electronic parameter v as derived from the frequency of a
CO stretch in a [Ni(CO)3PR 3] complex, and the steric parameter 0 as determined by a
phosphine's cone angle.76 However understanding the delicate interplay between these
two properties in a particular phosphine's success or lack thereof as a ligand is not
trivial, as structural modifications often induce both steric and electronic perturbations.
Thus, tools to unambiguously separate the effects of these two properties on reactivity
are of high utility.
To this end, in 1996 Hoic reported the preparation of potassium
diphenylphosphidoboratabenzene (K-DPB, 1), which is isosteric to triphenylphosphine,
yet electronically different as one phenyl ring has been replaced by a negatively
charged boratabenzene ring. 7 7  Once it was established that r-Iphosphorus-bound
transition metal complexes could be prepared (as opposed to DPB-complexes bound
through the 7r-system of the negatively charged boratabenzene ring), 78 the CO
stretching frequency of CpFe(CO)2(DPB) (Cp = cyclopentadienyl) was compared to
those reported for [CpFe(CO) 2(PPh 3)]*, Cp*Fe(CO)2(PPh2) and CpFe(CO)2(SiPh3).
DPB was found to be a less electron-releasing ligand than Ph 2P and Ph3Si-, but, as
's For a review of the properties of phosphine ligands, see: van Leeuwen, P. W. N. M.; Freixa, Z.;
Zuidema, E. In Phosphorus Ligands in Asymmetric Catalysis; B6rner, A., Ed.; Wiley-VCH: Weinheim,
2008, p 1433-1454.
76 Tolman, C. A. Chem. Rev. 1977, 77, 313-348.
77 Hoic, D. A.; Davis, W. M.; Fu, G. C. J. Am. Chem. Soc. 1996, 118, 8176-8177.
78 (DPB)2Sm(THF), in which DPB is bound through the boratabenzne ring, has recently been reported:
Cui, P.; Chen, Y.; Zeng, X.; Sun, J.; Li, G.; Xia, W. Organometallics 2007, 26, 6519-6521.
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expected, a more electron-donating phosphine than PPh3 (Figure 1). However, no
detailed reactivity studies comparing complexes bearing PPh3 versus those bearing
DPB have been reported.
/ B-P
K-DPB (1)
O K&
OC-,Fe' PPh3  OC-,Fe' DPB OC-,Fe' PPh2OC OC OC
Average vco (cm- 1) 2048 2003 1991
Figure 1: Comparison of Pco stretches of CpFe(CO) 2X complexes
OC-,Fe'SiPh3OC
1968
In a subsequent publication, Hoic noted that the analogous potassium
diphenylamidoboratabenzene (K-DAB) did not display the same reactivity with
transition-metal complexes and attributed this to a difference in the degree of 7r-
character in the phosphorus-boron and nitrogen-boron bonds. This hypothesis was
supported by comparison of crystallographic, NMR spectroscopic, and computational
data for the two complexes. 79
In 2009, a collaboration between the Fu and Peters groups began with the aim of
examining reactivity patterns of DPB-bearing complexes. The Peters group has long
79 Hoic, D. A.; DiMare, M.; Fu, G. C. J. A m. Chem. Soc. 1997, 119, 7155-7156.
120
had an interest in phosphine ligands bearing a negatively charged borate moiety.
Accordingly, they have prepared mono-,80 bis-," and tris-chelating8 2 ligands (Figure 2)
and studied the electronic properties of transition metal complexes bearing these
ligands. Therefore, the anionic boratabenzene moiety of DPB was a logical
continuation of this line of research.
PPh 2  PPh2
Ph 2P PPh2  Ph 2P | PPh 2
B BPh2I
®BPh3  Ph
Figure 2: Borate-containing phosphine ligands developed by the Peters group
The goals of this collaboration include: 1. to prepare new transition metal
complexes bearing DPB-type ligands; 2. to study the reactivity of DPB-bearing
transition metal complexes in fundamental reactions such as oxidative additions and
reductive eliminations; and 3. to determine whether DPB can be used to modulate
reactivity of transition metal complexes for novel transformations. Of these three goals,
the work done in this chapter is directed towards the first two. Section B. 1 of this
chapter contains a summary of our efforts toward developing new routes towards DPB-
and boratabenzene containing transition metal complexes, which builds upon the
80 Thomas, C. M.; Peters, J. C. Inorg. Chem. 2004, 43, 8-10.
8 1 (a) Thomas, J. C.; Peters, J. C. J. Am. Chem. Soc. 2001, 123, 5100-5101. (b) Lu, C. C.; Peters, J. C. J.
Am. Chem. Soc. 2002, 124, 5272-5273. (c) Thomas, J. C.; Peters, J. C. Inorg. Chem. 2003, 42, 5055-
5073. (d) Betley, T. A.; Peters, J. C. Angew. Chem., Int. Ed. 2003, 42, 2385-2389. (e)Thomas, J. C.;
Peters, J. C. Polyhedron 2004, 23, 2901-2913. (f) Lu, C. C.; Peters, J. C. J. Am. Chem. Soc. 2004, 126,
15818-15832.
82 (a) Shapiro, I. R.; Jenkins, D. M.; Thomas, J. C.; Day, M. C.; Peters, J. C. Chem. Commun. 2001,
2152-2153. (b) Jenkins, D. M.; Di Bilio, A. J.; Allen, M. J.; Betley, T. A.; Peters, J. C. J. Am. Chem. Soc.
2002, 124, 15336-15350. (c) Betley, T. A.; Peters, J. C. Inorg. Chem. 2003, 42, 5074-5084. (d) MacBeth,
C. E.; Thomas, J. C.; Betley, T. A.; Peters, J. C. Inorg. Chem. 2004, 2004, 4645-4662.
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previously reported work. Section B.2 concerns our studies of di(ortho-
tolyl)phosphido-2-methylboratabenzene (DPBoT, 2), a DPB derivative bearing ortho-
methyl substituents on the boratabenzene and phenyl rings. This section details the
preparation of K-DPBoT, compares its properties to that of K-DPB, and summarizes
our progress towards the synthesis of a DPBoT-containing palladium complex in order
to compare it to its neutral, isosteric variant tri-ortho-tolylphosphine. Tri-ortho-
tolylphosphine has been used by by Hartwig and co-workers in palladium complexes
for their studies on oxidative addition and reductive elimination of aryl halides.8 3 If the
analogous DPBoT-containing complexes can be prepared, similar studies to those of
Hartwig will be conducted with the goal of elucidating information regarding the
reactive properties of DPBoT.
e K E
Me K
/ B-P Me
Me
2
B: Results and Discussion
1. A new route to DPB-containing transition metal complexes
Scheme 1 contains the published synthetic route to the CpFe(CO) 2DPB complex
devised by Hoic.77 Boracycle 3 is prepared by a radical cyclization between Bu 2SnH2
and 1-trimethylsilyl-1,4-pentadiyne to produce the stannacycle precursor, followed by
transmetallation with boron trichloride. The reaction of 3 with trimethylphosphine
83 (a) Hartwig, J. F.; Paul, F. J. Am. Chem. Soc. 1995, 117, 5373-5374. (b) Roy, A. H.; Hartwig, J. F.
Organometallics 2004, 23, 1533-1541.
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leads to aromatization, resulting in the trimethylphosphine-borabenzene adduct 4; 84
substitution of trimethylphosphine by the more strongly donating potassium
diphenylphosphide forms K-DPB 1. Halide displacement of CpFe(CO) 21 with K-DPB,
to generates CpFe(CO)2(DPB) 5.
PMe 3  KPPh 2  ~K CpFe(CO) 21 T
pentane B THF ' THF, -78 C ' O C--Fe s .- BC1 i3 Ph2 OC Ph2
3 4 1 5
Scheme 1: Synthesis of CpFe(CO)2(DPB) (5).
A variety of different Lewis bases are able to effect the aromatization of 3 to
give the respective borabenzene-Lewis base adduct. We were interested in whether a
transition metal-phosphide complex might be capable of performing this
transformation as well, which would open a new route to complexes such as 5.
Whereas CpFe(CO) 2PPh2 is rather unstable and difficult to isolate in pure form, 85
Cp*Fe(CO)2PPh 2 (Cp* = pentamethylcyclopentadienyl) is a crystalline solid. Upon
reaction with 1 equivalent of boracycle 3 at room temperature, the Cp*Fe(CO)2(DPB) 6
forms cleanly (Equation 1). The identity of this complex was confirmed through single
crystal X-ray diffraction (Figure 3).
Cp* Cp* /
B TMS OC-Fes * (1)
i OC/ PPh2  C6H6 , r.t. O Ph2
4 1 equiv 6
84 For mechanistic details, see Hoic, D. A. Synthesis, Structure, and Reactivity of Borabenzene and
Boratabenzene Complexes. Ph.D. Thesis, Massachusetts Institute of Technology, Cambridge, MA, 1998.
85 Although some references report the synthesis of CpFe(CO)2PPh2, others note that it is quite unstable,
and, for their purposes, an in situ preparation is preferable. See: Ashby, M. T.; Enemark, J. H.
Organometallics 1987, 6, 1323-1327.
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Figure 3: Crystal structure of Cp*Fe(CO)2(DPB) (6)
As a comparison, 6 was also prepared from Cp*Fe(CO) 21 and K-DPB (Equation
2). This route required a low reaction temperature, and the product obtained was not as
clean by ' 1P and 1B NMR in this reaction as it was in the reaction in Equation 1.
Therefore, this experiment showcases a new, alternate route to transition metal-DPB
complexes, which may be preferable in cases where the starting transition metal-
diphenylphosphide complex is easily obtained. Furthermore, if a similar transformation
with transition metal-amido complexes is possible, the first examples of transition
metal-'-DAB-type complexes could be prepared.
Cp* Cp*
OC.'Fe, K-DPB OC''Fes -B I (2)
/ I THF,-780 C / POC OC Ph2
6
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2. The Chemistry of Di(ortho-tolyl)phosphido-2-methylboratabenzene
The preparation of potassium di(ortho-tolyl)phosphido-2-methyl-boratabenzene
(DPBoT) is shown in Scheme 2. The synthesis of trimethylphosphine-2-
methylborabenzene adduct 7 was carried out following previously established
procedures from the Fu group, which are similar to those used to make
trimethyphosphine-borabenzene 4. In the same fashion as the conversion of 4 to K-
DPB, K-DPBoT was then prepared through reaction of 7 with potassium di(ortho-
tolyl)phosphide.
MgBr + PhO 2SO K-
Me H
3 mol% CuBr
THF/toluene
68%
PMHS
Bu2SnO 42%
Me H
Bu2SnH 2
LDA, TMSCI
THF, -78 0C
97%
KP(o-tolyl) 2THF
-78 0C to 60 0C
29-51%
TMS
Sn Me
Bu' Bu
BC13
DCM/Hexanes
-78 0C
40%
K+
B Me
P(o-toIyI) 2 .
Scheme 2: Preparation of K-DPBoT
In order to compare the structure of K-DPB, K-DPBoT was complexed with 18-
crown-6 to generate K-DPBoT-18-crown-6 (8), which was crystallized to give the
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toluene
27%
| |
Sn Me
Bu *Bu
B Me
PMe 3
7
TMS
B Me
CI
PMe 3pentane
89%
structure in Figure 4. Free K-DPB is known to crystallize as a long polymer chain of
potassium ions complexed with the boratabenzene ring, but sequestration of the
postassium ion by the crown ether breaks up this chain so as to better approximate the
structures of K-DPB and K-DPBoT as they exist in transition metal complexes.
Figure 2: Crystal structure of K-DPBoT- 1 8-crown-6 (8)
In general, the bond lengths and angles of 8 are similar to those reported for K-
DPB-18-crown-6, although there are a few differences (Tables 1 and 2).79 Although
complexed by the crown ether, the potassium ion shows an interaction with the
negatively-charged boratabenzene ring in both complexes. However, whereas in K-
DPB-18-crown-6 an n5-interaction with the five carbons of the boratabenzene ring is
detected with the crown ether-complexed potassium ion, in complex 8 the potassium
interacts in an n3 fashion with the meta- and para-carbons on the ring. The para-
carbon-potassium bond of 8 is about 0.15 A shorter, the interatomic distance between
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potassium and boron is about 0.61 A larger, and the interatomic distances between
potassium and the ortho carbons are 0.42 A and 0.48 A larger than the analogous
values for K-DPB- 1 8-crown-6. Moreover, the K-Cpara-Cmeta bond angles are slightly
larger in 8 than in K-DPB-18-crown-6. This data indicates that the interaction of the
potassium ion with the boratabenzene has been compromised so that its position is
moved towards the back of the ring away from the ring's center (Figure 5). Presumably
this obstruction to binding with the full boratabenzene ring arises from a steric
interaction between the methyl substituent and the bulky potassium-crown ether
complex.
Table 1: Comparison of interatomic distance data
DPBoT- 18-crown-6
for K-DPB-18-crown-6 and K-
Bond K-DPBoT-18-crown-6 (8) K-DPB-18-crown-6
interatomic distance (A) interatomic distance (A)a
P-B 1.9641(17) 1.968(7)
B-C 1.511(2) (B-C2), 1.513(2) (B-C6) 1.480(8), 1.488(8)
K-B 4.1077(17) 3.498b
K-Cortho 3.9085(14) (K-C6), 3.7270(15) (K-C2) 3.491(6), 3.245(5)
K-Cmeta 3.3708(15) (K-C5), 3.1787(14)(K-C3) 3.341(5), 3.075(5)
K-Cpara 2.9909(14) 3.143(5)
a This data was obtained from reference 79. b This value was obtained by exporting
the .cif file of this crystal structure into Mercury 2.3 and measuring the interatomic
distance.
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Table 2: Comparison of bond angle data for K-DPBoT-18-crown-6 (9) and K-DPB-18-
crown-6
Angle K-DPBoT- 18-crown-6 (8) (0) K-DPB-18-crown-6 (o)a
P-B-C 119.63(11) (P-B-C6), 123.41(12)(P-B-C2) 117.9(4), 126.7(4)
C-B-C 116.74(13) 115.4(5)
K-Cpara-Cmeta 93.06(9) (K-C4-C5), 84.66(8) (K-C4-C3) 74.4(3), 85.7(3)
a This data was obtained from reference 79.
Figure 5: Comparison of the bonding of the
with DPBoT (A. and B.) versus that with DPB
ether-carbons have been deleted for clarity.
crown-ether-complexed potassium ion
(C. and D.).81 In B. and D. the crown
86 In DPB, the distance between the complexed potassium ion and one of the ortho-carbons of the
boratabenzene ring is at the threshold be considered a bond. In Mercury, the program used to generate
Figures 5, this distance was considered above this bonding threshold, but in the original paper, this
interaction was considered below this threshold. Therefore, the potassium--boratabenzene interaction
will be considered to be n5 even though in Figures 5C and 5D it appears as n4.
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To further characterize the structural differences between DPBoT and DPB,
CpFe(CO)2(DPBoT) (9) was prepared and the crystal structure in Figure 6 was obtained.
The P-B bond length is 0.12 A shorter in 9 than in 5, and the B-C bond lengths are
0.07-0.09 A shorter (Table 3).77 The bond angles are roughly equivalent for the two
species (Table 4).
Figure 2: Crystal structure of CpFe(CO) 2(DPBoT) (9)
Table 3: Comparison of bond lengths between CpFe(CO)2(DPBoT) (9) and
CpFe(CO)2(DPB) (5)
Bond CpFe(CO)2(DPBoT) (9) CpFe(CO)2(DPB) (5)
Bond Length (A) Bond Length (A) a
P-B 1.843(2) 1.967(9)
B-C 1.413(3) (B-CMe), 1.396(3) (B-CH) 1.483(12), 1.489(12)
Fe-P 2.3149(6) 2.276(2)
a This data was obtained from reference 77.
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Table 4: Comparison of Bond Angle Data for CpFe(CO)2(DPBoT) (9) and
CpFe(CO)2(DPB) (5)
Angle CpFe(CO)2(DPBoT) (9) (0) CpFe(CO) 2(DPB) (5) (O)a
Fe-P-B 113.65(7) 115.3(3)
P-B-C 122.48(18) (P-B-CMe), 120.4(6), 121.8(6)
118.87(17) (P-B-CH)
C-B-C 118.6(2) 117.8(7)
a This data was obtained from reference 77.
The IR stretching frequency of the CO ligands in 9 further corroborates the near
equivalency of electron donation between DPBoT and DPB in 9 and 5, respectively.
When measured in a dichloromethane solution, the stretching frequency of 9 is only 1
cm-1 less than that of 5; when measured with a KBr pellet, the difference is 3-5 cm-1.
Therefore, any additional electron density conferred to the complex by the presence of
the methyl substituents of DPBoT is minimal. Unfortunately, a direct comparison of
DPBoT to other ligand classes is not possible, as complexes such as CpFe(CO)2P(o-
tolyl)2, CpFe(CO)2P(o-tolyl) 3, and CpFe(CO)2 Si(o-tolyl) 3 are not known. It is expected,
however, that DPBoT would be more electron-releasing than tri-ortho-tolylphosphine,
by analogy to the enhanced electron-releasing character of DPB in comparison with
triphenylphosphine.
Table 5: Comparison of IR stretching data for CO of CpFe(CO) 2(DPBoT) (9) and
CpFe(CO)2(DPB) (5)
IR method v (CO) of 9 (cm- 1) P (CO) of 5 (cm- 1) (cm- )a
CH2Cl 2 solution 1988, 2034 1989, 2035
KBr pellet 1977, 2027 1982, 2024
a This data was obtained from reference 77.
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As previously noted, the goal of the development of DPBoT is to compare its
performance as a ligand against that of tri-ortho-tolylphosphine. One example of a
system suitable for this assessment is oxidative addition of aryl bromides to bis(tri-
ortho-tolylphosphine)palladium 10, which has been studied by Hartwig and co-workers
and has been determined to occur through ligand dissociation to form a monoligated
complex, followed by oxidative addition of the aryl bromide.s3a The increased
electron-releasing character of DPBoT as compared to P(o-Tol)3 may impact these two
steps differently, but should Coulombic repulsion between the two anionic DPBoT
ligands of 11 increase the rate of ligand dissociation relative to that of 10, then the
overall rate of conversion of 11 to 13 should be faster than 10 to 12. In that case, useful
conclusions regarding the perturbation in electronic properties in moving from P(o-
Tol)3 to DPBoT could be drawn.
Ar-Br (o-Tol)3P Br, , Ar
Pd[P(o-Tol) 312  - PdP(o-Tol) 3  Pd' Pd
- P(o-Tol)3  Ar Br P(o-Tol)3
10 12
Pd(DPBoT) 2- 2K+ Pd(DPBoT)- K+ Ar-Br DPBoTA Pd' Br Pd Ar ] 2 PK
- K-DPBoT
11 13
Scheme 3: Comparison of ligand effects of P(o-Tol)3 versus DPBoT in the oxidative
addition of aryl bromides to form dimeric palladium complexes.
To most efficiently prepare 11, we first needed a better understanding of the
reactivity of K-DPBoT towards palladium complexes. Therefore, a number of
commericially available bisphosphinepalladium(O) complexes and palladium(II) salts
were tested in reactions with KDPBoT. Of these, most did not proceed to a productive
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end. However, the reaction of CpPd(allyl) with 2 equiv of KDPBoT at low temperature
generated a relatively clean product that resembled a potential bis(DPBoT)palladium
species by 1H NMR. By "P NMR, it appeared that kinetic product with a resonance at
-16 ppm formed, which gradually converted to a very broad resonance at -29 ppm.
However, the 1H NMR spectrum contained a resonance that corresponded to potassium
cyclopentadienide, implying that the product generation likely proceeded through a
displacement of the organic ligands by DPBoT to give Pd(DPBoT) 2, rather than
reductive elimination of the cyclopentadienyl and allyl ligands followed by K-DPBoT
ligation to give [Pd(DPBoT)2]2-2K*.87 Furthermore, this putative Pd(DPBoT)2 species
did not appear to undergo oxidative addition of the aryl bromide used by Hartwig with
10, further supporting the assignment of a +2 oxidation state to the palladium (Equation
3), although other less sterically hindered aryl halides have not been tried.
Me
Br
t-Bu
CpPd(allyl) K-DPBoT - "Pd(DPBoT)2" no reaction (3)
THF, -60 OC THF
2 equiv
A different precursor complex, (COD)Pd(CH 2TMS)2, which is also known to
react with two equivalents of phosphine to form bisphosphinopalladium(O)
complexes,89 was reacted with 2 equivalents of K-DPBoT to generate a very clean
product by 1H and 3 1P NMR (resonance at -17 ppm; Equation 4). The difference in
87 Tatsuno, Y.; Yoshida, T.; Otsuka, S. Inorg. Synth. 1985, 28, 342-345.
88 Roy, A. H.; Hartwig, J. F. Organometallics 2004, 23, 1533-1541.
8 9 Pan, Y.; Young, G. B. J. Organomet. Chem. 1999, 577, 257-264.
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chemical shift between this species and the final product of the reaction of CpPd(allyl)
implies that this is a different species, potentially the desired [Pd(DPBoT)2]2-2K+.
Studies regarding the identity of this product and its competency in undergoing
oxidative addition of an aryl halide are ongoing.
(COD)Pd(CH 2TMS) 2 K-DPBoT [Pd(DPBoT) 2]2- 2K* (4)
THF, r.t.
2 equiv
C: Conclusions and Outlook
The chemistry of boratabenzene-containing transition metal complexes has been
advanced by some recent findings. A new route has been devised to transition metal
complexes bearing a DPB-type ligand through the reaction of chloroboracycle 3 and a
transition metal-diphenylphosphide complex. This alternative path to these types of
structures reduces the synthetic route by two steps, and may prove to be a useful
entryway when the transition metal-phosphide complex is readily obtained. It may also
be a means to selectively install a DPB ligand without displacement of a halide, which
would expand the scope of DPB-bearing transition metal complexes.
Secondly, a new variant of DPB, DPBoT, has been prepared, characterized, and
shown to be a competent ligand in transition metal complexes. DPBoT contains an
ortho-methyl substituent on each aryl ring, thus making it a negatively charged,
isosteric variant of triorthotolylphosphine. Through analysis of the IR CO stretch of
CpFe(CO)2(DPBoT) versus those of CpFe(CO)2(DPB), we have established that the
electron-releasing properties of DPBoT roughly mimic those of DPB. In order to
compare the reactivity of DPBoT versus triorthotolylphosphine, preliminary studies
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have been conducted on the preparation of a palladium-DPBoT complex. Future work
will include positive identification of the species generated in these reactions, with the
aim of generating the bis(DPBoT)palladium (0) complex 11.
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1. General Information
The following reagents were purchased and used without purification: n-
butyllithium (1.6 M in hexanes, Aldrich), diphenylphosphine (Aldrich), 1-propynyl
magnesium bromide (0.5 M solution, Aldrich), copper(I) bromide (Strem), n-
butyllithium (1.6 M in hexanes, Aldrich), boron trichloride (1.0 M solution in hexanes,
Aldrich), trimethylphosphine (Strem), di(ortho-tolyl)phosphine (Aldrich),
dicarbonylcyclopenta-dienyliron(II) iodide (Aldrich),
Phenyl propargyl sulfonate (Aldrich) was distilled prior to use.
Diisopropylamine (Aldrich) and chlorotrimethylsilane (Alfa Aesar) were distilled from
calcium hydride prior to use.
The following intermediates were prepared according to literature procedures:
dicarbonyliodo(pentamethylcyclopentadienyl)iron(II), 90 (1-chloro-1,4-dihydroborinin-
2-yl)trimethylsilane (boracycle),9 and dibutyltin dihydride.9'
All reactions were carried out in oven-dried glassware under an atmosphere of
argon or nitrogen.
2. Preparation of Compounds
Me5sZ
PPh
2Oc
Dicarbonyl(pentamethylcyclopentadienyl)iron(II) diphenylphosphide
[96013-18-2]. An oven-dried 20-mL vial with a septum cap under argon was charged
with 0.15 mL of a 1.6 M solution of n-BuLi in hexanes (0.25 mmol, 1.0 equiv). This
was then diluted with 0.5 mL toluene, and then diphenylphosphine was added dropwise
at a rate of two drops per second to give a yellow residue that coated the vial. This
suspension was cooled to -78 'C and a solution of 94.4 mg of dicarbonyliodo-
(pentamethylcyclopentadienyl)iron(II) in 2.0 mL toluene was added. The reaction was
stirred overnight as it warmed to room temperature and turned a murky red color. The
reaction was brought into a nitrogen-filled glovebox, and the solution was filtered
through an acrosdisc to give a dark red solution which was then concentrated. The
residue was then taken up in 1.3 mL pentane, filtered through an acrodisc, and placed in
a -60 'C freezer for 2.5 h. The supernatant solution was removed and the red
crystalline solid product was collected (32.7 mg, 30% yield).
94 Diaz, C.; Cabezas, N.; Mendizabal, F. Boletin de la Sociedad Chilena de Quimica 2002, 47, 213-220.
91 Qiao, S.; Hoic, D. A.; Fu, G. C. J. Am. Chem. Soc. 1996, 1996, 6329-6330.
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1H NMR (400 MHz, C6D6): 6 7.91 (ddd, 4H, J = 1.3, 6.2, 8.0 Hz), 7.24-7.18 (m,
4H), 7.12-7.07 (m, 2H), 1.51 (s, 15H);
"P NMR (162 MHz, C6D6): 6 41.1.
Me5
oc -Fep B I
OC Ph2
Dicarbonyl(pentamethylcyclopentadienyl)iron(H) diphenylphosphinobora-
tabenzene (6). In a nitrogen-filled glovebox, 11.9 mg of dicarbonyl(pentamethylcyclo-
pentadienyl)iron(II) diphenylphosphide (0.0275 mmol, 1.0 equiv) was dissolved in 0.3
mL benzene. A solution of 5.5 mg of (1 -chloro- 1,4-dihydroborinin-2-yl)trimethylsilane
(0.0300 mmol, 1.08 equiv) in 0.3 mL benzene as added dropwise. The resulting
solution was shaken, filtered through an acrosdisc, and the product was crystallized by
vapor diffusion with pentane with the exclusion of light to give 11.1 mg (0.0218 mmol,
79%) of the product as a orange solid
'H NMR (400 MHz, THF-d8 ): 6 7.80-7.74 (in, 4H), 7.51-7.45 (m, 1H), 7.32-
7.21 (m, 6H), 7.16-7.04 (m, 1H), 6.79-6.70 (in, 2H), 6.48-6.41 (m, 1H), 1.61 (s, 15H);
3C NMR (100 MHz, THF-d8 ): 6 216.9 (d, J= 19.0 Hz),135.5 (d, J= 9.1 Hz),
133.1 (d, J= 15.1 Hz), 129.7, 129.2, 128.6, 117.3, 99.4, 9.7;
11B NMR (128 MHz, C6D6): a 25.2;
"P NMR (162 MHz, C6D6): 6 26.6.
IR (CH 2Cl2 solution): 3055, 2987, 2013, 1964, 1422, 1263, 896, 765
HRMS (ESI) for C29H3,BFeO2P (M+H): calcd 509.1520, found 509.1504.
Sn Me
Bu' Bu
1,1-dibutyl-2-methyl-1,4-dihydrostannine [56578-02-0]. Copper(I) bromide
(870 mg, 6.1 mmol, 3.0 mol%) was added to an ovendried, three-neck, 1-L flask
equipped with a 50-mL addition funnel, and argon inlet and a septum. The apparatus
was evacuated and backfilled with argon three times. Propynyl magnesium bromide
(405 mL of 0.5 M solution in THF, 202.5 mmol, 1.01 equiv) was measured out into a
flame-dried 500-mL graduated addition funnel, then transferred via canula to the
reaction vessel. The resulting solution was concentrated to about half its volume. The
solution was cooled to 0 *C, and 32 mL of phenylpropargyl sulfonate (200. mmol, 1.00
equiv) was added dropwise with the addition funnel. The reaction was stirred overnight
as it warmed to room temperature, and 72 mL toluene were then added. The solution
was stirred for 2 h and cooled to 0 'C, whereupone a solution of 20 g ammonium
chloride in 200 mL 1 M HCl was added. The resulting suspension was vacuum filtered
and separated in a separatory funnel. The organic layers were washed with 75 mL
saturated sodium bicarbonate, which was then extracted with 5 x 75 mL THF. The
combined organic layers were dried with sodium sulfate and the resulting solution was
weighed. The relative concentration of 1,4-hexadiyne was determined via 1H NMR
analysis to be 0.89 M.
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A 250-mL oven dried Schlenk flask under argon was charged with 69 mL of the
0.89 M 1,4-hexadiyne solution (61.4 mmol, 1.00 equiv) and 14.43 g dibutyltin
dihydride (61.4 mmol, 1.00 equiv). The reaction was heated to 85 *C overnight, and
then cooled to room temperature. The solution was concentrated to about half its
volume, then transferred to a 1 00-mL round bottom flask, at which point all the solvent
was removed. The stannacycle was then distilled (320 mTorr, 82 *C boiling point) to
give 5.69 g (18.2 mmol, 30%) of the product as a yellow oil.
1H NMR (400 MHz, C6D6): 6.72-6.65 (m, 1H), 6.35 (dd, J= 6.9, 8.5 Hz, 1H),
6.18-6.14 (m, 1H), 3.03 (ddd, J= 1.9, 3.8, 5.8 Hz, 2H), 2.11-2.08 (m, 3H), 1.69-1.59
(m, 4H), 1.40 (qd, J= 7.2, 14.4Hz, 4H), 1.08-1.02 (m, 4H), 0.98-0.91 (m, 6H);
"C NMR (100 MHz, C6D6): 145.4, 137.0, 125.3, 36.5, 29.6, 27.3, 27.2, 13.9,
10.0;
HRMS (EI) for C1 4H2 5Sn (M-H): calcd 313.0982, found 313.0969.
TMS
Sn Me
Bu' Bu
(1,1-dibutyl-2-methyl-1,4-dihydrostannin-4-yl)trimethylsilane. Prepared
LDA by addition of 1.94 mL diisopropylamine (14.8 mmol, 1.00 equiv) to an oven
dried 100-mL Schlenk flask charged with 9.26 mL 1.6 M n-BuLi in hexanes (14.8
mmol, 1.00 equiv) and 15 mL THF at 0 'C. The solution was stirred 30 min at 0 'C,
then cooled to -78 'C. The stannacycle was added dropwise over 10 min and the
solution turned red. The mixture was stirred at -78 *C for 1.5 h, and 2.06 mL
chlorotrimethylsilane (16.3 mmol, 1.10 equiv) was added. The solution was swirled
and turned yellow. The reaction was allowed to warm to room temperature overnight.
The solution was then cooled to 0 *C, and 25 mL hexanes and 25 mL water was added.
The layers were separated and the organic layer was washed with 25 mL saturated
sodium bicarbonate solution, 25 mL brine, dried over sodium sulfate, and concentrated
to give 5.35 g of the product as a yellow oil (13.9 mmol, 94% yield).
1H NMR (400 MHz, C6D6): 6.80 (dd, J= 5.3, 13.7 Hz, 1H), 6.32-6.28 (m, 1H),
6.25 (d, J= 13.8 Hz, 1H), 2.93-2.86 (m, 1H), 2.17 (s, 3H), 1.76-1.64 (m, 4H), 1.55-1.35
(m, 4H), 1.19-1.06 (m, 4H), 0.98 (ddd, J= 5.9, 10.8, 14.2 Hz, 6H), 0.08 (s, 9H);
"C NMR (100 MHz, C6D6): 147.0, 138.6, 133.4, 122.3, 43.7, 30.1 (d, J= 24.1
Hz), 28.0 (d, J= 3.0 Hz), 27.9, 14.3 (d, J= 3.0 Hz), 11.7, 10.7, -2.6.
HRMS (El) for C17H35SiSn: calcd 387.1535, found 387.1558.
TMS
B Me
IC1
(1-chloro-2-methyl-1,4-dihydroborinin-4-yl)trimethylsilane. An oven-dried
100-mL 2-neck flask was equipped with an oven-dried short path distillation head with
a pig and 3 oven-dried receiving flasks; this entire apparatus was vacuum-purged and
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placed under argon. Added 5.34 g (1,1-dibutyl-2-methyl-1,4-dihydrostannin-4-
yl)trimethylsilane (13.9 mmol, 1.00 equiv) and purged with vacuum and backfilled with
argon three times. Added 3.5 mL dichloromethane and cooled to -78 *C. Slowly
added 13.9 mL of a 1.0 M boron trichloride solution in hexanes (13.9 mmol, 1.00
equiv) over 15 min, then removed the bath and allowed the solution to warm to room
temperature and stir 2 h. Heated under ambient pressure to remove solvent. Then
distilled under 300 mTorr-250 mTorr at 57 *C (oil bath 85 C). Distilled a second time
to remove residual stannane impurities at 200 mTorr and 35 'C (oil bath 45 C) to give
the 925 mg of the product as a clear colorless oil (4.66 mmol, 34%).
H NMR (400 MHz, C6D6): a 7.08 (d, J= 5.8 Hz, 1H), 6.43 (dd, J= 5.4, 8.4 Hz,
1H), 6.27 (dd, J= 6.1, 8.8 Hz, 1H), 3.41 (d, J= 5.2 Hz, 1H), 2.18 (s, 3H), 0.00 (m, 9H);
"C NMR (100 MHz, C6D6): 8 147.5, 140.5, 123.3, 53.5, 20.2, -0.9;
"B NMR (128 MHz,C 6D6): 6 58.8.
B _ Me
PMe 3
2-Methylborabenzene trimethylphosphine adduct (7). In a nitrogen-filled
glovebox, added 0.43 mL trimethylphosphine (4.15 mmol, 1.0 equiv) slowly to 840 mg
(1-chloro-2-methyl-1,4-dihydroborinin-4-yl)trimethylsilane (4.23 mmol, 1.02 mmol) in
3.5 mL pentane (CAUTION: trimethylphosphine is volatile and an irritant; take care
when using this reagent). The solution stirred overnight as the product precipitated out.
The product was collected via vacuum filtration and washed with pentane to give 640
mg of a pink solid (3.86 mmol, 93% yield).
1H NMR (400 MHz, C6D6): a 7.90-7.81(m, 1H), 7.71 (t, J= 7.1 Hz, 1H), 7.33-
7.28 (m, 1H), 7.07 (dt, J= 1.0, 9.7 Hz, 1H), 2.55 (s, 3H), 0.77 (d, J= 11.1Hz, 9H);
13 C NMR (100 MHz, C6D6 ): 6 136.1 (d, J= 15.1 Hz), 131.7 (d, J= 18.1 Hz),
120.7, 24.8 (d, J= 4.0 Hz), 10.8, (d, J= 41.3 Hz);
"B NMR (128 MHz, CrD6): 6 18.8 (d, J= 106 Hz);
'
1P NMR (162 MHz, C6D6): a -22.3 (q, J= 100 Hz).
e K(D
Me _
/ B-P Me
Me/
Potassium di(ortho-tolyl)phosphido(2-methylboratabenzene(2). In a
nitrogen-filled glovebox, 115 mg of potassium metal (2.94 mmol, 1.3 equiv) was cut
into small pieces and added to a 10-mL round bottom flask, and 3 mL THF was added.
The flask was equipped with a septum. Diorthotolylphosphine (485 mg, 2.26 mmol,
1.00 equiv) was weighed into a 4-mL vial and 2 mL of THF was added. The vial was
capped with a septum cap. The flask and the vial were brought outside the glovebox,
attached to an argon line, and cooled to -78 'C. The phosphine solution was added
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dropwise (1 drop per second) to the potassium suspension. The reaction was stirred at
-78 0C overnight, then allowed to warm to room temperature. The supernatant solution
was decanted off and added via canula to a solution of 2-methylborabenzene
trimethylphosphine adduct (375 mg, 2.26 mmol) in 1.5 mL THF, which had been
prepared in the glovebox. The resulting solution was heated to 60 'C, at which point
the color turned from red to orange. The flask was cooled to room temperature and
brought into the glovebox, and 13 mL of pentane was layer onto the THF solution. The
flask was cooled in the -20 *C freezer overnight, and the precipitate was collected.
This precipitate was extracted with diethyl ether to furnish 216 mg (28%) of the desired
product as a yellow solid.
'H NMR (400 MHz, THF-ds): 6 7.09 (dd, J= 4.5, 6.4 Hz, 2H), 6.99-6.94 (m,
3H,), 6.94-6.86 (m, 3H), 6.80 (t, J= 7.2 Hz, 2H), 6.15 (t, J= 6.9 Hz, 1H), 5.91 (dd, J=
3.6, 9.3 Hz, 1H), 2.32 (s, 6H) ppm 2.08 (s, 3H);
"C NMR (100 MHz, THF-ds): 6 143.4 (d, J= 15.1 Hz), 142.7 (d, J= 21.1 Hz),
135.8 (d, J= 3.0 Hz), 134.2 (d, J= 7.0 Hz), 131.32, 131.26, 129.6, 129.5, 126.1, 125.6,
113.2, 24.7 (d, J= 7.0 Hz), 22.6 (d, J= 20.1 Hz);
"B NMR (128 MHz, THF-d8): 6 31.4;
"P NMR (162 MHz, THF-d8): 6 55.0.
0 K. 1 8-crown-6
Me /
/ B-P Me
Me
Potassium di(ortho-tolyl)phosphido(2-methylboratabenzene) 18-crown-6
adduct (8). In a nitrogen-filled glovebox, a solution of 31.7 mg 18-crown-6 (0.120
mmol, 1.1 equiv) in 1 mL THF was added to 37.5 mg potassium di(ortho-
tolyl)phosphido(2-methylboratabenzene) powder (0.109 mmol) in a 20-mL vial. The
vial was shaken until all solid had dissolved, and the solution was then passed through
an acrodisc. Crystallization was induced by vapor diffusion with hexanes.
'H NMR (400 MHz, THF-d8): 6 7.26-7.19 (m, 2H), 6.94-6.88 (m, 2H), 6.88-6.72 (m,
6H), 6.01 (t, J= 7.0 Hz, 1H), 5.82 (dd, J= 4.5, 9.6 Hz, 1H), 3.47 (s, 24H), 2.30 (s, 6H),
2.05 (s, 3H);
13C NMR (100 MHz, THF-d8): 6 143.7 (d, J= 17.1 Hz), 143.0 (d, J= 19.1 Hz),
136.1 (d, J= 3.0 Hz), 133.7 (d, J= 8.0 Hz), 130.8, 130.7, 129.23, 129.19, 125.5, 125.2,
112.9, 22.8 (d, J= 18.1 Hz);
"B NMR (128 MHz, THF-d8): 6 +30.0;
31P NMR (162 MHz, THF-d8): 6 -50.3.
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OC /\ Me
o-To o-Tol
Dicarbonyl(cyclopentadienyl)iron(II)di(ortho-tolyl)phosphido(2-methyl)-
borata-benzene (9). A solution of 15.4 mg dicarbonylcyclopentadienyliron(II) iodide
(0.050 mmol, 1.0 mmol) in 0.5 mL THF and a solution of 17.3 mg potassium di(ortho-
tolyl)phosphido(2-methylboratabenzene) (0.05 mmol) in 1.25 mL THF were both
cooled to -78 *C. The K-DPBoT solution was added to the Fp-I solution, and the
resulting reaction was allowed to warm to room temperature overnight, under the
exclusion of light. The solution was brought into the glovebox, filtered through an
acrodisc, and the product was crystallized by vapor diffusion with hexanes to give 13.5
mg of the product as an orange crystalline solid (56%).
H NMR (400 MHz, THF-d8 ): 6 8.25-8.16 (in, 2H), 8.34-8.23 (m, 4H), 7.14-
7.05 (m, 3H), 6.95-6.86 (m, 1H), 6.38-6.31 (m, 1H), 5.93-5.84 (m, 1H), 2.29 (s, 3H),
1.88 (s, 6H);
13C NMR (100 MHz, THF-d8): 6 221.8, 143.6, 137.4 (d, J= 16.1 Hz), 137.0 (d,
J= 14.1 Hz), 135.5, 135.2, 132.6 (d, J= 6.0 Hz), 131.2 (d, J= 16.1 Hz), 130.7 (d, J=
3.0 Hz), 129.1 (d, J= 11.1 Hz), 126.5 (12.1 Hz), 117.7, 91.0, 23.4, 14.7;
"B NMR (128 MHz, THF-d8): 6 27.8;
"P NMR (162 MHz, THF-ds): 6 16.9.
IR (CH 2Cl2 solution): 3052, 2987, 2034, 1988, 1421, 1275, 896, 767, 667, 641.
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Table 1. Crystal data and structure refinement for 6 (D8_10094_0m)
Identification code d8_10094_Om
Empirical formula C29 H30 B Fe 02 P
Formula weight 508.16
Temperature 100(2) K
Wavelength 1.54178 A
Crystal system Orthorhombic
Space group Pbca
Unit cell dimensions a = 16.5519(2) A
b = 16.8541(2) A
c = 18.1903(2) A
Volume 5074.50(10) A,
Density (calculated)
Absorption coefficient
F(000)
Crystal size
Theta range for data collection
Index ranges
Reflections collected
Independent reflections
Completeness to theta = 63.690
Absorption correction
Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2sigma(I)]
R indices (all data)
Largest diff. peak and hole
1.330 Mg/m3
5.542 mm'
2128
0.40 x 0.40 x 0.05 mm3
4.46 to 63.690.
-19<=h<=19, -19<=k<=19, -21<=I<=16
91136
4172 [R(int) = 0.0673]
99.9%
None
0.7691 and 0.2153
Full-matrix least-squares on F2
4172 / 0 / 312
1.061
RI = 0.0326, wR2 = 0.0790
RI = 0.0366, wR2 = 0.0828
0.497 and -0.366 e.A-3
150
a= 900.
D3= 900.
y=90.
Table 2. Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (A2x 103)
for D8_10094_0m. U(eq) is defined as one third of the trace of the orthogonalized Ui tensor.
x y z U(eq)
Fe(1)
P(2)
0(1)
C(5)
C(7)
0(2)
C(25)
C(1)
C(4)
C(3)
C(26)
C(6)
C(2)
C(10)
C(18)
C(24)
B(1)
C(27)
C(13)
C(30)
C(20)
C(28)
C(14)
C(22)
C(8)
C(21)
C(23)
C(17)
C(9)
C(16)
C(12)
2175(1)
3346(1)
1766(1)
1671(1)
1973(1)
1257(1)
3234(1)
1944(1)
2527(1)
2702(1)
3938(1)
1330(1)
1645(1)
1212(1)
3963(1)
3344(1)
3863(2)
3901(1)
4076(1)
2491(1)
4750(1)
3156(1)
4727(1)
4533(2)
3492(1)
5041(1)
3701(2)
4484(2)
3095(1)
5118(2)
1876(2)
2321(1)
2948(1)
2014(1)
1188(1)
2058(1)
3769(1)
3644(1)
2162(1)
1158(1)
1688(1)
3944(1)
1749(1)
3226(1)
671(1)
1926(1)
4060(1)
3611(1)
4513(1)
2238(1)
3935(1)
3777(1)
4804(1)
1967(1)
4729(1)
1772(1)
4320(1)
4605(1)
1350(1)
584(1)
1076(1)
2596(2)
3791(1)
4101(1)
5321(1)
3605(1)
2667(1)
3539(1)
4884(1)
4730(1)
3477(1)
2883(1)
5211(1)
3113(1)
3664(1)
4124(1)
5188(1)
2833(1)
3359(1)
5761(1)
4482(1)
5128(1)
3341(1)
5989(1)
4066(1)
2350(1)
2494(1)
2829(1)
2361(1)
5462(1)
3833(1)
5034(2)
2014(1)
14(1)
15(1)
35(1)
18(1)
21(1)
26(1)
17(1)
22(1)
19(1)
21(1)
21(1)
19(1)
19(1)
24(1)
26(1)
24(1)
19(1)
23(1)
20(1)
22(1)
23(1)
24(1)
24(1)
29(1)
30(1)
26(1)
30(1)
34(1)
30(1)
35(1)
33(1)
151
C(29)
C(1 1)
C(15)
2455(1)
448(1)
5243(1)
4516(1)
1924(1)
1385(1)
5673(1)
3036(1)
4340(1)
25(1)
27(1)
31(1)
152
Table 3. Bond lengths [A] and angles [0] for D8_10094_0m.
Fe(1)-C(1) 1.771(2)
Fe(1)-C(2) 1.775(2)
Fe(1)-C(6) 2.100(2)
Fe(1)-C(5) 2.112(2)
Fe(1)-C(7) 2.119(2)
Fe(l)-C(4) 2.123(2)
Fe(l)-C(3) 2.151(2)
Fe(1)-P(2) 2.2776(6)
P(2)-C(13) 1.835(2)
P(2)-C(25) 1.854(2)
P(2)-B(l) 1.951(2)
O(1)-C(l) 1.142(3)
C(5)-C(6) 1.419(3)
C(5)-C(4) 1.437(3)
C(5)-C(10) 1.492(3)
C(7)-C(3) 1.414(3)
C(7)-C(6) 1.436(3)
C(7)-C(12) 1.504(3)
O(2)-C(2) 1.141(3)
C(25)-C(30) 1.396(3)
C(25)-C(26) 1.403(3)
C(4)-C(3) 1.431(3)
C(4)-C(9) 1.496(3)
C(3)-C(8) 1.494(3)
C(26)-C(27) 1.388(3)
C(6)-C(1 1) 1.496(3)
C(18)-C(17) 1.390(3)
C(18)-C(13) 1.400(3)
C(24)-C(23) 1.390(3)
C(24)-B(1) 1.492(3)
B(l)-C(20) 1.495(3)
C(27)-C(28) 1.389(3)
C(13)-C(14) 1.394(3)
C(30)-C(29) 1.395(3)
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C(20)-C(21)
C(28)-C(29)
C(14)-C(15)
C(22)-C(21)
C(22)-C(23)
C(17)-C(16)
C(16)-C(15)
C(1)-Fe(1)-C(2)
C(1)-Fe(1)-C(6)
C(2)-Fe(1)-C(6)
C(1)-Fe(1)-C(5)
C(2)-Fe(1)-C(5)
C(6)-Fe(1)-C(5)
C(1)-Fe(1)-C(7)
C(2)-Fe(1)-C(7)
C(6)-Fe(1)-C(7)
C(5)-Fe(1)-C(7)
C(1)-Fe(1)-C(4)
C(2)-Fe(1)-C(4)
C(6)-Fe(1)-C(4)
C(5)-Fe(1)-C(4)
C(7)-Fe(1)-C(4)
C(1)-Fe(1)-C(3)
C(2)-Fe(1)-C(3)
C(6)-Fe(1)-C(3)
C(5)-Fe(1)-C(3)
C(7)-Fe(1)-C(3)
C(4)-Fe(1)-C(3)
C(1)-Fe(1)-P(2)
C(2)-Fe(1)-P(2)
C(6)-Fe(1)-P(2)
C(5)-Fe(1)-P(2)
C(7)-Fe(1)-P(2)
C(4)-Fe(1)-P(2)
C(3)-Fe(1)-P(2)
1.391(3)
1.383(3)
1.394(3)
1.393(3)
1.394(3)
1.385(4)
1.381(4)
98.59(10)
110.59(9)
89.37(9)
86.06(9)
124.14(9)
39.37(8)
149.79(9)
88.64(9)
39.80(8)
65.99(8)
100.26(9)
153.40(9)
66.48(8)
39.66(8)
65.83(8)
138.81(9)
121.79(9)
65.86(8)
65.66(8)
38.66(8)
39.11(8)
90.90(7)
93.11(7)
157.75(6)
142.67(6)
118.11(6)
105.15(6)
94.37(6)
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C(13)-P(2)-C(25)
C(1 3)-P(2)-B(1)
C(25)-P(2)-B(1)
C(13)-P(2)-Fe(1)
C(25)-P(2)-Fe(1)
B(1)-P(2)-Fe(1)
C(6)-C(5)-C(4)
C(6)-C(5)-C(10)
C(4)-C(5)-C(10)
C(6)-C(5)-Fe(1)
C(4)-C(5)-Fe(1)
C(10)-C(5)-Fe(1)
C(3)-C(7)-C(6)
C(3)-C(7)-C(12)
C(6)-C(7)-C(12)
C(3)-C(7)-Fe(1)
C(6)-C(7)-Fe(1)
C(12)-C(7)-Fe(1)
C(30)-C(25)-C(26)
C(30)-C(25)-P(2)
C(26)-C(25)-P(2)
O(1)-C(1)-Fe(1)
C(3)-C(4)-C(5)
C(3)-C(4)-C(9)
C(5)-C(4)-C(9)
C(3)-C(4)-Fe(1)
C(5)-C(4)-Fe(1)
C(9)-C(4)-Fe(1)
C(7)-C(3)-C(4)
C(7)-C(3)-C(8)
C(4)-C(3)-C(8)
C(7)-C(3)-Fe(1)
C(4)-C(3)-Fe(1)
C(8)-C(3)-Fe(1)
C(27)-C(26)-C(25)
C(5)-C(6)-C(7)
100.86(9)
110.24(10)
102.29(9)
110.58(7)
113.48(7)
117.84(7)
108.34(18)
125.77(19)
125.73(19)
69.89(11)
70.61(11)
128.87(15)
108.38(18)
125.3(2)
125.9(2)
71.89(12)
69.39(11)
130.72(15)
118.05(19)
123.70(15)
118.05(15)
175.43(19)
107.40(18)
127.1(2)
124.9(2)
71.50(11)
69.73(11)
130.80(15)
108.24(18)
125.0(2)
126.4(2)
69.45(11)
69.39(11)
132.12(15)
121.2(2)
107.60(18)
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C(5)-C(6)-C(1 1) 125.42(19)
C(7)-C(6)-C(1 1) 126.78(19)
C(5)-C(6)-Fe(1) 70.74(11)
C(7)-C(6)-Fe(1) 70.82(11)
C(11)-C(6)-Fe(1) 127.91(15)
O(2)-C(2)-Fe(1) 173.49(18)
C(17)-C(18)-C(13) 120.6(2)
C(23)-C(24)-B(1) 119.1(2)
C(24)-B(1)-C(20) 117.2(2)
C(24)-B(1)-P(2) 118.79(17)
C(20)-B(1)-P(2) 123.60(17)
C(26)-C(27)-C(28) 119.9(2)
C(14)-C(13)-C(18) 118.5(2)
C(14)-C(13)-P(2) 121.12(17)
C(18)-C(13)-P(2) 120.29(17)
C(29)-C(30)-C(25) 120.7(2)
C(21)-C(20)-B(1) 118.5(2)
C(29)-C(28)-C(27) 119.8(2)
C(15)-C(14)-C(13) 120.7(2)
C(21)-C(22)-C(23) 120.9(2)
C(20)-C(2 1)-C(22) 122.4(2)
C(24)-C(23)-C(22) 121.9(2)
C(16)-C(17)-C(18) 120.1(2)
C(15)-C(16)-C(17) 120.1(2)
C(28)-C(29)-C(30) 120.4(2)
C(1 6)-C(1 5)-C(14) 120.0(2)
Symmetry transformations used to generate equivalent atoms:
156
Table 4. Anisotropic displacement parameters (A2x 103) for D8_10094_0m. The anisotropic
displacement factor exponent takes the form: -27r 2[ h2 a*2U 1 +. + 2 h k a* b* U12 ]
U11 U22 U33 U23 U13 U12
Fe(1)
P(2)
0(1)
C(5)
C(7)
0(2)
C(25)
C(1)
C(4)
C(3)
C(26)
C(6)
C(2)
C(10)
C(18)
C(24)
B(1)
C(27)
C(13)
C(30)
C(20)
C(28)
C(14)
C(22)
C(8)
C(21)
C(23)
C(17)
C(9)
C(16)
C(12)
15(1)
15(1)
52(1)
21(1)
28(1)
24(1)
22(1)
26(1)
20(1)
23(1)
20(1)
19(1)
18(1)
27(1)
28(1)
23(1)
23(1)
25(1)
20(1)
21(1)
24(1)
32(1)
23(1)
38(1)
26(1)
24(1)
37(1)
40(1)
25(1)
32(1)
46(2)
16(1)
16(1)
38(1)
15(1)
23(1)
22(1)
16(1)
19(1)
14(1)
23(1)
22(1)
22(1)
22(1)
22(1)
25(1)
30(1)
18(1)
24(1)
16(1)
24(1)
21(1)
24(1)
21(1)
30(1)
36(1)
29(1)
34(1)
26(1)
19(1)
20(1)
37(1)
12(1)
14(1)
15(1)
18(1)
12(1)
31(1)
13(1)
21(1)
23(1)
17(1)
21(1)
16(1)
17(1)
23(1)
26(1)
20(1)
15(1)
21(1)
24(1)
19(1)
22(1)
18(1)
29(1)
18(1)
28(1)
24(1)
18(1)
34(1)
46(2)
52(2)
16(1)
-1(1)
-1(1)
-2(1)
-4(1)
-4(1)
0(1)
0(1)
-4(1)
-7(1)
-10(1)
-1(1)
-4(1)
-2(1)
2(1)
2(1)
-2(1)
-4(1)
0(1)
-1(1)
-2(1)
-6(1)
-6(1)
-3(1)
-1(1)
-12(1)
-12(1)
3(1)
9(1)
-4(1)
2(1)
3(1)
-1(1)
-1(1)
6(1)
-2(1)
-4(1)
-4(1)
-1(1)
-2(1)
-1(1)
4(1)
-1(1)
-5(1)
0(1)
0(1)
-7(1)
-1(1)
2(1)
-6(1)
-6(1)
-2(1)
-2(1)
-1(1)
-6(1)
5(1)
8(1)
8(1)
-5(1)
-18(1)
-8(1)
-22(1)
-5(1)
0(1)
0(1)
-15(1)
-3(1)
-5(1)
4(1)
0(1)
-6(1)
0(1)
-4(1)
2(1)
-3(1)
-4(1)
-6(1)
-2(1)
-3(1)
-1(1)
-2(1)
-1(1)
-3(1)
2(1)
-2(1)
0(1)
-9(1)
-8(1)
-6(1)
-2(1)
-5(1)
2(1)
3(1)
-10(1)
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C(29)
C(1 1)
C(15)
23(1)
21(1)
23(1)
29(1)
27(1)
24(1)
22(1)
33(1)
46(2)
-4(1)
-1(1)
-6(1)
4(1)
-8(1)
-9(1)
2(1)
-1(1)
4(1)
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Table 5. Hydrogen coordinates ( x 104)
for D8_10094Om.
and isotropic displacement parameters (A2x 10 3)
x y z U(eq)
H(26)
H(1OA)
H(1OB)
H(1OC)
H(18)
H(24)
H(27)
H(30)
H(20)
H(28)
H(14)
H(22)
H(8A)
H(8B)
H(8C)
H(21)
H(23)
H(17)
H(9A)
H(9B)
H(9C)
H(16)
H(12A)
H(12B)
H(12C)
H(29)
H(11A)
H(11B)
H(1 IC)
H(15)
4449
752
1567
1016
3528
2776
4383
2005
5107
3129
4819
4757
3451
3914
3630
5606
3368
4404
3023
2980
3652
5468
2366
1413
1784
1945
194
377
194
5681
3753
967
507
201
2109
3974
4703
3735
3518
5199
2182
5098
1539
1497
2336
4416
4901
1143
58
556
762
676
2914
2949
2277
4714
1517
2446
1924
1200
5053
4323
4527
3862
5483
2821
5982
4920
3671
6360
3590
2012
2001
2773
2452
2806
2036
5942
3613
4361
3758
5219
1951
2093
1571
5829
2728
2807
3523
4049
159
160
Table 7. Crystal data and structure refinement
Identification code
Empirical formula
Formula weight
Temperature
Wavelength
Crystal system
Space group
Unit cell dimensions
Volume
for 8 (10143_0m).
10143_Om
C32 H45 B K 06 P
606.56
100(2) K
0.71073 A
Monoclinic
P2(1)/n
a = 9.6729(12) A
b = 13.4593(17) A
c = 25.290(3) A
3253.6(7) A3
Density (calculated)
Absorption coefficient
F(000)
Crystal size
Theta range for data collection
Index ranges
Reflections collected
Independent reflections
Completeness to theta = 29.13'
Absorption correction
Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2sigma(I)]
R indices (all data)
Largest diff. peak and hole
1.238 Mg/m3
0.253 mm- 1
1296
0.35 x 0.25 x 0.20 mm3
1.63 to 29.130.
-13<=h<=13, -18<=k<=18, -34<=1<=33
49382
8766 [R(int) = 0.0411]
99.9 %
Semi-empirical from equivalents
0.9511 and 0.9167
Full-matrix least-squares on F2
8766 / 529 / 403
1.028
RI = 0.0405, wR2 = 0.0964
RI = 0.0540, wR2 = 0.1053
0.733 and -0.651 e.A-3
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a=90'.
p= 98.825(2)0.
y = 9 0 .
Table 8. Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (A2 x 103)
for 10143_0m. U(eq) is defined as one third of the trace of the orthogonalized Uij tensor.
x y z U(eq)
K(1)
P(2)
B(1)
C(2)
C(3)
C(4)
C(5)
C(6)
C(19)
C(7)
C(8)
C(9)
C(10)
C(1 1)
C(12)
C(20)
C(13)
C(14)
C(15)
C(16)
C(17)
C(18)
C(21)
C(13A)
C(14A)
C(15A)
C(16A)
C(17A)
C(18A)
C(21A)
C(1C)
4887(1)
5407(1)
6027(2)
5234(2)
5708(2)
6895(2)
7653(2)
7288(2)
8177(2)
6718(1)
7899(2)
8902(2)
8730(2)
7573(2)
6573(1)
5365(2)
3924(2)
4066(2)
2953(2)
1649(2)
1473(2)
2586(2)
2368(2)
3855(11)
2757(13)
1394(13)
1029(16)
1962(14)
3523(12)
4552(15)
1194(2)
8390(1)
7668(1)
8486(1)
9385(1)
9890(1)
9583(1)
8740(1)
8170(1)
7270(1)
7812(1)
8418(1)
8489(1)
7967(1)
7359(1)
7259(1)
6560(1)
8400(1)
9023(1)
9581(1)
9512(1)
8879(2)
8324(1)
7686(1)
8093(9)
7730(9)
7974(10)
8637(11)
9069(11)
8798(9)
9355(11)
8533(1)
1530(1)
3724(1)
3162(1)
2919(1)
2498(1)
2295(1)
2497(1)
2916(1)
3100(1)
4329(1)
4344(1)
4800(1)
5257(1)
5253(1)
4795(1)
4809(1)
3928(1)
4376(1)
4504(1)
4189(1)
3750(1)
3611(1)
3114(1)
3712(5)
3327(6)
3293(5)
3664(6)
4029(6)
4060(5)
4433(6)
1756(1)
24(1)
26(1)
25(1)
26(1)
28(1)
30(1)
29(1)
27(1)
36(1)
22(1)
28(1)
34(1)
34(1)
28(1)
22(1)
30(1)
22(1)
29(1)
33(1)
32(1)
29(1)
26(1)
34(1)
22(2)
24(3)
36(3)
29(3)
32(3)
22(2)
34(3)
40(1)
162
C(2C)
O(3C)
C(4C)
C(5C)
O(6C)
C(7C)
C(8C)
O(9C)
C(1OC)
C(1 1C)
O(12C)
C(13C)
C(14C)
O(15C)
C(16C)
C(17C)
O(18C)
1383(2)
2833(1)
3104(2)
4658(2)
5269(1)
6727(2)
7280(2)
7197(1)
7655(2)
7663(2)
6273(1)
6230(2)
4731(2)
4038(1)
2585(2)
1899(2)
1907(1)
7430(1)
7216(1)
6176(1)
6020(1)
6315(1)
6068(1)
6402(1)
7463(1)
7858(1)
8970(1)
9316(1)
10376(1)
10704(1)
10274(1)
10509(1)
10059(1)
9006(1)
1719(1)
1863(1)
1930(1)
2058(1)
1603(1)
1663(1)
1170(1)
1144(1)
678(1)
720(1)
712(1)
756(1)
678(1)
1082(1)
992(1)
1429(1)
1373(1)
39(1)
30(1)
33(1)
31(1)
26(1)
28(1)
29(1)
27(1)
32(1)
34(1)
26(1)
33(1)
34(1)
31(1)
36(1)
38(1)
33(1)
163
Table 9. Bond lengths [A] and angles [0] for 10143_0m.
K(1)-O(3C)
K(1)-O(6C)
K(1)-O(15C)
K(1)-O(9C)
K(1)-O(12C)
K(1)-O(18C)
K(1)-C(4)
K(1)-C(3)
K(1)-C(5)
K(1)-C(5C)
P(2)-C(13A)
P(2)-C(7)
P(2)-C(13)
P(2)-B(1)
B(1)-C(2)
B(1)-C(6)
C(2)-C(3)
C(3)-C(4)
C(4)-C(5)
C(5)-C(6)
C(6)-C(19)
C(7)-C(8)
C(7)-C(12)
C(8)-C(9)
C(9)-C(10)
C(10)-C(1 1)
C(1 1)-C(12)
C(12)-C(20)
C(13)-C(14)
C(13)-C(18)
C(14)-C(15)
C(15)-C(16)
C(16)-C(17)
C(17)-C(18)
2.7687(11)
2.8198(11)
2.8461(11)
2.8587(11)
2.9115(10)
2.9669(11)
2.9909(14)
3.1787(14)
3.3708(15)
3.4786(16)
1.602(11)
1.8417(14)
1.8761(19)
1.9641(17)
1.511(2)
1.513(2)
1.398(2)
1.391(2)
1.403(2)
1.397(2)
1.516(2)
1.4002(18)
1.4168(18)
1.393(2)
1.384(2)
1.385(2)
1.3976(19)
1.5057(18)
1.401(3)
1.417(2)
1.391(2)
1.389(3)
1.389(3)
1.400(3)
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C(18)-C(21)
C(13A)-C(18A)
C(13A)-C(14A)
C(14A)-C(15A)
C(15A)-C(16A)
C(16A)-C(17A)
C(17A)-C(18A)
C(18A)-C(21A)
C(1C)-0(18C)
C(1C)-C(2C)
C(2C)-0(3C)
0(3C)-C(4C)
C(4C)-C(5C)
C(5C)-O(6C)
O(6C)-C(7C)
C(7C)-C(8C)
C(8C)-O(9C)
O(9C)-C(1OC)
C(1OC)-C(1 1C)
C(1 1C)-O(12C)
O(12C)-C(13C)
C(13C)-C(14C)
C(14C)-O(15C)
0(15C)-C(16C)
C(16C)-C(17C)
C(17C)-0(18C)
0(3C)-K(1)-0(6C)
0(3C)-K(1)-0(15C)
0(6C)-K(1)-0(15C)
0(3C)-K(1)-0(9C)
0(6C)-K(1)-0(9C)
0(15C)-K(1)-0(9C)
0(3C)-K(1)-0(12C)
0(6C)-K(1)-0(12C)
0(15C)-K(1)-0(12C)
1.510(3)
1.367(17)
1.413(19)
1.349(17)
1.380(19)
1.322(19)
1.543(18)
1.468(18)
1.422(2)
1.502(3)
1.4233(18)
1.4285(19)
1.503(2)
1.4286(17)
1.4341(16)
1.500(2)
1.4303(17)
1.4249(18)
1.501(2)
1.4203(18)
1.4325(18)
1.499(2)
1.4281(19)
1.4250(19)
1.501(2)
1.424(2)
60.49(3)
116.95(3)
159.33(3)
119.29(3)
59.23(3)
116.49(3)
152.92(3)
113.62(3)
58.14(3)
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O(9C)-K(1)-O(12C) 58.35(3)
O(3C)-K(1)-O(18C) 58.16(3)
O(6C)-K(1)-O(18C) 113.62(3)
O(15C)-K(1)-O(18C) 58.87(3)
O(9C)-K(1)-O(18C) 150.57(3)
O(12C)-K(1)-O(18C) 109.25(3)
O(3C)-K(1)-C(4) 122.32(4)
O(6C)-K(1)-C(4) 115.04(4)
O(15C)-K(1)-C(4) 84.17(4)
O(9C)-K(1)-C(4) 89.49(4)
O(12C)-K(1)-C(4) 84.59(4)
O(18C)-K(1)-C(4) 117.23(4)
O(3C)-K(1)-C(3) 103.55(4)
O(6C)-K(1)-C(3) 124.28(3)
O(15C)-K(1)-C(3) 76.33(3)
O(9C)-K(1)-C(3) 115.09(4)
O(12C)-K(1)-C(3) 100.81(4)
O(18C)-K(1)-C(3) 92.75(4)
C(4)-K(1)-C(3) 25.82(4)
O(3C)-K(1)-C(5) 112.69(4)
O(6C)-K(1)-C(5) 90.52(3)
O(15C)-K(1)-C(5) 108.21(4)
O(9C)-K(1)-C(5) 74.56(3)
O(12C)-K(1)-C(5) 93.14(3)
O(18C)-K(1)-C(5) 134.79(3)
C(4)-K(1)-C(5) 24.56(4)
C(3)-K(1)-C(5) 43.55(4)
O(3C)-K(1)-C(5C) 43.01(3)
O(6C)-K(1)-C(5C) 23.35(3)
O(15C)-K(1)-C(5C) 159.78(4)
O(9C)-K(1)-C(5C) 80.20(3)
O(12C)-K(1)-C(5C) 136.78(3)
0(18C)-K(1)-C(5C) 100.94(4)
C(4)-K(1)-C(5C) 108.45(4)
C(3)-K(1)-C(5C) 108.00(4)
C(5)-K(1)-C(5C) 86.53(4)
166
C(13A)-P(2)-C(7)
C(13A)-P(2)-C(13)
C(7)-P(2)-C(13)
C(13A)-P(2)-B(1)
C(7)-P(2)-B(1)
C(13)-P(2)-B(1)
C(2)-B(1)-C(6)
C(2)-B(1)-P(2)
C(6)-B(1)-P(2)
C(3)-C(2)-B(1)
C(4)-C(3)-C(2)
C(4)-C(3)-K(1)
C(2)-C(3)-K(1)
C(3)-C(4)-C(5)
C(3)-C(4)-K(1)
C(5)-C(4)-K(1)
C(6)-C(5)-C(4)
C(6)-C(5)-K(1)
C(4)-C(5)-K(1)
C(5)-C(6)-B(1)
C(5)-C(6)-C(19)
B(1)-C(6)-C(19)
C(8)-C(7)-C(12)
C(8)-C(7)-P(2)
C(12)-C(7)-P(2)
C(9)-C(8)-C(7)
C(10)-C(9)-C(8)
C(9)-C(10)-C(1 1)
C(10)-C(1 1)-C(12)
C(11)-C(12)-C(7)
C(1 1)-C(12)-C(20)
C(7)-C(12)-C(20)
C(14)-C(13)-C(18)
C(14)-C(13)-P(2)
C(1 8)-C(13)-P(2)
C(15)-C(14)-C(13)
120.1(5)
20.7(5)
100.05(7)
100.1(4)
107.16(6)
103.65(7)
116.74(13)
123.41(12)
119.63(11)
119.53(14)
121.49(13)
69.52(8)
101.90(9)
121.38(14)
84.66(8)
93.06(9)
122.81(14)
102.04(9)
62.38(8)
118.01(13)
118.39(14)
123.60(14)
117.93(12)
122.54(10)
119.47(10)
121.55(13)
120.00(13)
119.57(13)
121.28(13)
119.62(12)
118.73(12)
121.64(12)
117.94(16)
123.57(13)
118.49(14)
121.93(17)
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C(16)-C(15)-C(14)
C(15)-C(16)-C(17)
C(16)-C(17)-C(18)
C(17)-C(18)-C(13)
C(17)-C(18)-C(21)
C(1 3)-C(1 8)-C(2 1)
C(18A)-C(13A)-C(14A)
C(1 8A)-C(13A)-P(2)
C(14A)-C(13A)-P(2)
C(15A)-C(14A)-C(13A)
C(14A)-C(15A)-C(16A)
C(17A)-C(16A)-C(15A)
C(16A)-C(17A)-C(18A)
C(13A)-C(18A)-C(21A)
C(13A)-C(18A)-C(17A)
C(21A)-C(18A)-C(17A)
0(18C)-C(1C)-C(2C)
0(3C)-C(2C)-C(1C)
C(2C)-0(3C)-C(4C)
C(2C)-0(3C)-K(1)
C(4C)-0(3C)-K(1)
0(3C)-C(4C)-C(5C)
0(6C)-C(5C)-C(4C)
0(6C)-C(5C)-K(1)
C(4C)-C(5C)-K(1)
C(5C)-0(6C)-C(7C)
C(5C)-0(6C)-K(1)
C(7C)-0(6C)-K(1)
0(6C)-C(7C)-C(8C)
0(9C)-C(8C)-C(7C)
C(10C)-0(9C)-C(8C)
C(10C)-0(9C)-K(1)
C(8C)-0(9C)-K(1)
O(9C)-C(10C)-C(1 IC)
0(12C)-C(1 1C)-C(1OC)
C(1 1C)-O(12C)-C(13C)
119.81(17)
119.33(18)
121.58(19)
119.37(17)
119.85(16)
120.72(16)
117.3(10)
123.2(9)
119.5(10)
125.7(12)
117.6(13)
122.7(14)
119.3(14)
124.5(11)
117.1(11)
118.3(12)
108.90(13)
107.98(13)
112.57(12)
122.12(9)
117.94(8)
108.75(12)
108.13(12)
51.48(6)
84.80(8)
111.86(11)
105.17(8)
110.74(8)
108.21(11)
108.23(11)
112.81(11)
118.55(8)
117.49(8)
108.24(13)
109.35(12)
111.38(11)
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C(1 1C)-0(12C)-K(1) 112.86(8)
C(13C)-0(12C)-K(1) 110.42(8)
O(12C)-C(13C)-C(14C) 108.79(12)
0(15C)-C(14C)-C(13C) 109.64(12)
C(16C)-0(15C)-C(14C) 110.87(11)
C(16C)-0(15C)-K(1) 118.54(9)
C(14C)-0(15C)-K(1) 120.50(8)
O(15C)-C(16C)-C(17C) 109.29(12)
0(18C)-C(17C)-C(16C) 108.58(12)
C(1C)-0(18C)-C(17C) 111.57(12)
C(1C)-O(18C)-K(1) 110.28(9)
C(17C)-0(18C)-K(1) 106.54(9)
Symmetry transformations used to generate equivalent atoms:
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Table 10. Anisotropic displacement parameters (A2 x 103) for 10143_Om. The anisotropic
displacement factor exponent takes the form: -272[ h2 a*2 UI 1 + + 2 h k a* b* U 12 ]
Ull U22 U33 U23 U13 U12
K(1)
P(2)
B(1)
C(2)
C(3)
C(4)
C(5)
C(6)
C(19)
C(7)
C(8)
C(9)
C(10)
C(1 1)
C(12)
C(20)
C(13)
C(14)
C(15)
C(16)
C(17)
C(18)
C(21)
C(1C)
C(2C)
O(3C)
C(4C)
C(5C)
O(6C)
C(7C)
C(8C)
25(1)
30(1)
34(1)
30(1)
38(1)
44(1)
37(1)
38(1)
47(1)
23(1)
32(1)
30(1)
30(1)
30(1)
20(1)
26(1)
25(1)
27(1)
35(1)
30(1)
25(1)
28(1)
37(1)
33(1)
27(1)
27(1)
42(1)
44(1)
29(1)
31(1)
28(1)
20(1)
20(1)
20(1)
21(1)
19(1)
26(1)
28(1)
21(1)
26(1)
21(1)
30(1)
44(1)
46(1)
35(1)
23(1)
31(1)
19(1)
30(1)
30(1)
29(1)
32(1)
25(1)
38(1)
55(1)
53(1)
29(1)
27(1)
26(1)
26(1)
24(1)
28(1)
28(1)
24(1)
20(1)
26(1)
24(1)
18(1)
21(1)
20(1)
33(1)
22(1)
23(1)
29(1)
24(1)
20(1)
24(1)
32(1)
22(1)
28(1)
34(1)
39(1)
30(1)
23(1)
24(1)
35(1)
37(1)
33(1)
32(1)
24(1)
21(1)
26(1)
29(1)
-2(1)
4(1)
-1(1)
0(1)
1(1)
0(1)
-7(1)
-4(1)
-3(1)
2(1)
3(1)
0(1)
2(1)
5(1)
2(1)
6(1)
2(1)
-3(1)
-4(1)
6(1)
8(1)
6(1)
0(1)
3(1)
-2(1)
-5(1)
-3(1)
4(1)
4(1)
3(1)
-1(1)
3(1)
-4(1)
-3(1)
-3(1)
-7(1)
-2(1)
2(1)
-3(1)
0(1)
3(1)
6(1)
4(1)
-2(1)
5(1)
6(1)
8(1)
3(1)
2(1)
8(1)
13(1)
1(1)
1(1)
-6(1)
14(1)
9(1)
7(1)
13(1)
7(1)
2(1)
-2(1)
1(1)
-1(1)
-4(1)
-3(1)
-2(1)
-2(1)
-6(1)
-2(1)
1(1)
9(1)
-1(1)
-10(1)
-15(1)
-7(1)
-1(1)
0(1)
-5(1)
-3(1)
-2(1)
0(1)
2(1)
-6(1)
-7(1)
-7(1)
14(1)
-4(1)
-3(1)
-8(1)
0(1)
2(1)
6(1)
8(1)
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O(9C)
C(1OC)
C(1 IC)
O(12C)
C(13C)
C(14C)
O(15C)
C(16C)
C(17C)
O(18C)
30(1)
26(1)
25(1)
29(1)
48(1)
56(1)
45(1)
50(1)
48(1)
37(1)
27(1)
41(1)
42(1)
24(1)
25(1)
22(1)
27(1)
33(1)
41(1)
38(1)
25(1)
30(1)
35(1)
25(1)
24(1)
22(1)
20(1)
24(1)
27(1)
27(1)
3(1)
6(1)
9(1)
2(1)
2(1)
3(1)
2(1)
-1(1)
-3(1)
-3(1)
5(1)
9(1)
4(1)
2(1)
0(1)
0(1)
1(1)
3(1)
7(1)
9(1)
3(1)
5(1)
-5(1)
-3(1)
-10(1)
3(1)
10(1)
19(1)
22(1)
11(1)
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Table 11. Hydrogen coordinates ( x 104) and isotropic
for 10143_0m.
displacement parameters (A2 x 10 3)
x y z U(eq)
H(2)
H(3)
H(4)
H(5)
H(19A)
H(19B)
H(19C)
H(8)
H(9)
H(10)
H(11)
H(20A)
H(20B)
H(20C)
H(14)
H(15)
H(16)
H(17)
H(21A)
H(21B)
H(21C)
H(14A)
H(15A)
H(16A)
H(17A)
H(21D)
H(21E)
H(21F)
H(1C1)
H(1C2)
4420
5207
7200
8449
8796
7568
8740
8020
9704
9400
7457
5478
5343
4487
4948
3085
884
575
2849
1365
2746
3001
709
68
1675
4859
4124
5360
186
1577
9606
10455
9951
8551
7120
6699
7411
8789
8895
8026
7003
6219
6068
6936
9066
10009
9893
8822
7986
7637
7020
7275
7699
8790
9542
8950
9970
9519
8701
8767
172
3052
2347
2014
2343
2839
3134
3449
4035
4798
5572
5567
5156
4522
4759
4600
4807
4273
3539
2840
2979
3201
3069
3024
3658
4269
4751
4539
4258
1685
2121
H(2C1)
H(2C2)
H(4C1)
H(4C2)
H(5C1)
H(5C2)
H(7C1)
H(7C2)
H(8C1)
H(8C2)
H(1OA)
H(10B)
H(11A)
H(11B)
H(13A)
H(13B)
H(14B)
H(14C)
H(16B)
H(16C)
H(17B)
H(17C)
838
1049
2727
2641
5049
4865
6853
7241
8263
6718
7016
8606
8254
8060
6720
6705
4684
4260
2147
2458
2414
925
7084
7199
5816
5916
6423
5312
5341
6403
6185
6108
7645
7613
9178
9261
10685
10587
11438
10494
10244
11239
10252
10302
1964
1350
1598
2225
2374
2142
1710
1982
1184
848
354
651
1056
416
482
1114
697
320
641
989
1783
1403
173
174
Table 1. Crystal data and structure refinement
Identification code
Empirical formula
Formula weight
Temperature
Wavelength
Crystal system
Space group
Unit cell dimensions
Volume
for 10160_0m.
10160_Om
C30 H32 B Fe O2 P
522.29
180(2) K
0.71073 A
Triclinic
P-1
a = 8.8096(8) A
b = 11.7362(10) A
c = 13.5372(12) A
1305.5(2) A3
a= 70.9550(10)0.
p= 83.4600(10) .
y = 81.5780(10)0.
Density (calculated)
Absorption coefficient
F(000)
Crystal size
Theta range for data collection
Index ranges
Reflections collected
Independent reflections
Completeness to theta = 30.500
Absorption correction
Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2sigma(I)]
R indices (all data)
Largest diff. peak and hole
1.221 Mg/m3
0.659 mm-1
500
0.50 x 0.15 x 0.10 mm3
1.60 to 30.500.
-12<=h<=12, -16<=k<=16, -19<=l<=19
29041
7837 [R(int) = 0.0484]
98.3 %
Semi-empirical from equivalents
0.9371 and 0.7342
Full-matrix least-squares on F2
7837 / 356 / 329
1.082
RI = 0.0519, wR2 = 0.1504
RI = 0.0767, wR2 = 0.1703
0.883 and -0.644 e.A-3
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Table 2. Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (A2x 103)
for 10160_0m. U(eq) is defined as one third of the trace of the orthogonalized U'i tensor.
x y z U(eq)
Fe(1)
P(1)
C(1)
C(2)
C(3)
C(4)
C(5)
C(6)
C(7)
B(8)
C(9)
C(10)
C(1 1)
C(12)
C(13)
C(14)
C(15)
C(16)
C(17)
C(18)
C(19)
C(20)
C(21)
C(22)
C(23)
C(24)
C(25)
C(26)
C(27)
0(1)
C(28)
9223(1)
11631(1)
12755(3)
13935(3)
14781(3)
14481(4)
13362(3)
12480(3)
11374(3)
11577(3)
10185(3)
10050(3)
11342(3)
12746(3)
12901(3)
14495(3)
12747(3)
13218(3)
13962(3)
14249(3)
13812(3)
13084(3)
12747(3)
7983(3)
6988(3)
7529(3)
8855(3)
9162(3)
8479(3)
7870(2)
9992(3)
3894(1)
3373(1)
2228(2)
2631(3)
1869(3)
675(3)
261(3)
1003(2)
424(3)
2661(2)
2756(2)
2259(2)
1640(3)
1539(3)
2051(2)
1924(3)
4813(2)
5082(2)
6102(2)
6889(2)
6690(2)
5692(2)
5624(3)
5486(2)
4832(2)
4744(3)
5328(2)
5789(2)
2488(2)
1638(2)
3511(2)
2580(1)
3236(1)
2696(2)
1922(2)
1424(2)
1688(3)
2460(2)
2990(2)
3871(3)
4669(2)
5259(2)
6343(2)
6853(2)
6285(2)
5197(2)
4654(2)
2921(2)
3842(2)
3680(2)
2691(2)
1809(2)
1846(2)
788(2)
1657(2)
2454(2)
3426(2)
3224(2)
2133(2)
3171(2)
3508(2)
1450(2)
24(1)
22(1)
27(1)
43(1)
43(1)
55(1)
43(1)
34(1)
47(1)
20(1)
29(1)
35(1)
42(1)
40(1)
31(1)
38(1)
33(1)
28(1)
33(1)
35(1)
34(1)
29(1)
38(1)
38(1)
37(1)
38(1)
39(1)
38(1)
36(1)
60(1)
32(1)
176
10416(2) 3268(2)0(2)
C(1A)
C(3A)
C(2A)
C(4A)
C(5A)
C(6A)
C(5B)
C(3B)
C(2B)
C(1B)
C(6B)
C(4B)
9290(20)
11090(30)
10040(30)
8430(30)
8200(20)
10870(20)
8840(20)
11210(30)
10240(20)
9070(40)
8038(18)
10420(30)
940(15)
-610(20)
-600(30)
-850(20)
279(19)
550(20)
781(17)
-420(30)
-1349(13)
-450(30)
-40(20)
647(19)
10003(18)
10200(30)
9430(20)
10150(20)
10429(15)
10180(30)
10466(18)
10430(30)
10438(12)
9570(20)
10350(12)
10080(30)
177
70(5)
91(8)
135(11)
123(9)
93(8)
70(6)
78(5)
110(10)
79(5)
146(15)
80(6)
110(10)
709(2) 46(1)
Table 3. Bond lengths [A] and angles [0] for 10160_0m.
Fe(1)-C(28) 1.767(3)
Fe(1)-C(27) 1.769(3)
Fe(1)-C(26) 2.099(3)
Fe(1)-C(25) 2.105(3)
Fe(1)-C(22) 2.106(3)
Fe(1)-C(23) 2.106(2)
Fe(1)-C(24) 2.110(2)
Fe(1)-P(1) 2.3149(6)
P(1)-B(8) 1.843(2)
P(1)-C(1) 1.846(2)
P(1)-C(15) 1.981(3)
C(1)-C(2) 1.405(4)
C(1)-C(6) 1.411(3)
C(2)-C(3) 1.376(4)
C(3)-C(4) 1.386(4)
C(4)-C(5) 1.370(4)
C(5)-C(6) 1.399(4)
C(6)-C(7) 1.495(4)
B(8)-C(9) 1.396(3)
B(8)-C(13) 1.413(3)
C(9)-C(10) 1.389(3)
C(10)-C(11) 1.381(4)
C(1 1)-C(12) 1.392(4)
C(12)-C(13) 1.396(4)
C(13)-C(14) 1.520(4)
C(15)-C(16) 1.496(3)
C(15)-C(20) 1.510(4)
C(16)-C(17) 1.392(3)
C(17)-C(18) 1.376(4)
C(18)-C(19) 1.393(4)
C(19)-C(20) 1.400(3)
C(20)-C(2 1) 1.524(4)
C(22)-C(23) 1.401(4)
C(22)-C(26) 1.424(4)
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C(23)-C(24)
C(24)-C(25)
C(25)-C(26)
C(27)-O(1)
C(28)-O(2)
C(1A)-C(5A)
C(1A)-C(6A)
C(3A)-C(6A)
C(3A)-C(2A)
C(2A)-C(4A)
C(4A)-C(5A)
C(5B)-C(6B)
C(5B)-C(4B)
C(3B)-C(4B)
C(3B)-C(2B)
C(2B)-C(1B)
C(1B)-C(6B)
C(28)-Fe(1)-C(27)
C(28)-Fe(1)-C(26)
C(27)-Fe(1)-C(26)
C(28)-Fe(1)-C(25)
C(27)-Fe(1)-C(25)
C(26)-Fe(1)-C(25)
C(28)-Fe(1)-C(22)
C(27)-Fe(1)-C(22)
C(26)-Fe(1)-C(22)
C(25)-Fe(1)-C(22)
C(28)-Fe(1)-C(23)
C(27)-Fe(1)-C(23)
C(26)-Fe(1)-C(23)
C(25)-Fe(1)-C(23)
C(22)-Fe(1)-C(23)
C(28)-Fe(1)-C(24)
C(27)-Fe(1)-C(24)
C(26)-Fe(1)-C(24)
1.416(4)
1.396(4)
1.407(4)
1.138(3)
1.139(3)
1.28(2)
1.42(2)
1.33(2)
1.47(2)
1.64(3)
1.48(2)
1.330(19)
1.43(3)
1.31(2)
1.47(2)
1.65(3)
1.48(3)
93.01(12)
104.74(12)
155.24(11)
142.85(12)
123.88(12)
39.09(11)
91.05(11)
124.84(11)
39.58(10)
65.53(11)
114.17(11)
91.21(11)
65.95(10)
65.54(10)
38.86(10)
153.26(11)
90.99(12)
65.46(11)
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C(25)-Fe(1)-C(24)
C(22)-Fe(1)-C(24)
C(23)-Fe(1)-C(24)
C(28)-Fe(1)-P(1)
C(27)-Fe(1)-P(1)
C(26)-Fe(1)-P(1)
C(25)-Fe(1)-P(1)
C(22)-Fe(1)-P(1)
C(23)-Fe(1)-P(1)
C(24)-Fe(1)-P(1)
B(8)-P(1)-C(1)
B(8)-P(1)-C(1 5)
C(1)-P(1)-C(15)
B(8)-P(1)-Fe(1)
C(1)-P(1)-Fe(1)
C(15)-P(1)-Fe(1)
C(2)-C(1)-C(6)
C(2)-C(1)-P(1)
C(6)-C(1)-P(1)
C(3)-C(2)-C(1)
C(2)-C(3)-C(4)
C(5)-C(4)-C(3)
C(4)-C(5)-C(6)
C(5)-C(6)-C(1)
C(5)-C(6)-C(7)
C(1)-C(6)-C(7)
C(9)-B(8)-C(1 3)
C(9)-B(8)-P(1)
C(13)-B(8)-P(1)
C(10)-C(9)-B(8)
C(1 1)-C(10)-C(9)
C(10)-C(1 1)-C(12)
C(11)-C(12)-C(13)
C(12)-C(13)-B(8)
C(12)-C(13)-C(14)
B(8)-C(13)-C(14)
38.68(11)
65.29(11)
39.26(11)
89.61(8)
98.95(9)
98.31(7)
88.82(7)
136.09(8)
153.69(8)
115.85(8)
105.02(11)
106.09(11)
110.53(10)
113.65(7)
109.79(7)
111.52(8)
118.8(2)
116.66(19)
124.50(18)
121.4(3)
119.9(3)
119.3(3)
122.6(3)
117.9(2)
117.6(2)
124.4(2)
118.6(2)
118.87(17)
122.48(18)
122.5(2)
118.6(2)
120.1(2)
121.8(2)
118.3(2)
117.7(2)
124.0(2)
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C(16)-C(15)-C(20)
C(16)-C(15)-P(1)
C(20)-C(15)-P(1)
C(17)-C(16)-C(15)
C(18)-C(17)-C(16)
C(1 7)-C(1 8)-C(19)
C(18)-C(19)-C(20)
C(19)-C(20)-C(15)
C(19)-C(20)-C(21)
C(15)-C(20)-C(21)
C(23)-C(22)-C(26)
C(23)-C(22)-Fe(1)
C(26)-C(22)-Fe(1)
C(22)-C(23)-C(24)
C(22)-C(23)-Fe(1)
C(24)-C(23)-Fe(1)
C(25)-C(24)-C(23)
C(25)-C(24)-Fe(1)
C(23)-C(24)-Fe(1)
C(24)-C(25)-C(26)
C(24)-C(25)-Fe(1)
C(26)-C(25)-Fe(1)
C(25)-C(26)-C(22)
C(25)-C(26)-Fe(1)
C(22)-C(26)-Fe(1)
O(1)-C(27)-Fe(1)
O(2)-C(28)-Fe(1)
C(5A)-C(1A)-C(6A)
C(6A)-C(3A)-C(2A)
C(3A)-C(2A)-C(4A)
C(5A)-C(4A)-C(2A)
C(1A)-C(5A)-C(4A)
C(3A)-C(6A)-C(1A)
C(6B)-C(5B)-C(4B)
C(4B)-C(3B)-C(2B)
C(3B)-C(2B)-C(1B)
117.6(2)
116.45(18)
125.88(19)
119.5(2)
121.6(2)
121.1(2)
123.8(2)
116.3(2)
115.5(2)
128.1(2)
108.2(2)
70.59(14)
69.96(14)
107.6(2)
70.55(14)
70.50(14)
108.3(2)
70.47(14)
70.24(14)
108.6(2)
70.85(15)
70.23(15)
107.3(2)
70.68(15)
70.46(15)
173.3(2)
176.7(2)
123.8(17)
101.7(18)
101.9(17)
97.0(13)
111.1(15)
105.7(15)
113.2(17)
108.7(17)
96.6(15)
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C(6B)-C(1B)-C(2B) 93.8(16)
C(5B)-C(6B)-C(1B) 99.7(17)
C(3B)-C(4B)-C(5B) 118(2)
Symmetry transformations used to generate equivalent atoms:
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Table 4. Anisotropic displacement parameters (A2x 103) for 10160_0m. The anisotropic
displacement factor exponent takes the form: -2E2[ h2 a*2Ul +... + 2 h k a* b* U12 ]
U11 U22 U33 U23 U13 U12
Fe(1)
P(1)
C(1)
C(2)
C(3)
C(4)
C(5)
C(6)
C(7)
B(8)
C(9)
C(10)
C(1 1)
C(12)
C(13)
C(14)
C(15)
C(16)
C(17)
C(18)
C(19)
C(20)
C(21)
C(22)
C(23)
C(24)
C(25)
C(26)
C(27)
0(1)
C(28)
18(1)
18(1)
21(1)
42(1)
42(1)
62(2)
42(1)
31(1)
43(2)
21(1)
32(1)
42(1)
56(2)
44(2)
31(1)
28(1)
25(1)
25(1)
27(1)
27(1)
26(1)
20(1)
34(1)
32(1)
18(1)
31(1)
37(1)
27(1)
26(1)
41(1)
25(1)
29(1)
24(1)
29(1)
40(1)
40(1)
52(2)
40(1)
30(1)
28(1)
20(1)
29(1)
35(1)
43(2)
40(2)
31(1)
43(2)
32(1)
29(1)
34(1)
26(1)
28(1)
30(1)
44(2)
39(1)
42(1)
41(1)
36(1)
28(1)
36(1)
43(1)
39(1)
27(1)
24(1)
30(1)
44(1)
44(1)
49(2)
44(1)
40(1)
65(2)
19(1)
29(1)
29(1)
27(1)
35(1)
33(1)
40(1)
41(1)
32(1)
45(1)
55(2)
42(1)
34(1)
32(1)
35(1)
48(2)
39(1)
49(2)
55(2)
45(2)
88(2)
33(1)
-10(1)
-7(1)
-9(1)
-14(1)
-14(1)
-25(2)
-14(1)
-11(1)
-9(1)
-4(1)
-10(1)
-10(1)
-5(1)
-5(1)
-8(1)
-8(1)
-10(1)
-11(1)
-21(1)
-15(1)
-2(1)
-6(1)
-2(1)
-5(1)
-12(1)
-14(1)
-24(1)
-9(1)
-10(1)
-8(1)
-13(1)
-3(1)
-3(1)
-4(1)
2(1)
2(1)
1(1)
2(1)
-9(1)
6(1)
-4(1)
-3(1)
4(1)
-6(1)
-16(1)
-9(1)
-12(1)
-3(1)
-2(1)
-1(1)
-1(1)
-1(1)
-5(1)
-6(1)
-7(1)
-7(1)
2(1)
-12(1)
-2(1)
-3(1)
-2(1)
-6(1)
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-2(1)
-4(1)
0(1)
2(1)
2(1)
16(2)
2(1)
1(1)
-8(1)
-7(1)
-10(1)
-14(1)
-16(1)
-6(1)
-6(1)
0(1)
-4(1)
-4(1)
-5(1)
-5(1)
-4(1)
-2(1)
-10(1)
6(1)
4(1)
8(1)
8(1)
0(1)
-4(1)
-18(1)
-2(1)
64(1) 37(1) -27(1)
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O(2) 44(1)
-2(1) -2(1)
Table 5. Hydrogen coordinates ( x 104) and isotropic displacement parameters (A2x 10 3)
for 10160_Om.
x y z U(eq)
H(2)
H(3)
H(4)
H(5)
H(7A)
H(7B)
H(7C)
H(9)
H(10)
H(11)
H(12)
H(14A)
H(14B)
H(14C)
H(16)
H(17)
H(18)
H(19)
H(21A)
H(21B)
H(21C)
H(22)
H(23)
H(24)
H(25)
H(26)
H(1A1)
H(1A2)
H(3A1)
H(3A2)
14152
15571
15045
13177
10718
10733
11946
9296
9090
11272
13624
15272
14662
14580
13010
14280
14753
14021
12308
12013
13704
7888
6109
7069
9450
10000
9033
9209
10805
12171
3446
2161
149
-562
-24
1052
-138
3176
2342
1284
1110
1740
2686
1265
4560
6259
7580
7265
6425
5036
5368
5693
4506
4354
5403
6221
1691
1181
-1159
-850
1739
900
1336
2644
3630
4110
4452
4906
6726
7593
6647
5165
4098
4348
4532
4266
2608
1143
357
895
433
926
2360
4099
3738
1778
10199
9236
10904
9990
51
51
66
51
71
71
71
35
42
51
48
58
58
58
34
40
42
41
57
57
57
45
44
46
46
46
84
84
110
110
185
H(2A1)
H(2A2)
H(4A1)
H(4A2)
H(5A1)
H(5A2)
H(6A1)
H(6A2)
H(5B1)
H(5B2)
H(3B1)
H(3B2)
H(2B1)
H(2B2)
H(1B1)
H(1B2)
H(6B1)
H(6B2)
H(4B1)
H(4B2)
10399
9939
7595
8555
7204
8174
11531
11114
8797
8366
11507
12156
9701
10832
9575
8560
7022
7896
10459
10956
-1250
192
-912
-1588
740
77
1043
621
707
1604
-558
-469
-1694
-2010
216
-893
338
-704
880
1237
9107
8869
9742
10769
10195
11200
9602
10847
11218
10088
11145
9968
11131
10200
9040
9215
10082
11013
9311
10257
162
162
148
148
112
112
84
84
94
94
132
132
95
95
175
175
96
96
132
132
186
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